EP0777667A1

EP0777667A1 - Cyclic benzazepine urea derivatives with aggregation-inhibiting effect

Info

Publication number: EP0777667A1
Application number: EP95929874A
Authority: EP
Inventors: Frank Himmelsbach; Volkhard Austel; Helmut Pieper; Johannes Weisenberger; Brian Guth
Original assignee: Dr Karl Thomae GmbH
Current assignee: Boehringer Ingelheim Pharma GmbH and Co KG
Priority date: 1994-08-17
Filing date: 1995-08-16
Publication date: 1997-06-11
Also published as: AU3345995A; CO4410324A1; MX9700020A; CA2197789A1; IL114980A0; WO1996005194A1; DE4429079A1; JPH10504298A

Abstract

Cyclic urea derivatives having the general formula (I), in which R1 to R9, Ra, Rb, A, D, E and F have the definitions given in the first claim, their tautomers, their stereoisomers, including their mixtures and their salts, in particular their physiologically acceptable salts with inorganic or organic acids or bases, have valuable pharmacological and other properties, preferably aggregation-inhibiting effects. Also disclosed are medicaments containing said compounds, their use and a process for producing the same.

Description

BENZAZEPINE CYCLIC UREA DERIVATIVES WITH AGGREGATE ION-INHIBITING EFFECT

The invention relates to cyclic urea derivatives of the general formula

their tautomers, their stereoisomers including their mixtures and their salts, in particular their physiologically tolerable salts with inorganic or organic acids or bases, which, inter alia, have valuable pharmacological properties, preferably anti-aggregation effects, medicaments containing these compounds , their use and process for their manufacture.

In the above general formula I means that

(i) A is a straight-chain alkylene group with 2 to 3 carbon atoms substituted by one or two alkyl groups, in which a methylene group can be replaced by a carbonyl group, or a -CH-N group in which the hydrogen atom is replaced by an alkyl group ,

(ii) at least one of the radicals R _] _ to Rg has no hydrogen atom, (iii) R _{9 is} a cyclopropyl group, an alkenyl group with 3 to 6 carbon atoms substituted by an aryl group or an alkynyl group with 3 to 6 carbon atoms optionally substituted by an aryl group, a heteroarylalkyl group with 1 to 3 carbon atoms in the alkyl part, a 2, 2,2- trifluoroethyl group, an alkyl group which is substituted by an alkoxy, cyano, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, amino, alkylamino, dialkylamino, alkylcarbonylamino, N-alkylalkylcarbonylamino, Alkylsulfonylamino- or N-alkyl-alkylsulfonylamino group is substituted, an alkyl group with 2 to 4 carbon atoms, which is substituted by a carboxy or alkoxycarbonyl group, or an alkyl group with 3 or 4 carbon atoms, which is substituted by a hydroxy group ,

(iv) D is a cycloalkylene group with 5 to 7 carbon atoms, optionally substituted by one or two alkyl groups, in which a> CH unit is replaced by a nitrogen atom and, moreover, one each in the 5- to 7-membered rings mentioned above a methylene group adjacent to a nitrogen atom can be replaced by a carbonyl group,

(v) E is a -CONH-alkylene, -CON (alkyl) alkylene, -NHCO-alkylene or -N (alkyl) C0-alkylene group, the alkylene part of the above-mentioned groups in each case by one or two alkyl ¬ groups or can be substituted by an aryl or heteroaryl group, or an -N (Ri ₄ ) alkylene group, the alkyl part additionally having one or two alkyl groups each having 1 to 6 carbon atoms, one Alkenyl or alkynyl group each having 2 to 4 carbon atoms, by a hydroxy, amino, aryl or heteroaryl group, by an alkoxy or alkylamino group each having 1 to 6 carbon atoms, by a dialkylamino group having a total of 2 to 8 carbon atoms , can be substituted by an HNR ₁₃ - or N-alkyl-N τ_ ₃ group, (vi) R _{a is} not a hydrogen atom

represent, wherein at least one of the above conditions (i) to (vi) must be met, those in which

A is a straight-chain alkylene or alkenylene group each having 2 to 3 carbon atoms, which can additionally be substituted by one or two alkyl groups, by a trifluoromethyl, aryl or arylalkyl group and in which a methyl group can additionally be replaced by a carbonyl group ,

a 1,2-cycloalkylene or 1,2-cycloalkenylene group each having 5 to 7 carbon atoms, each of which can be substituted by one or two alkyl groups,

a 1,2-arylene group,

a -CO-NH or - H-CO group, in which the hydrogen atom can in each case be replaced by an alkyl, aryl or arylalkyl group, or a -CH = N or -N-CH group, in which the hydrogen atom can in each case be replaced by an alkyl, trifluoromethyl, aryl or arylalkyl group,

R _a and Rb, which may be the same or different, are a hydrogen, fluorine, chlorine, bromine or iodine atom, an alkyl, trifluoromethyl, alkoxy or cyano group,

R ₁ and R ₃ each independently represent a hydrogen atom, an alkyl, aryl, hydroxy, alkoxy, cyano, carboxy, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl or dialkylaminocarbonyl group,

R2, R ₄ , Rζ and Rg independently of one another each have a hydrogen atom or an alkyl group or

R _l together with R2 or R ₃ together with R ₄ each also have an oxygen atom, R5 and R ₇ independently of one another each represent a hydrogen atom, an alkyl, aryl, carboxy, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl or dialkylaminocarbonyl group,

Rg is a hydrogen atom, an alkyl group with 1 to 8 carbon atoms, a cycloalkyl group with 3 to 7 carbon atoms, a cycloalkylalkyl group with 3 to 7 carbon atoms in the cycloalkyl part and 1 to 3 carbon atoms in the alkyl part, an alkenyl group optionally substituted by an aryl group with 3 to 6 carbon atoms, where the alkenyl group cannot be connected to the nitrogen atom via the vinyl part, an alkynyl group with 3 to 6 carbon atoms optionally substituted by an aryl group, the alkynyl group not with the stick part via the ethynyl part Substance atom can be connected, an arylalkyl or heteroaryl alkyl group each having 1 to 3 carbon atoms in the alkyl part, a hydroxyalkyl, alkoxyalkyl, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, alkylcarbonylaminoalkyl, N-alkylalkylcarbonylaminoalkyl, alkylsulfonylaminoalkyl -, N-Alkyl- alkylsulfonylaminoalkyl-, cyanoalkyl-, carboxyalkyl-, alkoxy- car bonylalkyl, aminocarbonylalkyl, N-alkylaminocarbonylalkyl, N, N-dialkylaminocarbonylalkyl, alkoxycarbonyl, arylmethyloxycarbonyl, formyl, acetyl, trifluoroacetyl, 2,2,2-trifluoroethyl, amidino or R ^ CO-O- (__CR_2) -O-CO- group in which

R ^ _O - an alkyl group with 1 to 8 carbon atoms, a cycloalkyl group with 5 to 7 carbon atoms, an aryl or arylalkyl group with 1 to 3 carbon atoms in the alkyl part,

R is a hydrogen atom, an alkyl group, a cycloalkyl group with 5 to 7 carbon atoms or an aryl group and

R _! 2 represents a hydrogen atom or an alkyl group, D is an alkylene group,

an arylene group,

a cycloalkylene group with 4 to 7 carbon atoms optionally substituted by one or two alkyl groups,

a cycloalkylene group with 5 to 7 carbon atoms optionally substituted by one or two alkyl groups, in which a> CH unit is replaced by a nitrogen atom, the ring nitrogen atom being linked to a carbon atom of group E, and also in the abovementioned 5- up to 7-membered rings a methylene group adjacent to a nitrogen atom can be replaced by a carbonyl group,

E is an alkylene group with 1 to 6 carbon atoms, through one or two alkyl groups, each with 1 to 6 carbon atoms, with an alkenyl or alkynyl group, each with 2 to 4 carbon atoms, with a hydroxy, amino, aryl or He¬ teroaryl group, by an alkoxy or alkylamino group each having 1 to 6 carbon atoms, by a dialkylamino group having a total of 2 to 8 carbon atoms, by an HNR13 or N-alkyl-NRi ₃ group, where

R _{13 is} an alkylcarbonyl or alkylsulfonyl group each having 1 to 6 carbon atoms in the alkyl part, an alkyloxycarbonyl group having a total of 2 to 5 carbon atoms, a cycloalkylcarbonyl or cycloalkylsulfonyl group each having 5 to 7 carbon atoms in the cycloalkyl part, an arylalkylcarbonyl, arylalkylsulfonyl group, Represents arylalkoxycarbonyl, arylcarbonyl or arylsulfonyl group,

or an alkylene group linked via the radical W to the radical D, in which W represents an oxygen or sulfur atom, a sulfonyl, sulfonyl or -NRi4 ~ group, where R _{14 is} a hydrogen atom, an alkyl group, a cycloalkyl, cycloalkylalkyl, cycloalkylcarbonyl or cycloalkylsulfonyl group each having 3 to 7 carbon atoms in the cycloalkyl part, an aryl, heteroaryl, arylalkyl, heteroarylalkyl, alkylcarbonyl, Represents alkylsulfonyl, arylcarbonyl, heteroarylcarbonyl, arylsulfonyl or heteroarylsulfonyl group,

and the alkylene group additionally by one or two alkyl groups each having 1 to 6 carbon atoms, by an alkenyl or alkynyl group each having 2 to 4 carbon atoms, by a hydroxyl, amino, aryl or heteroaryl group, by one Alkoxy or alkylamino groups each having 1 to 6 carbon atoms, by a dialkylamino group having a total of 2 to 8 carbon atoms, can be substituted by an -HNR13- or N-alkyl-NRi3 group, the heteao atom of the additional substituent being substituted by at least 2 carbons ¬ is separated from a heteroatom of the radical W and R ^ _{3 is} as defined above,

a -CO H-alkylene, -CON (alkyl) alkylene, -NHCO-alkylene or -N (alkyl) CO-alkylene group, the alkylene part of the above-mentioned groups in each case having one or two alkyl groups or an aryl or heteroaryl group may be substituted, and

F is a carbonyl group which is substituted by a hydroxyl group, by an alkoxy group having 1 to 8 carbon atoms, by an arylalkoxy group or by an R ^ O group, where

R 5 represents a cycloalkyl group with 4 to 7 carbon atoms or a cycloalkylalkyl group with 3 to 7 carbon atoms in the cycloalkyl part, a benzocycloalkyl group with 9 to 12 carbon atoms or an aryl group, or represent an R ₁ gC0-0-CHR ₁₇ -0-C0 group, wherein

R g is an alkyl or alkoxy group each having 1 to 6 carbon atoms, a cycloalkyl or cycloalkoxy group each having 5 to 7 carbon atoms in the cycloalkyl part, an aryl, aryloxy, arylalkyl or arylalkoxy group and

R ^ _{7 represent} a hydrogen atom or an alkyl group,

and the shortest distance between the radical F and the nitrogen atom substituted by Rg is at least 11 bonds,

unless otherwise mentioned,

among the aryl parts mentioned in the definition of the above radicals, a phenyl group which is monosubstituted by rig, mono-, di- or trisubstituted by R_g or monosubstituted by rig and additionally mono- or disubstituted by rig, where the substituents can be the same or different and

Ri a cyano, carboxy, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxycarbonyl, alkylcarbonyl, alkylsulfonyl, alkylsulfinyl, alkylsulfonyl, alkylsulfonyloxy, perfluoroalkyl, perfluoroalkoxy, nitro, Amino, alkylamino, dialkylamino, alkylcarbonylamino, phenylalkylcarbonylamino, no, phenylcarbonylamino, alkylsulfonylamino, phenylalkylsulfonylamino, phenylsulfonylamino, N, alkylalkylcarbonylami.no, N-alkylphenylalkylcarbonylam , N-alkyl-phenylcarbonylamino, N-alkyl-alkyl-sulfonylamino, N-alkyl-phenylalkylsulfonylamino, N-alkyl-phenylsulfonylamino, aminosulfonyl, alkylaminosulfonyl or dialkylaminosulfσnyl group and

R ^ g represent an alkyl, hydroxyl or alkoxy group, a fluorine, chlorine, bromine or iodine atom, two radicals Rig, provided that these are bonded to adjacent carbon atoms, can also represent an alkylene group with 3 to 5 carbon atoms, a 1,3-butadiene-1,4-diylene group or a methylenedioxy group,

among the arylene parts mentioned in the definition of the above radicals, a phenylene group which can be mono-substituted by R i, mono- or disubstituted by Rig or mono-substituted by R i and additionally mono-substituted by Rig, where the substituents can be the same or different and as above mentioned are defined

among the heteroaryl parts mentioned in the definition of the above radicals, a 5-membered heteroaromatic ring which contains an oxygen, sulfur or nitrogen atom, a nitrogen atom and an oxygen, sulfur or nitrogen atom or two nitrogen atoms and one oxygen atom, Contains sulfur or nitrogen atom, or a 6-membered heteroaromatic ring which contains 1, 2 or 3 nitrogen atoms and in which one or two -CH-N groups can each be replaced by a -CO-NH group, in which

the heteroaromatic rings mentioned above can be substituted by one or two alkyl groups or on the carbon skeleton by a fluorine, chlorine, bromine or iodine atom, by a hydroxyl or alkoxy group,

is to be understood, and, unless stated otherwise, the alkyl, alkylene or alkoxy parts mentioned above can each contain 1 to 4 carbon atoms, and each carbon atom in the above-mentioned alkylene and cycloalkylene parts with at most one Heteroatom is linked

their tautomers, their stereoisomers and salts.

Preferred compounds of the above general formula I are with the exception of 2- [trans-4- (2-carboxyethyl) cyclohexyl] -4- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -5-methyl-4H-l, 2.4 -triazol-3-one,

2- [trans-4- (2-carboxyethyl) cyclohexyl] -4- (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -5-methyl-4H -l, 2,4-triazol-3-one,

1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (3-cyclopropyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2-one,

1- [1- (2-carboxyethyl) -4-piperidinyl] -3- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2-one,

1- [1- (2-Carboxyethyl) -4-piperidinyl] -3- (3-methyl-2,3,4,5-tetra-hydro-lH-3-benzazepin-7-yl) imidazolidin-2- on and

1- [2- [(2-Carboxyethyl) aminocarbonyl] ethyl] -3- (2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) imidazolidin-2-one

and with the provisos that

(i) A is a straight-chain alkylene group with 2 to 3 carbon atoms substituted by one or two alkyl groups, in which a methylene group can be replaced by a carbonyl group, or a -CH = N group in which the hydrogen atom is replaced by an alkyl group ,

(ii) at least one of the radicals Ri to Rg has no hydrogen atom,

(iii) Rg is a cyclopropyl group, an alkenyl group with 3 to 6 carbon atoms substituted by an aryl group or an alkynyl group with 3 to 6 carbon atoms optionally substituted by an aryl group, a heteroarylalkyl group with 1 to 3 carbon atoms in the alkyl part, a 2.2 , 2-Trif1uorethylgruppe, an .Alkylgruppe through an alkoxy, cyano, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, amino, alkylamino, dialkylamino, alkylcarbonylamino, N-alkylalkylcarbonylamino, Alkylsulfonylamino or N-alkyl-alkylsulfonylamino group is substituted, an alkyl group with 2 to 4 carbon atoms which is substituted by a carboxy or alkoxycarbonyl group, or an alkyl group with 3 or 4 carbon atoms which is substituted by a hydroxy group,

(v) E is a -CONH-alkylene, -CON (alkyl) -alkylene, -NHCO-alkylene or -N (alkyl) CO-alkylene group, the alkylene part of the above-mentioned groups each having one or two alkyl groups ¬ groups or can be substituted by an aryl or heteroaryl group, or an -N (Rι ₄ ) alkylene group, the alkyl part additionally by one or two alkyl groups each having 1 to 6 carbon atoms, by one Alkenyl or alkynyl group each having 2 to 4 carbon atoms, by a hydroxy, amino, aryl or heteroaryl group, by an alkoxy or alkylamino group each having 1 to 6 carbon atoms, by a dialkylamino group having a total of 2 to 8 carbon atoms , can be substituted by an H R1 ₃ or N-alkyl-NR 3 group, and

(vi) R _{a is} not a hydrogen atom

A is a straight-chain alkylene or alkenylene group each having 2 to 3 carbon atoms, which can additionally be substituted by one or two alkyl groups, by a trifluoromethyl, aryl or arylalkyl group and in which a methyl group can also be replaced by a carbonyl group , a 1,2-cycloalkylene or 1,2-cycloalkenylene group each having 5 to 7 carbon atoms, each of which can be substituted by one or two alkyl groups,

a 1,2-arylene group,

a -CO-NH or -NH-CO group, in which the hydrogen atom can in each case be replaced by an alkyl, aryl or arylalkyl group, or a -CH-N or -N-CH group, in which the hydrogen atom can in each case be replaced by an alkyl, trifluoromethyl, aryl or arylalkyl group,

R _a and R_ _> , which may be the same or different, a hydrogen, fluorine, chlorine, bromine or iodine atom, an alkyl, trifluoromethyl, alkoxy or cyano group,

R ₁ and R 3 each independently represent a hydrogen atom, an alkyl, aryl, hydroxy, alkoxy, cyano, carboxy, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl or dialkylaminocarbonyl group,

R2 R ₄ , _β and Rg independently of one another each have a hydrogen atom or an alkyl group or

R _l together with R2 or R ₃ together with R4 each also have an oxygen atom,

R5 and R ₇ independently of one another each represent a hydrogen atom, an alkyl, aryl, carboxy, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl or dialkylaminocarbonyl group,

Rg is a hydrogen atom, an alkyl group with 1 to 8 carbon atoms, a cycloalkyl group with 3 to 7 carbon atoms, a cycloalkylalkyl group with 3 to 7 carbon atoms in the cycloalkyl part and 1 to 3 carbon atoms in the alkyl part, an AI optionally substituted by an aryl group kenyl group with 3 to 6 carbon atoms, where the alkenyl group cannot be connected to the nitrogen atom via the vinyl part, an alkynyl group with 3 to 6 carbon atoms optionally substituted by an aryl group, the alkynyl group not with the stick via the ethynyl part ¬ substance atom can be connected, an arylalkyl or heteroarylalkyl group each having 1 to 3 carbon atoms in the alkyl part, a hydroxyalkyl, alkoxyalkyl, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, alkylcarbonylaminoalkyl, N-alkylalkylcarbonylaminoalkyl, Alkylsulfonylaminoalkyl-, N-alkyl- alkylsulfonylaminoalkyl-, cyanoalkyl-, carboxyalkyl-, alkoxycarbonylalkyl-, aminocarbonylalkyl-, N-alkylaminocarbonylalkyl-, N, N-dialkylaminocarbonylalkyl-, alkoxycarbonyl-, aryl- methyloxycarbonyl-, formyl-, acetyl -, trifluoroacetyl, 2,2,2-trifluoroethyl, amidino or RI _Q CO-O- (R ₁₁ CR ₁ 2) -O-CO- group, in which

Rio an alkyl group with 1 to 8 carbon atoms, a cycloalkyl group with 5 to 7 carbon atoms, an aryl or arylalkyl group with 1 to 3 carbon atoms in the alkyl part,

R _{11 represents} a hydrogen atom, an alkyl group, a cycloalkyl group with 5 to 7 carbon atoms or an aryl group and

R 2 _l is a hydrogen atom or an alkyl group,

D is an alkylene group,

an arylene group,

a cycloalkylene group with 5 to 7 carbon atoms optionally substituted by one or two alkyl groups, in which a> CH unit is replaced by a nitrogen atom, the ring nitrogen atom being linked to a carbon atom of group E, and, moreover, in the 5- to 7-membered rings mentioned above, a methylene group adjacent to a nitrogen atom is replaced by a carbonyl group can,

E is an alkylene group with 1 to 6 carbon atoms, through one or two alkyl groups, each with 1 to 6 carbon atoms, with an alkenyl or alkynyl group, each with 2 to 4 carbon atoms, with a hydroxy, amino, aryl or He¬ teroaryl group, by an alkoxy or alkylamino group each having 1 to 6 carbon atoms, by a dialkylamino group having a total of 2 to 8 carbon atoms, by an HNR ₁₃ - or N-alkyl-NR ₁ 3 group, where

R _{13 is} an alkylcarbonyl or alkylsulfonyl group each having 1 to 6 carbon atoms in the alkyl part, an alkyloxycarbonyl group having a total of 2 to 5 carbon atoms, a cycloalkylcarbonyl or cycloalkylsulfonyl group each having 5 to 7 carbon atoms in the cycloalkyl part, an arylalkylcarbonyl, arylalkylsulfonyl, Represents arylalkoxycarbonyl, arylcarbonyl or arylsulfonyl group,

or an alkylene group linked via the radical W to the radical D, in which W represents an oxygen or sulfur atom, a sulfonyl, sulfonyl or -NR ₁ 4 group, where

R _{14 is} a hydrogen atom, an alkyl group, a cycloalkyl, cycloalkylalkyl, cycloalkylcarbonyl or cycloalkylsulfonyl group each having 3 to 7 carbon atoms in the cycloalkyl part, an aryl, heteroaryl, arylalkyl, heteroarylalkyl, alkylcarbonyl, Represents alkylsulfonyl, arylcarbonyl, heteroarylcarbonyl, arylsulfonyl or heteroarylsulfonyl group, and the alkylene group additionally by one or two alkyl groups each having 1 to 6 carbon atoms, by an alkenyl or alkynyl group each having 2 to 4 carbon atoms, by a hydroxyl, amino, aryl or heteroaryl group, by one Alkoxy or alkylamino groups each having 1 to 6 carbon atoms, by a .dialkylamino group having a total of 2 to 8 carbon atoms, can be substituted by an -HNR ₁₃ - or N-alkyl-NR ₁₃ group, the heteroatom of the additional substituent being able to be substituted at least 2 carbon atoms are separated from a heteroatom of the radical W and R _{13 is} as defined above,

a -CONH-alkylene, -CON (alkyl) alkylene, -NHCO-alkylene or -N (alkyl) CO-alkylene group, the alkylene part of the aforementioned groups in each case by one or two alkyl groups or by an aryl or Heteroaryl group can be substituted, and

F is a carbonyl group which is substituted by a hydroxyl group, by an alkoxy group having 1 to 8 carbon atoms, by an arylalkoxy group or by a RisO group, where

R _{15 represents} a cycloalkyl group with 4 to 7 carbon atoms or a cycloalkylalkyl group with 3 to 7 carbon atoms in the cycloalkyl part, a benzocycloalkyl group with 9 to 12 carbon atoms or an aryl group,

or represent a RigCO-O-CHR ^ -O-CO group, where

Ri is an alkyl or alkoxy group each having 1 to 6 carbon atoms, a cycloalkyl or cycloalkoxy group each having 5 to 7 carbon atoms in the cycloalkyl part, an aryl, aryloxy, arylalkyl or arylalkoxy group and

R _{17 represents} a hydrogen atom or an alkyl group, and the shortest distance between the radical F and the nitrogen atom substituted by Rg is at least 11 bonds,

unless otherwise mentioned,

among the aryl parts mentioned in the definition of the above radicals, a phenyl group which is monosubstituted by R i, mono-, di- or tri-substituted by R i or monosubstituted by R i and additionally mono- or disubstituted by R g, the Substituents can be the same or different and

Ri a cyano, carboxy, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxycarbonyl, alkylcarbonyl, alkylsulfenyl, alkylsulfinyl, alkylsulfonyl, alkylsulfonyloxy, perfluoroalkyl, perfluoroalkoxy, nitro, Amino, alkylamino, dialkylamino, alkylcarbonylamino, phenylalkylcarbonylamino, phenylcarbonylamino, alkylsulfonylamino, phenylalkylsulfonylamino, phenylsulfonylamino no, N-alkylalkylcarbonylamino, N-alkylphenylalkylcarbonylamino -phenylcarbonylamino, N-alkyl-alkyl-sulfonylamino, N-alkyl-phenylalkylsulfonylamino, N-alkyl-phenylsulfonyl-amino, aminosulfonyl, alkylaminosulfonyl or dialkylaminosulfonyl group and

Rig represent an alkyl, hydroxyl or alkoxy group, a fluorine, chlorine, bromine or iodine atom, two residues of the rig, if these are bonded to adjacent carbon atoms, also an alkylene group with 3 to 5 carbon atoms, a 1,3- Can represent butadiene-1,4-diylene group or a methylenedioxy group,

among the arylene parts mentioned in the definition of the above radicals, a phenylene group, each of which is mono-substituted by rig, mono- or disubstituted by rig or monosubstituted by ri and additionally monosubstituted by rig where the substituents may be the same or different and are defined as mentioned above,

among the heteroaryl parts mentioned in the definition of the above radicals, a 5-membered heteroaromatic ring which contains an oxygen, sulfur or nitrogen atom, a nitrogen atom and an oxygen, sulfur or nitrogen atom or two nitrogen atoms and one oxygen atom, Contains sulfur or nitrogen atom, or a 6-membered heteroaromatic ring which contains 1, 2 or 3 nitrogen atoms and in which one or two -CH = N groups can each be replaced by a -CO-NH group, in which

the heteroaromatic rings mentioned above can be substituted by one or two alkyl groups or, on the carbon skeleton, also by a fluorine, chlorine, bromine or iodine atom, by a hydroxyl or alkoxy group,

their tautomers, their stereoisomers and salts.

Particularly preferred compounds of the general formula I above are with the exception of

2- [trans-4- (2-carboxyethyl) cyclohexyl] -4- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -5-methyl-4H-l, 2.4 -triazol-3-one,

1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (3-cyclopropyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2-one, 1- [1- (2-carboxyethyl) -4-piperidinyl] -3- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2-one,

and with the provisos that

(i) A is a -CH2CH2-, -CH2CH2CH2-, -CH2CO- or -COCH group, each of which is substituted by one or two methyl groups, or a -C (CH ₃ ) = N group,

(ii) at least one of the radicals Ri to Rg has no hydrogen atom,

(iii) Rg is a cyclopropyl, cinnamyl or 2,2,2-trifluoroethyl group, an alkynyl group with 3 or 4 carbon atoms, a pyridylalkyl group with 1 to 3 carbon atoms in the alkyl part or an alkyl group which is substituted by an alkoxy, cyano , Amino¬ carbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, amino, alkyla ino, dialkylamino, alkylcarbonylamino, N-alkyl-alkylcarbonylamino, alkylsulfonylamino or N-alkyl-alkylsulfonylamino group, an alkyl group with 2 to 4 carbon atoms substituted by a carboxy or alkoxycarbonyl group or an alkyl group having 3 or 4 carbon atoms substituted by a hydroxy group,

(iv) D is a 1,4-piperidinylene group optionally substituted by one or two methyl groups,

(v) E is a -N (R _i4) alkylene, -CONH-alkylene or -CON (alkyl) - group Alkylengruppe- ^'in each of which the alkylene moiety is straight-chain and in each case by an alkyl, pyridyl , Pyrida- zinyl, pyrimidinyl or pyrazinyl group or can be substituted by an optionally substituted phenyl group,

(vi) Ra no hydrogen atom

A is a -CH2CH2-, -CH2CH2CH2-, -CH-CH-, -CH CO- or -C0CH ₂ - group, each of which can be substituted by one or two methyl groups,

a -CH = N- or -N-CH group, in each of which the hydrogen atom can be replaced by a methyl group,

R _{a is} a hydrogen, fluorine, chlorine, bromine or iodine atom, a methyl, trifluoromethyl, methoxy or cyano group,

Rj-, a hydrogen atom,

R ₁ and R ₃ each independently represent a hydrogen atom, an alkyl, phenyl, hydroxy, alkoxy, cyano, carboxy, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl or dialkylaminocarbonyl group,

R2, R ₄ , Rg and Rg each independently of one another are a hydrogen atom or an alkyl group or

R _l together with R2 or R ₃ together with R ₄ each also have an oxygen atom,

R5 and R7 independently of one another each represent a hydrogen atom, an alkyl, phenyl, carboxy, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl or dialkylaminocarbonyl group,

Rg is a hydrogen atom, an alkyl group with 1 to 6 carbon atoms, a cycloalkyl group with 3 to 7 carbon atoms men, a cycloalkylalkyl group with 3 to 7 carbon atoms in the cycloalkyl part and 1 to 3 carbon atoms in the alkyl part, an alkenyl group with 3 to 6 carbon atoms optionally substituted by a phenyl group, it being possible for the alkenyl group not to be connected to the nitrogen atom via the vinyl part, an alkynyl group with 3 or 4 carbon atoms, where the alkynyl group cannot be connected to the nitrogen atom via the ethynyl part, a phenylalkyl or pyridylalkyl group each with 1 to 3 carbon atoms in the alkyl part, a hydroxyalkyl, alkoxyalkyl, carboxyalkyl, alkoxycarbonylalkyl, aminocarbonylalkyl -, alkylaminocarbonylalkyl, dialkylaminocarbonylalkyl, 2,2,2-trifluoroethyl, alkoxycarbonyl, phenylmethyloxycarbonyl, formyl, acetyl or trifluoroacetyl group or an alkyl group which is replaced by an amino, alkylamino, dialkylamino, cyano , Alkylcarbonyl¬ amino, N-alkyl-alkylcarbonylamino, alkylsulfonylamino or N-alkyl-alkylsulfo nylamino group is substituted,

D is an alkylene group,

a 1,4-phenylene group,

a 1,4-cyclohexylene group optionally substituted by one or two methyl groups,

a 1,4-piperidinylene group optionally substituted by one or two methyl groups, the ring nitrogen atom being linked to a carbon atom of group E,

E is a straight-chain alkylene group which can be substituted by an alkyl, phenyl, pyridyl, pyridazinyl, pyrimidinyl or pyrazinyl group,

a straight-chain alkylene group linked via the radical W to the radical D, in which W represents an oxygen or sulfur atom, a sulfinyl, sulfonyl or —NR ₄ ~ group, the Alkylene part can be substituted by an alkyl, phenyl, pyridyl, pyridazinyl, pyrimidinyl or pyrazinyl group and

R 4 _l is a hydrogen atom, an alkyl group, a cycloalkyl, cycloalkylalkyl, cycloalkylcarbonyl or Cycloalkylsul- fonylgruppe each having 3 to 7 carbon atoms in the alkyl part Cyclo¬, a phenylalkyl, Pyridylalkyl-, alkylcarbonyl, alkylsulfonyl, phenylsulfonyl or phenylcarbonyl each having 1 to 3 carbon atoms in the alkyl parts of the cycloalkylalkyl, phenylalkyl and pyridylalkyl group,

a -CONH-alkylene or -CON (alkyl) alkylene group, in each of which the alkylene part is straight-chain and can in each case be substituted by an alkyl, phenyl, pyridyl, pyridazinyl, pyrimidinyl or pyrazinyl group,

F is a carbonyl group which is substituted by a hydroxyl group or by an alkoxy group having 1 to 6 carbon atoms or by a cycloalkoxy group having 5 to 7 carbon atoms,

wherein the shortest distance between the radical F and the nitrogen atom substituted by Rg is at least 11 bonds, and

where, unless stated otherwise, the above-mentioned alkyl, alkoxy and alkylene parts can each contain 1 to 4 carbon atoms, and

each carbon atom in the above-mentioned alkylene and cycloalkylene parts is linked to at most one heteroatom, and

the phenyl parts of the groups mentioned above can each be substituted by a fluorine, chlorine or bromine atom, by a methyl, tri-fluoromethyl, hydroxyl or methoxy group, their tautomers, their stereoisomers and salts.

Very particularly preferred compounds of the above general formula I are with the exception of

2- [trans-4- (2-carboxyethyl) cyclohexyl] -4- (2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) -5-methyl-4H-1,2,4 -triazol-3-one,

and with the provisos that

(i) A is a -CH2CH2 "'-CH2CO or -COCH2 group, each of which is substituted by one or two methyl groups, or a -C (CH3) = N group,

(ii) at least one of the radicals Ri to Rg has no hydrogen atom,

(iii) Rg is cyclopropyl, propargyl, cinnamyl, pyridylmethyl, 2-carboxyethyl, 2- (Ci- _4- alkoxycarbonyl) ethyl, 2- (aminocarbonyl) ethyl, 2- (methylaminocarbonyl) ethyl -, 2- (dimethylaminocarbonyl) ethyl, 2-cyanoethyl, 2-methoxyethyl, 2-aminoethyl, 2- (methylamino) ethyl, 2- (dimethylamino) ethyl. 3-hydroxypropyl, 3-aminopropyl, 3- (methylamino) propyl,

3- (dimethylamino) propyl, 3- (acetylamino) propyl, 3- (methanesulfonylamino) propyl or 2,2,2-trifluoroethyl group,

(iv) D is a 1,4-piperidinylene group,

(v) E is a -N (Ri ₄ ) -CH2 group in which the -CH2 ~ group can be substituted by a methyl, phenyl or pyridyl group, or

a -C0NHCH ₂ -, -CON (CH ₃ ) CH ₂ -, -C0NHCH ₂ CH ₂ - or

-CON (CH ₃ ) CH2CH2 group, in which the alkylene part can in each case be substituted by a methyl, phenyl or pyridyl group,

(vi) R _{a is} a fluorine or chlorine atom

A is a -CH ₂ CH2- / -CH2CO- or -COCH2 group, which can each be substituted by one or two methyl groups,

a -CH = N or -N-CH group in which the hydrogen atom can be replaced by a methyl group,

R _{a is} a hydrogen, fluorine or chlorine atom,

R_, a hydrogen atom,

Rl and R3 independently of one another each represent a hydrogen atom, a methyl, phenyl, hydroxy, methoxy, cyano, carboxy, methoxycarbonyl, ethoxycarbonyl, aminocarbonyl, methylaminocarbonyl or dimethylaminocarbonyl group,

R2, R4, Rg and Rg each independently of one another are a hydrogen atom or a methyl group or R _l together with R2 or R ₃ together with R ₄ each also have an oxygen atom,

R5 and R ₇ independently of one another each represent a hydrogen atom, a methyl, phenyl, carboxy, methoxycarbonyl, ethoxycarbonyl, aminocarbonyl, methylaminocarbonyl or dimethylaminocarbonyl group,

Rg is a hydrogen atom, an alkyl group with 1 to 4 carbon atoms, a cycloalkyl group with 3 to 6 carbon atoms, an allyl group optionally substituted in the 3-position by a phenyl group or one or two methyl groups, a propargyl, 2-carboxyethyl, 2- (Ci. ₄ -alkoxycarbonyl) ethyl, 2- (aminocarbonyl) ethyl, 2- (methylaminocarbonyl) ethyl, 2- (dimethylaminocarbonyl) ethyl, 2-cyanoethyl, 2-methoxyethyl, 2 -Aminoethyl-, 2- (methylamino) ethyl-, 2- (dimethylamino) ethyl-. 3-hydroxypropyl-, 3-aminopropyl-, 3- (methyl¬ amino) propyl-, 3- (dimethylamino) propyl-, 3- (acetylamino) propyl-, 3- (methanesulfonylamino) propyl-, 2,2,2 Trifluoroethyl or pyridylmethyl group,

D is a methylene, ethylene or 1,4-phenylene group,

a 1,4-cyclohexylene group or

a 1,4-piperidinylene group, the ring nitrogen atom being linked to a carbon atom of group E,

E is a straight-chain alkylene group with 1 to 3 carbon atoms, which can be substituted by a methyl, phenyl or pyridyl group,

a methylene group linked via the radical W to the radical D, in which W represents an oxygen atom or an —NR ₄ group, where the methylene group can be substituted by a methyl, phenyl or pyridyl group, and R _{14 is} a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, a cycloalkyl, cycloalkylcarbonyl or cycloalkylsulfonyl group each having 3 to 6 carbon atoms in the cycloalkyl part, a benzyl, alkylcarbonyl or alkylsulfonyl group each having 1 to 4 carbon atoms in the alkyl part represents a phenylcarbonyl or phenylsulfonyl group,

a -C0NHCH ₂ - '-C0N (CH ₃ ) CH ₂ -, -CONHCH ₂ CH ₂ - or -CON (CH ₃ ) CH2CH2 group, where the alkylene part of the above-mentioned groups each by a methyl, phenyl or pyridyl group can be substituted, and

F represents a carbonyl group which is substituted by a hydroxyl group or by an alkoxy group having 1 to 4 carbon atoms,

the shortest distance between the radical F and the nitrogen atom substituted by Rg is at least 11 bonds,

their tautomers, their stereoisomers and salts,

in particular the compounds of the above general formula I with the exception of

2- [trans-4- (2-carboxyethyl) cyclohexyl] -4- (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -5-methyl-4H -1,2,4-triazol-3-one,

1- [1- (2-carboxyethyl) -4-piperidinyl] -3- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2-one, 1- [1- (2-Carboxyethyl) -4-piperidinyl] -3- (3-methyl-2,3,4,5-tetra-hydro-lH-3-benzazepin-7-yl) imidazolidin-2- on and

and with the provisos that

(i) A is a -CH2CO group substituted by one or two methyl groups or a -C (CH ₃ ) = N group,

(ii) Rg is a cyclopropyl, cinnamyl, propargyl, 2,2,2-trifluoroethyl, 2-carboxyethyl, 2- (tert-butyloxycarbonyl) ethyl or 2-cyanoethyl group,

(iii) D is a 1,4-piperidinylene group,

(iv) E is a -N (Ri4) -CH ₂ group or a -CONHCH ₂ CH ₂ group, in which the ethylene part can be substituted by a methyl, phenyl or pyridyl group,

(v) Ri or R2 or Ri and R is a methyl group,

(vi) R _{a is} a fluorine atom

A is a -CH2-CH2 group, a -C ^ CO group substituted by one or two methyl groups or a -C (CH ₃ ) = N group,

R _{a is} a hydrogen or fluorine atom,

Rb is a hydrogen atom, _R1 and R2, which may be the same or different, each represent a hydrogen atom or a methyl group,

R3 to Rg each represent a hydrogen atom,

Rg is a hydrogen atom, a methyl, cyclopropyl, cinnamyl, propargyl, 2,2,2-trifluoroethyl, 2-carboxyethyl, 2- (tert-butyloxycarbonyl) ethyl or 2-cyanoethyl group,

D is a -CH2-, -CH2CH2-, 1,4-cyclohexylene group or

E is a -CH2 group, a -CH2CH2 group which is optionally substituted by a methyl group or a -CONHCH2CH2 group in which the ethylene part can be substituted by a methyl, phenyl or pyridyl group,

a -NR ₄ -CH2- group linked via the nitrogen atom to the 1,4-cyclohexylene group of the radical D, where

R _{14 represents} a hydrogen atom, a methyl, benzyl, acetyl or methanesulfonyl group,

F represents a carbonyl group which is substituted by a hydroxyl, methoxy or ethoxy group,

their tautomers, their stereoisomers and salts.

The following are mentioned as particularly preferred compounds:

(1) 1- [trans-4- (carboxymethylamino) cyclohexyl] -3- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2-one, ⁽ 2 ⁾ 1- [trans-4- (N-methyl-N-carboxymethylamino) cyclohexyl] -

3- (2,3,4, 5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2-one,

(3) 1- [trans-4- (N-benzyl-N-carboxymethylamino) cyclohexyl] -

3- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2-one,

(4) 1- [trans-4- (N-methyl-N-carboxymethylamino) cyclohexyl] -3- (3-methyl-2, 3,4, 5-tetrahydro-lH-3-benzazepin-7-yl ) -imidazoli- din-2-one,

(5) 1- [trans-4- (N-benzyl-N-carboxymethylamino) cyclohexyl] -3- (3-methyl-2, 3,4, 5-tetrahydro-lH-3-benzazepin-7-yl ) -imidazoli- din-2-one,

(6) 1- [trans-4- (carboxymethylamino) cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2-one and

(7) 1- [trans-4- (N-acetyl-N-carboxymethylamino) cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl ) -imidazoli- din-2-one,

their tautomers, their stereoisomers and salts.

The new compounds can be produced, for example, by the following processes:

a) For the preparation of compounds of the general formula I in which Rg is as defined at the outset and F represents a carboxyl group or F is as defined at the outset and Rg is a hydrogen atom: Conversion of a compound of the general formula

in the

A, D, E, Ri to Rg, R _a and R_, with the proviso as defined at the beginning that F 'has the meanings mentioned for F and Rg one by means of hydrolysis, treatment with an acid or base, thermolysis or Hydrogenolysis removable protective residue for an imino group or

^■ Rg has the meanings given for Rg and F 'by means of a means Hydrolysis treatment with an acid or base, thermolysis or hydrogenolysis into a Carboxy1gruppe über¬ group convertible,

into a compound of the general formula I in which R9 is as defined at the outset and F represents a carboxy1 group or F is as defined at the outset and Rg represents a hydrogen atom.

For example, functional derivatives of the carboxy1 group, such as their unsubstituted or substituted amides, esters, thioesters, trimethylsilyl esters, orthoesters, iminoesters, amidines or anhydrides, or the nitrile group by hydrolysis into a carboxy1 group,

Esters with tertiary alcohols, for example the tert. Butyl ester, by means of treatment with an acid or thermolysis in a Carboxy1gruppe and Esters with aralkanols, for example the benzyl ester, by means of hydrolysis in a carboxyl group and

Functional derivatives of the imino group such as their formyl, acetyl, trifluoroacetyl, ethoxycarbonyl, tert.butoxycarbonyl or benzyloxycarbonyl derivatives by means of hydrolysis and

Benzyloxycarbonyl, benzyl, methoxybenzyl or 2,4-dimethoxybenzyl derivatives are converted into the corresponding imino compounds by means of hydrogenolysis.

The hydrolysis is expediently carried out either in the presence of an acid such as hydrochloric acid, sulfuric acid, phosphoric acid, acetic acid, trichloroacetic acid, trifluoroacetic acid or a mixture thereof or in the presence of a base such as lithium hydroxide, sodium hydroxide or potassium hydroxide in a suitable solvent such as Water, water / methanol, water / ethanol, water / - isopropanol, methanol, ethanol, water / tetrahydrofuran or water / dioxane at temperatures between -10 and 120 ° C, e.g. at temperatures between room temperature and the boiling point of the reaction mixture.

Under the reaction conditions mentioned above, any N-acylamino or N-acylimino groups present, such as an N-trifluoroacetylimino group, can be converted into the corresponding amino or imino groups. In addition, alcoholic hydroxyl groups which may be present can be converted simultaneously into a corresponding acyloxy group such as the trifluoroacetoxy group in the treatment with an organic acid such as trichloroacetic acid or trifluoroacetic acid.

If F "in a compound of the formula II denotes a cyano or aminocarbonyl group, these groups can also be mixed with a nitrite, for example sodium nitrite, in the presence of an acid such as sulfuric acid, which expediently simultaneously as Solvent is used, be converted into the carboxy1 group at temperatures between 0 and 50 ° C.

F 'and / or Rg' in a compound of the formula II means, for example, the tert. Butyloxycarbonylgruppe, so in the case of F 'the tert. Butyl group or in the case of Rg 'the tert-butyloxycarbonyl group also by treatment with an acid such as trifluoroacetic acid, formic acid, p-toluenesulfonic acid, sulfuric acid, hydrochloric acid, phosphoric acid or polyphosphoric acid, optionally in an inert solvent such as methylene chloride, chloroform, benzene, Toluene, diethyl ether, tetrahydrofuran or dioxane preferably at temperatures between -10 and 120 ° C, for example at temperatures between 0 and 60 ° C, or also thermally optionally in an inert solvent such as methylene chloride, chloroform, benzene, toluene, tetrahydrofuran or dioxane and preferably in the presence of a catalytic amount of an acid such as p-toluenesulfonic acid, sulfuric acid, phosphoric acid or polyphosphoric acid preferably at the boiling point of the solvent used, eg split off at temperatures between 40 and 120 ° C. In the reaction conditions mentioned above, any N-tert-butyloxycarbonylamino or N-tert-butyloxycarbonylimino groups present can be converted into the corresponding amino or imino groups.

If F 'and / or Rg' in a compound of the formula II means, for example, the benzyloxycarbonyl group, then in the case of F 'the benzyl group or in the case of Rg' the benzyloxycarbonyl group can also be hydrogenolytically in the presence of a hydrogenation catalyst such as palladium / carbon in a suitable solvent such as methanol, ethanol, ethanol / water, glacial acetic acid, ethyl acetate, dioxane or dimethylformamide, preferably at temperatures between 0 and 50 ° C, for example at room temperature, and a hydrogen pressure of 1 to 5 bar. In hydrogenolysis, other residues, for example a nitro group in an amino group, a benzyloxy group in a hydroxyl group and an N-benzylamino group, N-benzylimino, N-benzyloxycarbonylamino or N-benzyloxycarbonylimino group can be converted into a corresponding amino or imino group.

b) For the preparation of compounds of the general formula I in which A is a straight-chain alkylene group having 2 to 3 carbon atoms, which can additionally be substituted by one or two alkyl groups, by a trifluoromethyl, aryl or arylalkyl group and in which in addition, a terminal methylene group is replaced by a carbonyl group:

Cyclization of a compound of the general formula optionally formed in the reaction mixture

in the

R ₁ to Rg, R _a , R_ ,, D, E and F are as defined in the introduction, one of the radicals Ui or U _{2 is} a hydrogen atom and the other of the radicals Ui or U is one, if appropriate, by one or two alkyl groups, by a trifluoromethyl , Aryl- or Arylalkyl¬ group substituted straight-chain alkylene group with 2 to 3 carbon atoms, in which a terminal methylene group is replaced by a Zi-CO group, where Z is a nucleophilic leaving group such as a halogen atom, a hydroxy, alkoxy, aryl - oxy or arylalkoxy group, e.g. B. represents a chlorine or bromine atom, a hydroxyl, methoxy, ethoxy, phenoxy or benzyloxy group.

The reaction is preferably carried out in a solvent such as methylene chloride, acetonitrile, tetrahydrofuran, toluene, dimethyl formamide or dimethyl sulfoxide, optionally in the presence of a base such as sodium hydride, potassium carbonate, potassium tert-butylate or N-ethyl-diisopropylamine or optionally in the presence of a dehydrating agent such as triphenylphosphine / diethyl azodicarboxylate or N, N'-carbonyldiimidazole Temperatures between -20 and 200 ° C, preferably at temperatures between 0 and 160 ° C, carried out.

c) For the preparation of compounds of the general formula I in which Rg is one of the optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, arylalkyl or heteroarylalkyl radicals mentioned in the definition of the radical Rg :

Implementation of a compound of the general formula

in the

Rl to R ₈ , ^l a »R_ ,, A, D, E and F as defined above, with a compound of the general formula

^z 2 ^"R 20. (V)

in the

R20 is an alkyl group with 1 to 8 carbon atoms, a cycloalkyl group with 3 to 7 carbon atoms, a cycloalkylalkyl group with 3 to 7 carbon atoms in the cycloalkyl part and 1 to 3 carbon atoms in the alkyl part, an alkenyl group with 3 to 6 carbons optionally substituted by an aryl group ¬ atoms, the alkenyl group does not have the vinyl part can be connected to the nitrogen atom, an alkynyl group with 3 to 6 carbon atoms optionally substituted by an aryl group, where the alkynyl group cannot be connected to the nitrogen atom via the ethynyl part, an arylalkyl or heteroarylalkyl group each with 1 to 3 carbon atoms in the alkyl part, a hydroxyalkyl, alkoxyalkyl, 2,2,2-trifluoroethyl, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, alkylcarbonylaminoalkyl, N-alkylalkylcarbonyl¬ aminoalkyl, alkylsulfonylaminoalkyl, N-alkylalkylsulfonylaminoalkyl- , Cyanoalkyl, carboxyalkyl, alkoxycarbonylalkyl, aminocarbonylalkyl, N-alkylaminocarbonylalkyl or N, N-dialkylaminocarbonylalkyl group in which the aryl part and the alkyl parts are as defined at the beginning, and

Z2 is a nucleophilic leaving group such as a halogen atom, for example a chlorine, bromine or iodine atom, or a sulfonic acid ester group, for example a methanesulfonyloxy or p-toluenesulfonyloxy group, or Z2 together with an adjacent hydrogen atom of the radical R2 _{0 is} an oxygen atom.

The alkylation with a compound of the formula V, in which Z2 represents a nucleophilic leaving group, is expediently carried out in a solvent such as methylene chloride, tetrahydrofuran, dioxane, dimethyl sulfoxide or dimethylformamide, if appropriate in the presence of a base such as sodium carbonate, potassium carbonate or Sodium hydroxide solution or in the presence of a tertiary organic base such as N-ethyl-diisopropylamine or N-methyl-morpholine, which can simultaneously serve as a solvent, at temperatures between -30 and 150 ° C., but preferably at temperatures between 20 and 120 ° C.

The reductive alkylation with a carbonyl compound of the general formula V is advantageously carried out in the presence of a complex metal hydride such as sodium borohydride, lithium borohydride or sodium cyanoborohydride at a pH of 6-7 and at room temperature or in the presence of a hydrogenation catalyst, for example with hydrogen in the presence of palladium / carbon, at a hydrogen pressure of 1 to 5 bar. The methyl tion, however, is preferably in the presence of formic acid as a reducing agent at elevated temperatures, for. B. at temperatures between 60 and 120 ° C.

d) For the preparation of compounds of the general formula I in which F represents a carbonyl group which is substituted by an alkoxy group having up to 8 carbon atoms, by an arylalkoxy group or by a RisO group:

Implementation of a carboxylic acid of the general formula

in the

Rl to Rg ^R a, Rl _> AA ,, DD ,, and E are as defined in the introduction, or their reactive derivatives optionally prepared in the reaction mixture with an alcohol of the general formula

HO - R ₂₁ , (VII)

in the

R2 _{1 is} an alkyl group having 1 to 8 carbon atoms, one

Arylalkyl group or an R 5 group, wherein

mean. Examples of reactive derivatives of a compound of the general formula VI are their acid chlorides, acid azides, mixed anhydrides with aliphatic or aromatic carboxylic acids or carbonic acid monoesters, their imidazolides and their esters such as their alkyl, aryl and aralkyl esters such as methyl, ethyl, Isopropyl, pentyl, phenyl, nitrophenyl or benzyl ester into consideration.

The reaction of a carboxy compound is optionally carried out in a solvent or solvent mixture such as methylene chloride, dimethylformamide, benzene, toluene, chlorobenzene, tetrahydrofuran, benzene / tetrahydrofuran or dioxane or particularly advantageously in a corresponding alcohol of the general formula VII, if appropriate in Presence of an acid such as hydrochloric acid or in the presence of a dehydrating agent, e.g. in the presence of isobutyl chloroformate, thionyl chloride, trimethylchlorosilane, sulfuric acid, methanesulfonic acid, p-toluenesulfonic acid, phosphorus trichloride, phosphorus pentoxide, N, N '-dicyclohexylcarbodiimide, N, N'-dicyclohexylhydroxy-1-hydroxysuccinic or hydroxysuccinic or hydroxysuccinic or hydroxysuccinic hydroxyduccinic or hydroxysuccinic or hydroxysuccinic or hydroxysuccinic hydroxysuccinic or hydroxysuccinic or hydroxysuccinic or hydroxysuccinic -benztriazole and optionally additionally in the presence of 4-dimethylamino-pyridine, N, N'-carbonyldiimidazole or triphenylphosphine / carbon tetrachloride, advantageously at temperatures between 0 and 150 ° C, preferably at temperatures between 0 and 80 ° C , carried out.

The reaction of a corresponding alkoxycarbonyl compound with an alcohol of the general formula VII is preferably carried out in a corresponding alcohol as solvent, if appropriate in the presence of a further solvent such as methylene chloride or ether, preferably in the presence of an acid such as hydrochloric acid at temperatures between 0 and 150 ° C., preferably at temperature temperatures between 50 and 100 ° C. e) For the preparation of compounds of the general formula I in which F represents a RIQCO-0- (1 ₁ CR ₁ 2) -O-CO group:

Implementation of a carboxylic acid of the general formula

in the

R _l to Rg, R _a , Rj _j , A, D, and E as defined in the introduction, with a compound of the general formula

^z 3 " ^R 22, (VIII)

in the

R22 is a RIQCO-O- (R1 ₁ CR12) group, Rio to R12 being defined as mentioned at the beginning, and

Z3 is a nucleophilic leaving group such as a halogen atom, for example a chlorine or bromine atom.

The reaction is preferably carried out in a solvent such as methylene chloride, tetrahydrofuran, dioxane, dimethyl sulfoxide or dimethylformamide, optionally in the presence of a reaction accelerator such as sodium or potassium iodide and preferably in the presence of a base such as sodium carbonate, potassium carbonate or sodium hydroxide solution or in the presence of a tertiary organic base such as .N-ethyl-diisopropylamine or N-methyl-morpholine, which can also serve as a solvent, or optionally in the presence of silver carbonate or silver oxide at temperatures between -30 and 100 ° C, but preferably at temperatures between -10 and 80 ° C. f) For the preparation of compounds of general formula I, in which Rg represents an alkyl group with 2 carbon atoms, which is in the 2-position by a cyano, carboxy, alkoxycarbonyl, aminocarbonyl, N-alkylaminocarbonyl or N, N-dialkylaminocar - bonyl group is substituted: -

Implementation of a compound of the general formula

in the

Rl to Rg, R _a , Rt ,, A, D, E and F are as defined above,

with an ethylene which is substituted by a cyano, carboxy, alkoxycarbonyl, aminocarbonyl, N-alkylaminocarbonyl or N, N-dialkylaminocarbonyl group.

The reaction is preferably carried out in a solvent such as methanol, ethanol, methylene chloride, tetrahydrofuran, toluene, dioxane, dimethyl sulfoxide or dimethylformamide, optionally in the presence of a tertiary organic base such as N-ethyldiisopropylamine or N-methylmorpholine at temperatures between -30 and 150 ° C, but preferably at temperatures between 0 and 100 ° C.

g) For the preparation of compounds of the general formula I in which A represents a —CH = N or —N-CH group which is optionally substituted by an alkyl, trifluoromethyl, aryl or arylalkyl group: Cyclization of a compound of the general formula optionally formed in the reaction mixture

in the

R ₁ to Rg, R _a , Rj-, D, E and F are as defined in the introduction, one of the radicals U ₃ or U _{4 is} a hydrogen atom and the other of the radicals U ₃ or U _{4 is} a R2 ₃ -CO-NH- Group, where R _{3 represents} a hydrogen atom, an alkyl, trifluoromethyl, aryl or aralkyl group.

The reaction is optionally carried out in a solvent such as methylene chloride, acetonitrile, tetrahydrofuran, toluene, decalin, dimethylformamide or dimethyl sulfoxide, optionally in the presence of a base such as sodium hydride, potassium carbonate, potassium tert-butoxide or N-ethyl-diisopropylamine or optionally in the presence of an acid such as toluenesulfonic acid or optionally in the presence of a dehydrating agent such as acetic anhydride or trifluoroacetic anhydride at temperatures between 0 and 200 ° C, preferably at temperatures between 20 and 180 ° C, but particularly advantageously by dry heating to temperatures between 120 and carried out at 200 ° C.

h) For the preparation of compounds of the general formula I in which A represents a straight-chain alkylene group having 2 or 3 carbon atoms, which can additionally be substituted by one or two alkyl groups, by a trifluoromethyl, aryl or arylalkyl group : Cyclization of a compound of the general formula optionally formed in the reaction mixture

in the

Rl to Rg, R _a , Rb, D, E and F are as defined in the introduction, one of the radicals U5 or Ug is a hydrogen atom and the other of the radicals U5 or Ug is optionally one or two alkyl groups, a trifluoromethyl, aryl or aralkyl group substituted straight-chain alkylene group having 2 or 3 carbon atoms, which are additionally terminated by a nucleophilic leaving group such as a halogen atom, a hydroxyl or sulfonic acid ester group, for example by a chlorine, bromine or iodine atom, by a hydroxyl or methanesulfonyloxy - or p-toluenesulfonyloxy group is substituted.

The reaction is preferably carried out in a solvent such as methylene chloride, acetonitrile, tetrahydrofuran, toluene, dimethylformamide or dimethyl sulfoxide, if appropriate in the presence of a base such as sodium hydride, potassium carbonate, potassium tert. - Butylate or N-ethyl-diisopropylamine or optionally in the presence of a dehydrating agent such as triphenylphosphine / diethyl azodicarboxylate at temperatures between -20 and 100 ° C, preferably at temperatures between 0 and 60 ° C.

i) For the preparation of compounds of the general formula I in which D represents a cycloalkylene group with 5 to 7 carbon atoms which is optionally substituted by one or two alkyl groups and in which a> CH unit is replaced by a nitrogen atom is set and also in the 5- to 7-membered rings mentioned above a methylene group adjacent to a nitrogen atom can be replaced by a carbonyl group:

Alkylation of a compound of the general formula

in the

R ₁ to R ₉ , R _a , R and A are as defined in the introduction and D ^{1 represents} a cycloalkylene group with 5 to 7 carbon atoms optionally substituted by one or two alkyl groups, in which a> CH unit is replaced by a nitrogen atom is, wherein the ring nitrogen atom is linked to a hydrogen atom and, moreover, in the above 5- to 7-membered rings a methylene group adjacent to a nitrogen atom can be replaced by a carbonyl group, with a compound of the general formula

Z ₅ -E'-F (XII)

or with a compound of the general formula

CH ₂ = CH-F, (XIII)

in which

F as defined at the beginning,

E 'is an alkylene group with 1 to 6 carbon atoms, which is separated by one or two alkyl groups each having 1 to 6 carbon atoms, by an alkenyl or alkynyl group each having 2 to 4 Carbon atoms, by a hydroxyl, amino, aryl or heteroaryl group, by an alkoxy or alkylamino group each having 1 to 6 carbon atoms, by a dialkylamino group having a total of 2 to 8 carbon atoms, by an HNR ₁₃ - or N Alkyl NRi ₃ group can be substituted, where R1 _{3 is} as defined at the outset,

Z _{5 is} a nucleophilic leaving group such as a halogen atom, a hydroxyl or sulfonic acid ester group, for example a chlorine, bromine or iodine atom, a hydroxyl, methanesulfonyloxy or p-toluenesulfonyloxy group, and in addition the vinyl group in a compound of the general formula XIII can be substituted by one or two alkyl groups each having 1 to 6 carbon atoms, by an alkenyl or alkynyl group each having 2 to 4 carbon atoms, by an aryl or heteroaryl group.

The reaction is preferably carried out in a solvent such as methanol, ethanol, methylene chloride, tetrahydrofuran, toluene, dioxane, dimethyl sulfoxide or dimethylformamide, optionally in the presence of an inorganic or a tertiary organic base or, if appropriate, in the presence of a dehydrating agent at temperatures between -30 and 200 ° C carried out.

With a compound of general formula XII, in which Z5 represents a nucleophilic leaving group, the reaction is preferably carried out in a solvent such as methylene chloride, acetonitrile, tetrahydrofuran, toluene, dimethylformamide or dimethyl sulfoxide, optionally in the presence of a base such as sodium hydride, potassium carbonate, potassium tert-butylate or N-ethyl-diisopropylamine or, if appropriate, in the presence of a dehydrating agent such as triphenylphosphine / azodicarboxylic acid diethyl ester at temperatures between -20 and 100 ° C., preferably at temperatures between 0 and 60 ° C.

With a compound of general formula XIII, the reaction is preferably carried out in a solvent such as methanol, Ethanol, methylene chloride, tetrahydrofuran, toluene, dioxane, dimethyl sulfoxide or dimethylformamide, optionally in the presence of a tertiary organic base such as N-ethyldiisopropylamine or N-methylmorpholine at temperatures between -30 and 150 ° C, but preferably at temperatures between 0 and 100 ° C.

j) For the preparation of compounds of the general formula I in which A represents one of the straight-chain alkenylene groups with 2 or 3 carbon atoms mentioned at the beginning, which additionally comprises one or two alkyl groups, a trifluoromethyl, aryl or arylalkyl group can be substituted:

in the

R ₁ to Rg, R _a , Rb, D, E and F are as defined in the introduction, one of the radicals U ₇ or Ug is a hydrogen atom and the other of the radicals U ₇ or Ug is one in the alkylidene part, if appropriate, by one or two alkyl groups, - (CH2) _m HC (0R24) 2 group substituted by a trifluoromethyl, aryl or aralkyl group, where

m is the number 1 or 2 and

R24 represents an alkyl group with 1 to 4 carbon atoms.

The reaction is optionally carried out in a solvent such as methylene chloride, acetonitrile, tetrahydrofuran or toluene. preferably in the presence of an acid such as trifluoroacetic acid, acetic acid, p-toluenesulfonic acid or hydrochloric acid at temperatures between 20 and 200 ° C, preferably at temperatures between 20 and 100 ° C.

k) For the preparation of compounds of the general formula I in which E is a -CONH-alkylene, -CON (alkyl) alkylene, -NHCO-alkylene or -N (alkyl) CO-alkylene group which is optionally substituted in the alkylene part represents:

Implementation of a compound of the general formula

with an amine of the general formula

HNR ₂ 5 E "- F, (XVI)

or reaction of an amine of the general formula

with a carboxylic acid of the general formula

HOOC - E "- F, (XVIII)

in which

R _l to Rg, R _a , Rb, A, D and F are as defined in the introduction,

E "optionally substituted as mentioned at the beginning

Alkylene group,

R25 and R ₂₆ ', which may be the same or different, each represent a hydrogen atom or an alkyl group, or their reactive derivatives.

The reaction is optionally in a solvent or solvent mixture such as methylene chloride, dimethylformamide, benzene, toluene, chlorobenzene, tetrahydrofuran, benzene / tetrahydrofuran or dioxane with a corresponding derivative, if appropriate in the presence of a tertiary organic base or in the presence of an inorganic base and / or in the presence of a dehydrating agent, e.g. in the presence of isobutyl chloroformate, thionylchloride, trimethylchlorosilane, phosphorus trichloride, phosphorus pentoxide, N, N '-dicyclohexylcarbodiimide, N, N' -dicyclohexylcarbodiimide / N-hydroxysuccinimide or 1-hydroxy-benzylzide, n-tri-benzylzide, n-tri-benzylzene, phosphine / carbon tetrachloride or 2- (1H-benzotriazol-4-yl) - 1,1,3, 3-tetramethyluronium tetrafluoroborate and optionally additionally in the presence of 4-dimethylamino-pyridine, preferably at temperatures between 0 and 150 ° C., preferably ¬ performed at temperatures between 0 and 80 ° C.

If, according to the invention, a compound of the general formula I in which R1 _{4 represents} a hydrogen atom is obtained, this can be converted into a corresponding compound of the general formula I by means of acylation or sulfonation, in which R1 _{4 is} an alkylcarbonyl-, alkylsulfonyl- Represents cycloalkylcarbonyl, cycloalkylsulfonyl, arylcarbonyl, heteroarylsulfonyl or heteroarylcarbonyl group, or a compound of the general formula I which contains a carbon-carbon double bond, this can be converted into a corresponding saturated compound by means of hydrogenation.

The subsequent acylation or sulfonation is optionally in a solvent or solvent mixture such as methylene chloride, dimethylformamide, benzene, toluene, chlorobenzene, tetrahydrofuran, benzene / tetrahydrofuran or dioxane with a corresponding acyl or sulfonyl derivative, optionally in the presence of a tertiary organic base or in the presence of an inorganic base or in the presence of a dehydrating agent, for example tylester in the presence of Chlorameisensäureisobu-, thionyl chloride, trimethylchlorosilane, sulfuric acid, methanesulfonic acid, p-toluenesulfonic acid, phosphorus trichloride, phosphorus pentoxide, N, N '-dicyclohexylcarbodiimide, N, N' -Dicyclo- hexylcarbodiimid / N-hydroxysuccinimide or 1-hydroxy-benzotriazole and optionally additionally carried out in the presence of 4-dimethylamino-pyridine, N, N'-carbonyldiimidazole or triphenylphosphine / carbon tetrachloride, advantageously at temperatures between 0 and 150 ° C., preferably at temperatures between 0 and 80 ° C. .

The subsequent hydrogenation is preferably carried out with hydrogen in the presence of a catalyst such as palladium / carbon in a solvent such as methanol, ethanol, ethyl acetate or glacial acetic acid, optionally with the addition of an acid such as hydrochloric acid at temperatures between 0 and 100 ° C, but preferably at temperatures between 20 and 60 ° C, and at a hydrogen pressure of 1 to 7 bar, but preferably of 3 to 5 bar.

In the reactions described above, any reactive groups present, such as hydroxyl, carboxy, amino, alkylamino, imino or amidino groups, can be protected during the reaction by customary protective groups, which are split off again after the reaction. For example, the trimethylsilyl, acetyl, benzoyl, tert-butyl, trityl, benzyl or tetrahydropyranyl group comes as a protective radical for a hydroxyl group,

as protective residues for a carboxy1 group, the trimethylsilyl, methyl, ethyl, tert.butyl, benzyl or tetrahydropyranyl group,

as a protective radical for an amidino group optionally substituted by an alkyl group, the benzyloxycarbonyl group and

as a protective radical for an amino, alkylamino or imino group, the for yl, acetyl, trifluoroacetyl, ethoxycarbonyl, tert.butoxycarbonyl, benzyloxycarbonyl, benzyl, methoxybenzyl or 2,4-dimethoxybenzyl group for the imino group additionally the methyl group and the phthalyl group for the amino group.

The subsequent subsequent splitting off of a protective residue used takes place, for example, hydrolytically in an aqueous solvent, e.g. in water, isopropanol / water, acetic acid / water, tetrahydrofuran / water or dioxane / water, in the presence of an acid such as trifluoroacetic acid, hydrochloric acid or sulfuric acid or in the presence of an alkali base such as sodium hydroxide or potassium hydroxide or by ether cleavage, e.g. in the presence of iodotrimethylsilane, at temperatures between 0 and 120 ° C, preferably at temperatures between 10 and 100 ° C.

However, a benzyl, methoxybenzyl or benzyloxycarbonyl radical is split off, for example by hydrogenolysis, for example using hydrogen in the presence of a catalyst such as palladium / carbon in a solvent such as methanol, ethanol, ethyl acetate or glacial acetic acid, optionally with the addition of an acid such as hydrochloric acid at temperatures between 0 and ₁ 00 ° C, but preferably at temperatures between 20 and 60 ° C, and at a hydrogen pressure of 1 to 7 bar, but preferably from 3 to 5 bar.

A tert-butyl or tert-butyloxycarbonyl radical is preferably cleaved off by treatment with an acid such as trifluoroacetic acid or hydrochloric acid or by treatment with iodotrimethylsilane, optionally using a solvent such as methylene chloride, dioxane, methanol or ether.

A trifluoroacetyl radical is preferably cleaved by treatment with an acid such as hydrochloric acid, if appropriate in the presence of a solvent such as acetic acid or methanol at temperatures between 50 and 120 ° C. or by treatment with sodium hydroxide solution if appropriate in the presence of a solvent such as tetrahydrofuran or methanol at temperatures between between 0 and 50 ° C.

A methyl group is preferably cleaved from a methylimino group in the presence of 1-chloroalkyl chloroformate such as 1-chloroethyl chloroformate, preferably in the presence of a base such as 1,8-bis (dimethylamino) naphthalene in the presence of a solvent such as methylene chloride , 1,2-dichloroethane, toluene or dioxane at temperatures between 0 and 150 ° C, preferably at temperatures between 20 ° C and the boiling point of the reaction mixture, and subsequent treatment with an alcohol such as methanol at temperatures between 20 ° C and the boiling point of the alcohol used.

A phthalyl radical is preferably cleaved in the presence of hydrazine or a primary amine such as methylamine, ethylamine or n-butylamine in a solvent such as methanol, ethanol, isopropanol, toluene / water or dioxane at temperatures between 20 and 50 ° C. Furthermore, as already mentioned at the beginning, the compounds of general formula I obtained can be separated into their enantiomers and / or diastereomers. For example, cis / trans mixtures can be separated into their ice and trans isomers, and compounds with at least one optically active carbon atom can be separated into their enantiomers.

For example, the cis / trans mixtures obtained can be chromatographed into their eis and trans isomers, the compounds of general formula I obtained which occur in racemates, according to methods known per se (see Allinger NL and Eliel EL in "Topics in Stereochemistry", Vol. 6, Wiley Interscience, 1971)) in their optical antipodes and compounds of the general formula I with at least 2 asymmetric carbon atoms on the basis of their physico-chemical differences according to methods known per se, for example by chromatography and / or fractional crystallization, into their diastereomers, which, if they occur in racemic form, can then be separated into the enantiomers as mentioned above.

The enantiomers are separated preferably by column separation on chiral phases or by recrystallization from an optically active solvent or by reaction with an optically active substance which forms salts or derivatives, such as esters or amides, with the racemic compound, in particular acids and their activated derivatives or alcohols, and separation of the diastereomeric salt mixture or derivative obtained in this way, for example on the basis of different solubilities, it being possible for the free antipodes to be released from the pure diastereomeric salts or derivatives by the action of suitable agents. Particularly common, optically active acids are, for example, the D and L forms of tartaric acid or dibenzoyl tartaric acid, di-o-tolyltartaric acid, malic acid, mandelic acid, camphorsulfonic acid, glutamic acid, aspartic acid or quinic acid. For example, (+) - or (-) menthol is used as optically active alcohol and as optically active Acyl radical in amides, for example, {+) or (-) menthyloxycarbonyl.

Furthermore, the compounds of the formula I obtained can be converted into their salts, in particular for pharmaceutical use into their physiologically tolerable salts with inorganic or organic acids. Examples of suitable acids for this purpose are hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, fumaric acid, succinic acid, lactic acid, citric acid, tartaric acid or maleic acid.

In addition, the new compounds of formula I thus obtained, if they contain a carboxyl group, can, if desired, subsequently be converted into their salts with inorganic or organic bases, in particular for their pharmaceutical use into their physiologically tolerable salts. Suitable bases here are, for example, sodium hydroxide, potassium hydroxide, arginine, cyclohexylamine, ethanolamine, dieethanolamine and triethanolamine.

Some of the compounds used as starting materials are known from the literature or can be obtained by processes known from the literature (see examples).

As already mentioned at the beginning, the new cyclic urea derivatives of the general formula I and their salts, in particular their physiologically tolerable salts with inorganic or organic acids or bases, have valuable properties. Thus, the new compounds of general formula I have valuable pharmacological properties, in addition to an anti-inflammatory and bone-depleting action, in particular antithrombotic, anti-aggregation and anti-tumor or metastatic effects.

For example, the compounds of general formula I were examined for their biological effects as follows: 1. Inhibition of ³ H-BIBU 52 binding to human platelets:

A suspension of human platelets in plasma is mixed with ³ H-BIBU 52 [= (3S, 5S) -5- [(4 '-amidino-4-biphenylyl) oxymethyl] - 3- [(carboxy) methyl] -2-pyrrolidinone [ 3- ³ H-4-biphenylyl]], which replaces the ligand ¹²⁵ J-fibrinogen known from the literature (see DE-A-4,214,245) and incubates various concentrations of the substance to be tested. The free and bound ligand is separated by centrifugation and quantified by scintillation counting. The inhibition of the ³ H-BIBU 52 binding by the test substance is determined from the measured values.

For this purpose, donor blood is drawn from an anti-cubital vein and anticoagulated with trisodium citrate (final concentration 13 mM). The blood is centrifuged at 170 xg for 10 minutes and the supernatant platelet-rich plasma (PRP) is removed. The residual blood is sharply centrifuged off again to obtain plasma. The PRP is diluted 1:10 with autologous plasma. 750 μl are incubated with 50 μl physiological saline, 100 μl test substance solution, 50 μl ¹ C-sucrose (3,700 Bq) and 50 μl ³ H-BIBU 52 (final concentration: 5 nM) at room temperature for 20 minutes. To measure the non-specific binding, 5 μl BIBU 52 (final concentration: 30 μM) is used instead of the test substance. The samples are centrifuged at 10,000 xg for 20 seconds and the supernatant is removed. 100 μl of this are measured to determine the free ligand. The pellet is dissolved in 500 μl of 0.2N NaOH, 450 μl are mixed with 2 ml of scintillator and 25 μl of 5N HC1 and measured. The residual plasma remaining in the pellet is determined from the ¹⁴ C content, the bound ligand from the ³ H measurement. After deduction of the non-specific binding, the pellet activity is plotted against the concentration of the test substance and the concentration for a 50% inhibition of binding is determined. 2nd Antithrombotic effect:

methodology

Platelet aggregation is measured by the method of Born and Cross (J. Physiol. 170, 397 (1964)) in platelet-rich plasma from healthy subjects. To inhibit coagulation, the blood is mixed with 3.14% sodium citrate in a volume ratio of 1:10.

Collagen-induced aασreαation

The course of the decrease in the optical density of the platelet suspension is measured and registered photometrically after the addition of the aggregation-triggering substance. The rate of aggregation is inferred from the angle of inclination of the density curve. The point of the curve at which the greatest light transmittance is present is used to calculate the "optical density".

The amount of collagen is chosen to be as small as possible, but in such a way that there is an irreversible reaction curve. The commercial collagen from Hormonchemie, Munich, is used.

Before the collagen addition, the plasma is incubated with the substance at 37 ° C. for 10 minutes.

An EC5 ₀ is determined graphically from the measured numbers obtained and relates to a 50% change in the "optical density" in the sense of an inhibition of aggregation. The following table contains the results found

Substance fibrinogen inhibition of

(Example No.) Binding test platelet aggregation

IC ₅₀ [nM] EC ₅₀ [nM]

3 390 1200

1 (3) 57 150

1 (2) 150 140

9 100 160

1 (6) 750 3700

3 (5) 340 1000

1 (18) 26 3300

1 (20) 360 3700

11 (11) 250 4000

11 (13) 450

15 (6) 880

Because of their inhibitory effect on cell-cell or cell-matrix interactions, the new cyclic urea derivatives of the general formula I and their physiologically tolerable salts are suitable for combating or preventing diseases in which smaller or larger ones Zeil aggregates occur or Zeil-matrix interactions play a role, for example in combating or preventing venous and arterial thrombosis, cerebrovaseular diseases, pulmonary embolism, myocardial infarction, arteriosclerosis, osteoporosis and the metastasis of tumors and therapy genetically related or acquired disorders of the interactions of cells with one another or with solid structures. These are also suitable for accompanying therapy in thrombolysis with fibrinolytics or vascular interventions such as transluminal angioplasty or in the therapy of shock conditions, psoriasis, diabetes and inflammation. To combat or prevent the abovementioned diseases, the dose is between 0.1 μg and 30 mg / kg body weight, preferably 1 μg to 15 mg / kg body weight, with up to 4 doses per day. For this purpose, the compounds of the formula I prepared according to the invention, optionally in combination with other active substances such as thromboxane receptor antagonists and thromboxane synthesis inhibitors or their combinations, serotonin antagonists, α-receptor antagonists, alkyl nitrates such as glycerol trinitrate, phosphodiesterase inhibitors, prostacyclin and their Analogs, fibrinolytics such as tPA, prourokinase, urokinase, streptokinase, or anticoagulants such as heparin, dermatan sulfate, activated protein C, vitamin K antagonists, hirudin, inhibitors of thrombin or other activated coagulation factors, together with one or more inert customary carriers and / or diluents, for example with corn starch, milk sugar, cane sugar, microcrystalline cellulose, magnesium stearate, polyvinylpyrrolidone, citric acid, tartaric acid, water, water / ethanol, water / glycerol, water / sorbitol, water / polyethylene glycol, propylene glycol. kol, stearyl alcohol, carboxymethyl cell Incorporate ulose or fat-containing substances such as hard fat or their suitable mixtures into conventional pharmaceutical preparations such as tablets, dragees, capsules, powders, suspensions, solutions, sprays or suppositories.

The following examples are intended to explain the invention in more detail:

Hfi-ra el l unςr of the Ausςiang products:

Example I

N- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -N '- [1- (meth-oxycarbonyl) ethyl] -N' - (3-trifluoroacetyl-2,3,4,5-tetrahydro- lH-3-benzazepin-7-yl) urea

4.9 g of 7- [[1- (methoxycarbonyl) ethyl] amino] -3-trifluoroacetyl-2,3,4,5-tetrahydro-1H-3-benzazepine and 3.0 g of [trans-4- [2- (Methoxycarbonyl) ethyl] cyclohexyl] isocyanate (prepared from the corresponding amine hydrochloride by reaction with phosgene) are stirred in 5 ml of dioxane at room temperature for 3 days and then at 70 ° C. for 4 hours. The reaction mixture is concentrated and the residue is purified by chromatography on a silica gel column using cyclohexane / ethyl acetate (65:35 and 50:50).

Yield: 5.4 g (68% of theory), Rf value: 0.35 (silica gel; cyclohexane / ethyl acetate = 1: 1)

The following compounds are obtained analogously to Example I:

(1) N- (1-Benzyl-4-piperidinyl) -N- (2,2-dimethoxyethyl) -N ¹ - (3-trifluoroacetyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7 -yl) - urea

The (3-trifluoroacetyl-2,3,4,5-tetrahydro-1H-benzazepin-7-yl) isocyanate is obtained by reacting the corresponding amine with phosgene. The N- (1-benzyl-4-piperidinyl) -N- (2,2-dimethoxyethyl) amine [R _f value: 0.64 (silica gel; toluene / dioxane / methanol / concentrated aqueous ammonia = 20 : 50: 20: 10)] is obtained by reductive amination of 1-benzyl-4-piperidone with aminoacetal dehyd dimethyl acetal.

Rf value: 0.47 (silica gel; methylene chloride / acetone / concentrated aqueous ammonia = 80: 20: 1) (2) 1-Acetyl-2- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] - 4- (3-trifluoroacetyl-2, 3,4,5-tetrahydro-1H-3-benzazepine-7- yl) - semicarbazide

Reaction of l-acetyl-2- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] hydrazine with (3-trifluoroacetyl-2, 3.4, 5-tetrahydro-lH-3-benzazepin-7-yl) isocyanate ,

Melting point: 163-165 ° C

Rf value: 0.38 (silica gel; cyclohexane / ethyl acetate = 1: 4)

(3) N- (2,2-Diethoxyethyl) -N- (1,4-dioxaspiro [4,5] decan-8-yl) - N '- (3-trifluoroacetyl-2, 3,4,5-tetrahydro -1H-3-benzazepin-7-yl) - urea

The N- (2, 2-diethoxyethyl) -N- (1,4-dioxaspiro [4, 5] - decan-8-yl) amine used [R _f value: 0.42 (silica gel; methylene chloride / methanol) = 20: 1)] is obtained by reductive amination of 1,4-cyclohexanedione-monoethylene ketal with aminoacetaldehyde diethyl acetal. Rf value: 0.75 (silica gel; methylene chloride / methanol = 20: 1)

(4) N- (3-tert-butyloxycarbonyl-9-fluoro-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) -N '- (2,2-diethoxyethyl) -N' - [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] urea

Preparation of the isocyanate in situ by treating the compound of Example VI (3) with phosphoric acid diphenyl ester azide in the presence of triethylamine. R _f value: 0.53 (silica gel; cyclohexane / ethyl acetate = 1: 1)

(5) N- (3-tert-Butyloxycarbonyl-8-fluoro-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) -N "- (2,2-dimethoxyethyl) -N ' - [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] urea Example II

7- [[1- (methoxycarbonyl) ethyl] amino] -3-trifluoroacetyl-2, 3,4,5-tetrahydro-1H-3-benzazepine

To 4.59 g of 7-amino-3-trifluoroacetyl-2, 3,4, 5-tetrahydro-1H-3-benzazepine and 2.3 g of N-ethyl-diisopropylamine in 5 ml of dimethyl formamide are added 2.97 g of D , L-2-Bromopropionic acid methyl ester and give 18 hours at room temperature, 1 hour at 50 ° C. and then 4 hours at 75 ° C. The reaction mixture is cooled, mixed with ice water and extracted with tert-butyl methyl ether. The organic phase is washed with water, thinned citric acid and brine, dried and concentrated. The residue is purified by chromatography on a silica gel column using cyclohexane / ethyl acetate (73:27).

Yield: 5.7 g (93% of theory), melting point: 95-98 ° C Rf value: 0.75 (silica gel; cyclohexane / ethyl acetate = 6: 4)

Analogously to Example II, the following compound will contain:

(1) 7- [[2- (ethoxycarbonyl) -2-propyl] amino] -3-trifluoroacetyl-

2,3,4,5-tetrahydro-1H-3-benzazepine

Rf value: 0.60 (silica gel; cyclohexane / ethyl acetate = 6: 4)

Example III

7-amino-3-trifluoroacetyl-2,3,4,5-tetrahydro-1H-3-benzazepine

17.3 g of 7-nitro-3-trifluoroacetyl-2,3,4,5-tetrahydro-lH-3-benzazepine are dissolved in 200 ml of ethyl acetate with 3 g of 10% palladium on activated carbon at room temperature and a hydrogen pressure of 50 psi hydrogenated for one hour. The catalyst is suctioned off and the filtrate is evaporated. The residue is heated with tert-butyl methyl ether and cooled. The precipitate is filtered off, washed with tert-butyl methyl ether and dried. Yield: 12.2 g (79% of theory),

Melting point: 102-104 ° C

Rf value: 0.31 (silica gel; cyclohexane / ethyl acetate = 2: 1)

The following compounds are obtained analogously to Example III:

(1) 7-Amino-3-cyclopropyl-2, 3,4,5-tetrahydro-1H-3-benzazepine x 2 HC1 x 0.5 H ₂ 0

Carried out in methanol / methanolic hydrochloric acid Melting point: 220-230 ° C

Rf value: 0.47 (silica gel; methylene chloride / methanol / concentrated aqueous ammonia = 95: 5: 2) calc .: C 54.94 H 7.45 N 9.85 Cl 24.95 found: 54 , 64 7.56 9.69 25.12

(2) 7-Amino-3,5-dimethyl-2,3,4,5-tetrahydro-1H-3-benzazepin-4-one

Melting point: 186-191 ° C

(3) 7-Amino-1, 1,3-trimethyl-2,3,4,5-tetrahydro-lH-3-benzazepin-2-one

Melting point: 117-121 ° C

(4) 8-amino-7-methoxycarbonyl-3-trifluoroacetyl-2, 3,4,5-tetra-hydro-1H-3-benzazepine

Melting point: 125-128 ° C

9-Amino-7-methoxycarbonyl-3-trifluoroacetyl-2, 3,4,5-tetrahydro-1H-3-benzazepine Melting point: 201-203 ° C

Hydrogenation of the mixture of the corresponding nitro compounds from Example IV (2) and subsequent chromatographic separation of the isomers on silica gel with cyclohexane / methylene chloride (8: 100) and methylene chloride / ethyl acetate (100: 6) Example IV

7-nitro-3-trifluoroacetyl-2, 3,4,5-tetrahydro-lH-3-benzazepine

To a solution of 100 g of 3-trifluoroacetyl-2, 3, 4, 5-tetrahydro-1H-3 _τ benzazepine cooled to -10 ° C. [R _f value: 0.76 (silica gel; cyclohexane / ethyl acetate = 1 : 1), prepared by reacting 2, 3,4, 5-tetrahydro-lH-3-benzazepine with trifluoroacetic acid methyl ester] in 260 ml of concentrated sulfuric acid, a mixture of 29.9 ml of 65% nitric acid and 10 ml of concentrated sulfuric acid was added dropwise at an internal temperature of -5 to -12 ° C. The mixture is then stirred at -10 ° C for 4 hours. The reaction mixture is poured onto ice, extracted with ethyl acetate and the combined organic phases are washed 3 times with water. The organic phase is separated off, dried and evaporated. The residue is heated to boiling with 80 ml of tert-butyl methyl ether with stirring, then cooled in an ice bath and the precipitate is filtered off with suction. The product obtained is washed with tert-butyl methyl ether and then dried in vacuo. Yield: 75 g (64% of theory), melting point: 121-123 ° C Rf value: 0.57 (silica gel; cyclohexane / ethyl acetate 2: 1)

The following compounds are obtained analogously to Example IV:

(1) 3,4-bis (carboxymethyl) nitrobenzene Melting point: 198-200 ° C

Rf value: 0.30 (silica gel; methylene chloride / methanol / glacial acetic acid

95: 5: 2)

(2) 7-methoxycarbonyl-8-nitro-3-trifluoroacetyl-2, 3,4,5-tetrahyroid-1H-3-benzazepine and

7-methoxycarbonyl-9-nitro-3-trifluoroacetyl-2, 3,4,5-tetrahydro-1H-3-benzazepine

R _f value: 0.28 (silica gel; cyclohexane / methylene chloride = 1: 9). The crude product obtained after nitration is treated with thionyl chloride and then reacted with metha- nol in the presence of N-ethyl-diisopropylamine converted into the methyl ester. The 7-carboxy-3-trifluoroacetyl-2,3,4,5-tetrahydro-1H-3-benzazepine (melting point: 244-246 ° C.) used as the starting material is obtained by reacting 7-carboxy-2,3, 4,5-tetrahydro-lH-3-benzazepine hydrochloride with methyl trifluoroacetate in methanol and in the presence of triethylamine.

Example V

1- (4-Piperidinyl) -3- (3-ter .butyloxycarbonyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) -imidazolidin-2-one

10.9 g of 1- (1-benzyl-4-piperidinyl) -3- (3-tert-butyloxycarbonyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -3H-imidazole- 2-one are hydrogenated in 200 ml of methanol at 50 ° C. and a hydrogen pressure of 50 psi for 14 hours in the presence of 4.5 g of palladium on carbon. It is filtered and the filtrate is concentrated. Yield: 8.42 g (94% of theory),

Rf value: 0.08 (silica gel; methylene chloride / methanol / concentrated aqueous ammonia = 95: 5: 1)

Example VT

1- (1-Benzyl-4-piperidinyl) -3- (3-tert-butyloxycarbonyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) -3H-imidazol-2-one

To 15.79 g of 1- (1-benzyl-4-piperidinyl) -3- (3-trifluoroacetyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -3H-imidazol-2 9 ml of 4N sodium hydroxide solution are added to 150 ml of methanol and the mixture is heated on the steam bath for 45 minutes. The residue obtained on concentration is mixed with 100 ml of tetrahydrofuran and 7.9 g of di-tert-butyl pyrocarbonate, after which 15 ml of 2N sodium hydroxide solution are added dropwise. After stirring for 30 minutes, the reaction mixture is mixed with tert-butyl methyl ether and saturated sodium chloride solution, the aqueous phase is extracted with tert-butyl methyl ether and the combined organic phases are washed with sodium chloride solution. The organic phase is dried concentrated and the residue by chromatography on a

Silica gel column cleaned with methylene chloride / methanol (97: 3 and 95: 5).

Yield: 9.6 g (60% of theory),

Melting point: 171-174 ° C

Rf value: 0.48 (silica gel; methylene chloride / methanol = 95: 5)

The following compounds are obtained analogously to Example VI:

(1) 1- (2-Carboxyethyl) -3- (3-tert-butyloxycarbonyl-2,3,4,5-te-trahydro-1H-3-benzazepin-7-yl) -imidazolidin-2-one melting point: 149-151 ° C

(2) 1-Carboxymethyl-3- (3-tert-butyloxycarbonyl-2,3,4,5-tetra-hydro-1H-3-benzazepin-7-yl) -imidazolidin-2-one

R _f value: 0.16 (silica gel; cyclohexane / ethyl acetate = 1: 1)

(3) 7-carboxy-9-fluoro-3-tert-butyloxycarbonyl-2,3,4,5-tetra-hydro-1H-3-benzazepine

R _f value: 0.30 {silica gel; Cyclohexane / ethyl acetate = 7: 3)

(4) 7-carboxy-8-fluoro-3-tert-butyloxycarbonyl-2,3,4,5-tetra-hydro-1H-3-benzazepine

Example VII

1- (1-Benzyl-4-piperidinyl) -3- (3-trifluoroacetyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) -3H-imidazol-2-one

23.01 g of N- (1-benzyl-4-piperidinyl) -N- (2,2-dimethoxyethyl) -N '- (3-trifluoroacetyl-2,3,4,5-tetrahydro-1H-3-benzazepine 7-yl) urea are heated with 85 ml of trifluoroacetic acid on the steam bath for one hour. It is concentrated and the residue is partitioned between ethyl acetate and aqueous sodium carbonate solution. The aqueous phase is extracted with ethyl acetate and the combined organic phases are washed with brine and then dried. It is concentrated, the residue with tert. - Butyl methyl ether stirred and the solid filtered off and dried.

Yield: 15.89 g (89% of theory), melting point: 169-171 ° C

Rf value: 0.42 (silica gel; methylene chloride / acetone / concentrated aqueous ammonia = 80: 20: 1)

The following compounds are obtained analogously to Example VII:

(1) 1- (4-Oxocyclohexyl) -3- (3-trifluoroacetyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) -3H-imidazol-2-one Starting material: compound of Example 1 (3). Melting point. 214-216 ° C

Rf value: 0.34 (silica gel; cyclohexane / ethyl acetate = 1: 3)

(2) 1- [trans-4- (2-methoxycarbonyl) ethyl] cyclohexyl] -3- (3-trifluoroacetyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) - 3H-imidazol-2-one

Melting point: 132-134 ° C

Rf value: 0.35 (silica gel; methylene chloride / ethyl acetate = 85:15)

Example VIII

l-acetyl-2- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] hydrazin

To 22.2 g of 4- [2- (methoxycarbonyl) ethyl] cyclohexanone-acetylhydrazone (melting point: 101-104 ° C., prepared by reacting acetylhydrazine with 4- [2- (methoxycarbonyl) ethyl] cyclohexanone) and 7.9 g of sodium cyanoborohydride in 1.9 l of methanol are added to 5.3 ml of glacial acetic acid and stirred at room temperature for 18 hours. The reaction mixture is concentrated, mixed with water, made slightly alkaline with sodium bicarbonate and extracted three times with methylene chloride. The combined organic phases are dried and evaporated. The residue is dissolved in ethyl acetate by heating, the solution is cooled in an ice bath, the precipitate is suctioned off and with cold ethyl acetate washed. The solid is heated in tert-butyl methyl ether, it is cooled, the product is filtered off with suction, washed with tert-butyl methyl ether and then dried. Yield: 7.0 g (31% of theory), melting point: 98-100 ° C

The following compounds are obtained analogously to Example VIII:

(1) 1- [trans-4- (benzylamino) cyclohexyl] -3- (3-trifluoroacetyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2-one Starting material: compound of Example IX and benzylamine, isolation of the trans compound by chromatography over aluminum oxide.

Melting point: 205-208 ° C

Rf value: 0.35 {aluminum oxide; Methylene chloride / methanol

100: 2)

(2) 1- [trans-4- (methylamino) cyclohexyl] -3- (3-trifluoroacetyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) imidazolidin-2-one Starting material: compound of Example IX and methylamine, isolation of the trans compound by chromatography on aluminum oxide.

Melting point: 169-171 ° C

Rf value: 0.19 (aluminum oxide; methylene chloride / methanol =

100: 3)

Example IX

1- (4-Oxocyclohexyl) -3- (3-trifluoroacetyl-2, 3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -imidazolidin-2-one

12.7 g of 1- (4-hydroxycyclohexyl) -3- (3-trifluoroacetyl-2, 3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -imidazolidin-2-one and 9, 7 g of pyridinium chlorochromate are stirred in 60 ml of methylene chloride for 18 hours at room temperature. Another 1 g of pyridinium chlorochromate is added and the mixture is stirred for a further 3 hours. It is suctioned off from the solid, the filtrate is concentrated and the Residue by chromatography on a silica gel column

Methylene chloride / methanol (40: 1) cleaned.

Yield: 7.6 g (60% of theory),

Melting point: 80-82 ° C

Rf value: 0.50 (silica gel; methylene chloride / methanol = 20: 1)

Example X

1- (4-Hydroxycyclohexyl) -3- (3-trifluoroacetyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) imidazolidin-2-one

23.5 g of 1- (4-oxocyclohexyl) -3- (3-trifluoroacetyl-2,3,4,5-tetra-hydro-lH-3-benzazepin-7-yl) -3H-imidazol-2-one hydrogenated in 600 ml of methanol for 6 hours at room temperature in the presence of 6 g of platinum oxide and a hydrogen pressure of 3 bar. It is suctioned off from the catalyst, the filtrate is concentrated and the residue is purified by chromatography on a silica gel column with methylene chloride / methanol (100: 5). Yield: 12.8 g (54% of theory), Rf value: 0.41 (silica gel; methylene chloride / methanol = 20: 1)

The following compounds are obtained analogously to Example X:

(1) 1- [trans-4- (2-methoxycarbonyl) ethyl] cyclohexyl] -3- (3-trifluoroacetyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) - imidazolidin-2-one

Carried out in ethyl acetate with palladium / coal

Melting point: 165-168 ° C

Rf value: 0.44 (silica gel; cyclohexane / ethyl acetate = 1: 1)

(2) 1- [2- (ethoxycarbonyl) ethyl] -3- (3-trifluoroacetyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) -imidazolidin-2-one procedure in ethyl acetate with palladium / activated carbon. Melting point: 108-110 ° C

(3) 1- (Ethoxycarbonylmethyl) -3- (3-trifluoroacetyl-2,3,4,5-e-trahydro-1H-3-benzazepin-7-yl) -imidazolidin-2-one

R _f value: 0.40 (silica gel; cyclohexane / ethyl acetate = 1: 1) Example XI

Methyl 3- [trans-4- [(2,2-dimethoxyethyl) amino] cyclohexane] propionate x 0.5 fumaric acid

23.8 g of methyl 3- (4-oxocyclohexane) propionate, 14.1 ml of aminoacetaldehyde dimethyl acetal and 60 g of molecular sieve (3A) are stirred with 300 ml of toluene for 18 hours at room temperature. It is filtered and the filtrate is spun in at 40 ° C. in vacuo. The residue is dissolved in 100 ml of methanol and 3.8 g of sodium borohydride are added in portions at -25 to -30 ° C. The mixture is stirred for 15 minutes at -25 ° C, 30 minutes at -10 ° C and then overnight at room temperature. It is concentrated, water is added and the pH is adjusted to 5 using hydrochloric acid. The mixture is stirred for one hour at room temperature, made alkaline with potassium carbonate and extracted with ethyl acetate. The ethyl acetate extracts are dried and concentrated.

Yield: 34.7 g (98% of theory),

For ice / trans separation, 1.35 g are dissolved in 6 ml of tetrahydrofuran and 0.29 g of fumaric acid in 1 ml of tetrahydrofuran is added with stirring. The mixture is stirred for one hour at room temperature, the solid is filtered off and washed with tetrahydrofuran and tert-butyl methyl ether. Yield: 0.97 g (58.5% of theory),

For further purification, crystals are recrystallized from isopropanol. Melting point: 163-164 ° C

Rf value: 0.52 (silica gel, treated with ammonia; ethyl acetate / methanol = 9: 1) Example XII

N- (2,2-Dimethoxyethyl) -N- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -N '- (3-trifluoroacetyl-2,3,4,5-tetrahydro-lH-3 -benz- azepin-7-yl) urea

2.58 g of 7-amino-3-trifluoroacetyl-2, 3,4,5-tetrahydro- are added to 1.02 g of imidazole and 1.78 g of N, -carbonyldiimidazole in 7 ml of dimethylformamide at -8 ° C. 1H-3-benzazepine in 7 ml of dimethyl formamide was added dropwise within 18 minutes. After stirring for 25 minutes at -5 ° C., a mixture of 3.31 g of methyl 3- [trans-4- [(2,2-dimethoxyethyl) amino] cyclohexane] propionate x 0.5 fumaric acid, 2.77 ml triethylamine aand 15 ml of dimethylformamide added at once. After stirring at room temperature for 18 hours, the mixture is poured into 150 ml of water, stirred for 10 minutes and decanted. The residue is taken up in ethyl acetate, washed with water, dried and concentrated. The residue is crystallized from tert-butyl methyl ether / cyclohexane. Yield: 4.83 g (86% of theory), melting point: 116-118 ° C

Rf value: 0.28 (silica gel; cyclohexane / ethyl acetate = 7: 3) calc. : C 58.16 H 6.87 N 7.54 Found: 58.28 7.00 7.65

The following compounds are obtained analogously to Example XII:

(1) N- (2-Hydroxyethyl) -N- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -N '- (3-cyclopropyl-2,3,4,5-tetrahydro-lH- 3-benz azepin-7-yl) urea

Melting point: 162-165 ° C

Rf value: 0.12 (silica gel; methylene chloride / methanol = 95: 5)

(2) N- (2,2-Dimethoxyethyl) -N- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -N ¹ - (3,5-dimethyl-2,3,4,5- tetrahydro-1H-3-benzazepin-7-yl) urea

Rf value: 0.25 (aluminum oxide; cyclohexane / ethyl acetate = 1: 1) (3) N- (2,2-Dimethoxyethyl) -N- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -N '- (1, 1, 3-trimethyl-2, 3,4, 5-tetrahydro-1H-3-benzazepin-7-yl) urea

Melting point: 103-105 ° C

(4) N- (2,2-Dimethoxyethyl) -N- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -N ¹ - [3- (2,2,2-trifluoroethyl-2,3 , 4,5-tetra-hydro-lH-3-benzazepin-7-yl) urea

Rf value: 0.40 (silica gel; cyclohexane / ethyl acetate = 3: 2)

Example XIII

1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) imidazolidin-2-one x HC1

Prepared analogously to Example 1 from the compound of Example X (l).

Melting point:> 250 ° C

Rf value: 0.46 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) calc. : C 62.62 H 7.64 N 9.98 Cl 8.40 Found: 62.24 7.67 10.01 8.86

Example XTV

1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2-one hydrochloride

Prepared analogously to Example 4 from the compound of Example XIII.

Rf value: 0.26 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution: 6: 4) calc .: C 63.36 H 7.86 N 9.64 Cl 8.13 found: 63, 34 7.88 9.73 8.11 Example XV

N- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] ethanolamine

5.0 g of N-benzyl-N- [trans-4- [2-methoxycarbonyl) ethyl] cyclohexyl] ethanolamine are dissolved in 150 ml of methanol with 1.0 g of 10% palladium on charcoal for 1 3/4 hours at 50 ° C. and hydrogenated to a hydrogen pressure of 50 psi. It is filtered and evaporated.

Yield: 3.3 g (92% of theory),

Rf value: 0.20 {silica gel; Methylene chloride / methanol / conc. aqueous ammonia = 9: 1: 0.4)

The following compound is obtained analogously to Example XV:

(1) N- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] aminoacetaldehyde diethyl acetal

R _f value: 0.60 (aluminum oxide; cyclohexane / ethyl acetate = 3: 2)

Example XVI

N-benzyl-N- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] ethanolamine

6.2 g of N- [trans-4- [2-methoxycarbonyl) ethyl] cyclohexyl] benzylamine hydrochloride, 12.8 g of N-ethyl-diisopropylamine and 5.0 g of 2-bromoethanol are 22 hours at 100 ° C stirred and then cooled. It is partitioned between ethyl acetate and water, the aqueous phase is shaken out with ethyl acetate and the combined ethyl acetate phases are washed with saturated sodium chloride solution. The ethyl acetate phase is evaporated and the residue is purified by chromatography on a silica gel column with methylene chloride / methanol (9: 1). "Yield: 5.1 g (80% of theory), Rf value: 0.67 (silica gel; methylene chloride / Methanol = 9: 1)

The following compound is obtained analogously to Example XVI: (1) N-Benzyl-N- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] aminoacetaldehyde diethyl acetal R _f value: 0.44 (silica gel; cyclohexane / ethyl acetate = 9: 1)

Example XVII

N- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] benzylamine hydrochloride

8.0 g of 3- (trans-4-aminocyclohexyl) propionic acid methyl ester hydrochloride, 4.3 g of benzaldehyde and 5.0 ml of triethylamine in 150 ml of methanol are mixed with 1.0 g of Raney nickel at 50 C and a hydrogen pressure of 50 psi hydrogenated for 4 hours. After cooling, it is suctioned off and the filtrate is evaporated. The residue is partitioned between ethyl acetate and water, the aqueous phase is adjusted to pH 8-9 with sodium hydroxide solution and extracted with ethyl acetate. The combined ethyl acetate phases are washed with saturated sodium chloride solution, dried and rotated in. The residue is suspended in diethyl ether and methanolic hydrochloric acid is added. The precipitate is filtered off, washed with diethyl ether and dried. Yield: 7.4 g (66% of theory), melting point: 170-172 ° C

Calc .: C 65.47 H 8.40 N 4.49 Cl 11.37 Found: 65.38 8.44 4.46 11.40

Example XVTTT

3-Cyclopropyl-7-nitro-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride

A mixture of 3.2 g of cyclopropylamine and 15.2 g of N-ethyl-diisopropylamine are added to 20.5 g of 3,4-bis- [2- (methanesulfonyloxy) ethyl] nitrobenzene in 200 ml of dimethylformamide at 70-80 ° C. added dropwise within 30 minutes. The mixture is then stirred at 90 ° C for 6 hours. The reaction mixture is poured onto 600 g of ice water mixture and extracted again with tert-butyl methyl ether. The combined extracts are with water and Washed saline, dried and concentrated. The residue is dissolved in a mixture of 50 ml of acetone and 50 ml of diethyl ether and then mixed with ethereal hydrochloric acid. After stirring a little, the product is filtered off with suction and the solid is washed with a little diethyl ether and acetone. Yield: 4.7 g (30% of theory), melting point: from 220 ° C (dec.)

Rf value of the free base: 0.65 (silica gel; methylene chloride / -

Methanol = 95: 5)

Example XTX

3,4-bis- [2- (methanesulfonyloxy) ethyl] nitrobenzene

To 13.6 g of 3,4-bis (2-hydroxyethyl) nitrobenzene (melting point: 117-119 ° C; prepared from 2,4-bis (carboxymethyl) nitrobenzene by esterification with methanol / thionyl chloride and subsequent reduction with Lithium borohydride in tetrahydrofuran in the presence of methanol) and 18.44 g of methanesulfonic acid chloride in 160 ml of methylene chloride are added dropwise at 0 to 10 ° C with stirring 17.6 g of triethylamine. After stirring for two hours, ice water is added, the organic phase is separated off, washed with ice water, dried and concentrated. The residue is purified by crystallization with a little vinegar and stirring with tert-butyl methyl ether. Yield: 20.5 g (87% of theory), melting point: 91-100 ° C (dec.) Rf value: 0.81 (silica gel; methylene chloride / methanol = 95: 5)

Example XX

7-amino-3,5-dimethyl-2,3,4,5-tetrahydro-1H-3-benzazepine

8.8 ml of a 1-molar borane solution are added to 450 mg of 7-amino-3,5-dimethyl-2,3,4,5-tetrahydro-1H-3-benzazepin-4-one in 10 ml of tetrahydrofuran with stirring added in tetrahydrofuran and then heated under reflux for 5 hours. Another 1 ml of the borane solution is added and a further 4 hours heated. The mixture is then concentrated, 10 ml of semi-concentrated hydrochloric acid are added to the residue and the mixture is heated on a steam bath for 3 hours. It is concentrated and the residue is partitioned between methylene chloride and sodium hydroxide solution. The organic phase is separated off and the aqueous phase is extracted again with methylene chloride. The combined organic phases are dried and concentrated. Yield: 410 mg (93% of theory), R _f value: 0.11 (silica gel; methylene chloride / methanol = 95: 5)

The following compounds are obtained analogously to Example XX:

(1) 7-Amino-l, 1,3-dimethyl-2,3,4,5-tetrahydro-lH-3-benzazepine dihydrochloride

Isolation as hydrochloride

Melting point: 267-280 ° C

Ber. : C 56.32 H 8.00 N 10.10 Cl 25.58

Gef. : 56, 19 8, 02 10, 01 24, 98

(2) 7-Amino-3- (2, 2, 2-trifluoroethyl) -2,3,4,5-tetrahydro-1H-3-benzazepine

Representation from the corresponding trifluoroacetyl compound Rf value: 0.78 (silica gel; cyclohexane / ethyl acetate = 1: 1)

Example XXI

7-nitro-l, l, 3-trimethyl-2, 3,4, 5-tetrahydro-1H-3-benzazepin-2-one and

3, 5-Dimethyl-7-nitro-4, 5-dihydro-3H-3-benzazepin-4-one

60 g of 3-tert-butyloxycarbonyl-7-nitro-2, 3,4, 5-tetrahydro-1H-3-benzazepine in 600 ml of ethyl acetate are mixed with 190 g of sodium metaperiodate and 6.2 g of ruthenium trichloride with vigorous stirring -hydrate in 800 ml of water added. After 2 and 3 hours of stirring, a further 22 g of sodium metaperiodate are added in a little water. After a further hour, the mixture is diluted with ethyl acetate and suction filtered. The aqueous phase is extracted with ethyl acetate and the combined organic phases with Na trium thiosulfate and saline solution, dried and evaporated. The residue is taken up in methylene chloride and mixed with 60 ml of trifluoroacetic acid while cooling with ice. After stirring overnight, the mixture is diluted with methylene chloride and methanol and washed neutral with water and sodium hydrogen carbonate solution. The organic phase is concentrated, the residue is boiled with 150 ml of ethyl acetate, the mixture is cooled with stirring and the precipitate is filtered off with suction.

8.0 g of this mixture consisting of 7-nitro-2,3,4,5-tetra-hydro-lH-3-benzazepin-2-one and 7-nitro-2, 3,, 5-tetrahydro-lH-3 -benzazepin-4-one, 120 ml methylene chloride, 22.2 g methyl iodide, 20.5 g powdered potassium hydroxide and 800 mg dibenzo-18-krone- 6 are stirred vigorously for 5 hours at room temperature. 5 ml of methyl iodide are added and the mixture is stirred for a further 16 hours. The reaction mixture is diluted with methylene chloride and water and acidified with hydrochloric acid. The organic phase is separated off, the aqueous phase is extracted with methylene chloride and the combined organic phases are washed with sodium hydrogen sulfate solution and water, dried and concentrated. The residue is separated by chromatography on silica gel with cyclohexane / ethyl acetate (1: 1 to 2: 8).

The following connections are obtained:

3,5-dimethyl-7-nitro-4,5-dihydro-3H-3-benzazepin-4-one

Yield: 240 mg (2.6% of theory),

Melting point: 192-194 ° C

R _f value: 0.56 (silica gel; cyclohexane / ethyl acetate = 1: 1)

and

7-nitro-l, 1, 3-trimethyl-2, 3,4, 5-tetrahydro-1H-3-benzazepine

2-one

Yield: 2.4 g (25% of theory),

Melting point: 85-89 ° C

R _f value: 0.44 (silica gel; cyclohexane / ethyl acetate = 1: 1) Example XXTI

1- [2- (Ethoxycarbonyl) ethyl] -3- (3-trifluoroacetyl-2,3,4,5-tetra-hydro-lH-3-benzazepin-7-yl) -3H-imidazol-2-one

20 g 7- [(2,2-dimethoxyethyl) amino] -3-trifluoroacetyl-2,3,4,5-tetrahydro-lH-3-benzazepine [R _f value: 0.59 (silica gel; cyclohexane / Essiges_er = 3: 2), prepared by reacting 7-amino-3-trifluoroacetyl-2,3,4,5-tetrahydro-1H-3-benzazepine with bromoacetaldehyde dimethyl acetal in the presence of N-ethyl-diisopropylamine] and 8.3 g 2- (Ethoxycarbonyl) ethyl isocyanate are refluxed in 10 ml of dioxane for 3 hours. The reaction mixture is concentrated and the residue is purified by chromatography on a silica gel column using cyclohexane / ethyl acetate (3: 7).

Yield: 17.2 g (70% of theory), melting point: 88-91 ° C.

The following compound is obtained analogously to Example XXII:

(1) 1- (ethoxycarbonylmethyl) -3- (3-trifluoroacetyl-2,3,4,5-te-trahydro-1H-3-benzazepin-7-yl) -3H-imidazol-2-one melting point: 105- 110 ° C

Example XXITT

1- (2-carboxyethyl) -3- (3-methyl-2,3,4,5-tetrahydro-1H-3-benz¬ azepin-7-yl) imidazolidin-2-one hydrochloride

7.5 g of 1- [2- (ethoxycarbonyl) ethyl] -3- (3-trifluoroacetyl-2,3,, 5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2-one, 80 ml Tetrahydrofuran, 4.5 ml of water and 17.5 ml of 2N sodium hydroxide solution are stirred at 50 ° C. for 3 hours. It is cooled, mixed with 4.8 ml of formic acid and concentrated. The residue is mixed with 16 ml of water, 6.6 ml of formic acid, 5.3 ml of 37% formalin solution and 2.95 g of sodium hydrogen carbonate are added and the mixture is stirred at 65 ° C. for 18 hours. 16 ml of 2N hydrochloric acid are added, the mixture is concentrated, again 16 ml of 2N hydrochloric acid added and evaporated again. The residue is stirred with ethanol, the solid is filtered off with suction and the filtrate is evaporated. The residue is brought to crystallization with acetone, suction filtered, washed with acetone and dried. R _f value: 0.69 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4)

The following compound is obtained analogously to Example XXIII:

(1) 1-Carboxymethyl-3- {3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) imidazolidin-2-one hydrochloride Melting point: 273-275 ° C.

Example XXIV

9-fluoro-7-methoxycarbonyl-3-trifluoroacetyl-2,3,4,5-tetrahydro-1H-3-benzazepine

1.2 g of nitrosonium tetrafluoroborate are added to 2.9 g of 9-amino-7-methoxycarbonyl-3-trifluoroacetyl-2,3,4,5-tetrahydro-lH-3-benzazepine in 50 ml of methylene chloride, and the mixture is stirred for 30 minutes stirs. 30 ml of 1,2-dichlorobenzene are added and the methylene chloride is then distilled off at a bath temperature of 110 ° C. The mixture is heated to 150 ° C. for one hour, cooled, concentrated and the residue is purified by chromatography on a silica gel column using cyclohexane / ethyl acetate (2: 8).

Yield: 2.1 g (72% of theory), melting point: 100-102 ° C

The following compound is obtained analogously to Example XXIV:

(1) 8-fluoro-7-methoxycarbonyl-3-trifluoroacetyl-2,3,4,5-tetrahydro-1H-3-benzazepine Hp- ellung the end products:

example 1

3- [trans-4- (2-carboxyethyl) cyclohexyl] -1- (2,3,4, 5-tetrahydro-1H-3-benzazepin-7-yl) -5-methyl _r hydantoin hydrochloride

4.7 g of 3- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -1- (3-trifluoroacetyl-2, 3,4,5-tetrahydro-lH-3-benzazepin-7-yl) - 5-methylhydantoin are refluxed with 20 ml of glacial acetic acid and 50 ml of 3N hydrochloric acid for 5 hours. After standing at room temperature overnight, the mixture is concentrated and the residue is evaporated several times with toluene. The residue is stirred with acetone, the solid is filtered off with suction, washed with acetone and diethyl ether and then dried. Yield: 3.28 g (88% of theory), melting point:> 250 ° C

Rf value: 0.42 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) calc. : C 61.39 H 7.17 N 9.34 Cl 7.88 Found: 61.48 7.20 9.37 8.03

The following compounds are obtained analogously to Example 1:

(1) 3- [trans-4- (2-carboxyethyl) cyclohexyl] -1- (2, 3,4,5-tetrahydro-1H-3-benzazepin-7-yl) -5, 5-dimethyl- hydantoin hydrochloride x H ₂ 0

Melting point:> 250 ° C

Rf value: 0.41 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) calc. : C 59.80 H 7.53 N 8.72 Cl 7.36 Found: 59.43 7.86 8.69 7.85

(2) 1- [1- (2-Carboxyethyl) -4-piperidinyl] -3- (3-methyl-2, 3,4, 5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2 -on x 2 HC1 x H ₂ 0

Carried out with 3N hydrochloric acid Rf value: 0.68 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) calc. : C 53.77 H 7.38 N 11.40 Cl 14.43 Found: 53.52 7.46 10.92 14.75

(3) 1- [1- (2-Carboxyethyl) -4-piperidinyl] -3- (2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) imidazolidin-2-one x 2 HCl x 0.5 H2O Melting point:> 250 ° C

Rf value: 0.74 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) calc. : C 53.85 H 7.10 N 11.96 Cl 15.14 Found: 53.76 7.10 11.75 15.79

(4) 1- (1-Carboxymethyl-4-piperidinyl) -3- (2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) imidazolidin-2-one dihydrochloride

Rf value: 0.71 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4)

(5) 2- [trans-4- (2-carboxyethyl) cyclohexyl] -4- (2,3,4,5-tetrahyroid-1H-3-benzazepin-7-yl) -5-methyl-4H- 1,2,4-triazol-3-one x 1.1 HCl

Melting point:> 220 ° C

Rf value: 0.58 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) calc. : C 60.24 H 7.15 N 12.77 Cl 8.89 Found: 60.33 7.16 12.92 8.63

(6) 1- [trans-4- (N-benzyl-N-carboxymethylamino) cyclohexyl] -3- (2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidine 2-on x 2.5 HCl x 3.5 H ₂ 0

Carried out with 2N hydrochloric acid

Rf value: 0.53 (reversed phase silica gel; methanol / 5% strength aqueous saline solution = 6: 4) calc .: C 53.31 H 7.27 N 8.88 Cl 14.05 found: ^• 53 , 43 7.37 8.88 14.17 (7) 1- [trans-4- (N-methyl-N-carboxymethylamino) cyclohexyl] -3- (2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidine 2-on x 2.6 HCl x 4 H ₂ 0

Rf value: 0.67 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) calc .: C 46.57 H 7.56 N 9.87 Cl 16.25 found: 46, 43 7.55 9.79 16.21

(8) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (3-cinnamyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2- on x 1, 1 HCl

Melting point:> 250 ° C

Rf value: 0.08 (silica gel; methylene chloride / methanol / concentrated aqueous ammonia = 90: 10: 2) calc. : C 68.73 H 7.46 N 7.76 Cl 7.20 Found: 68.87 7.61 7.71 7.40

(9) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (3-cyclopropyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidin-2- on x HCl

Melting point:> 230 ° C (decomp.)

Rf value: 0.29 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) calc. : C 64.99 H 7.85 N 9.09 Cl 7.67 Found: C 64.35 7.86 9.02 7.64

(10) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (3,5-dimethyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidine 2-on x 1.2 HCl x 0.5 H ₂ 0

Melting point: 240 ° C (decomp.)

Rf value: 0.34 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) calc. : C 61.82 H 8.04 N 9.01 Cl 9.12 Found: C 62.13 8.05 9.08 9.00 (11) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (3,5,5-trimethyl-2, 3,4,5-tetrahydro-lH-3-benzazepin-7-yl ) imidazolidin-2-one hydrochloride

(12) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (1, 1,3, 5, 5-pentamethyl-2, 3,4, 5-tetrahydro-IH-3-benzazepine -7-yl) imidazolino din-2-one hydrochloride

(13) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (3,4-dimethyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidine 2-one hydrochloride

(14) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (2,3,4-trimethyl-2, 3,4,5-tetrahydro-IH-3-benzazepin-7-yl ) imidazolidin-2-one hydrochloride

(15) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (2,2,3-trimethyl-2, 3,4, 5-tetrahydro-1H-3-benzazepin-7-yl ) imidazolidin-2-one hydrochloride

(16) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (3-methyl-5-oxo-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) - imidazolidin-2-one hydrochloride

(17) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (2-carboxy-3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) - imidazolidin-2-one hydrochloride

(18) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (3-propargyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidin-2- on melting point: 182-185 ° C

Ber. : C 70.89 H 7.85 N 9.92 Found: C 70.64 7.82 -9.87

(19) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (1,1,3-trimethyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) - imidazolidin-2-one hydrochloride x H2O Melting point: 176-180 ° C (decomp.)

Ber. : C 62.29 H 8.36 N 8.72 Cl 7.35

Found: C 62.15 8.53 8.80 7.58

(20) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- [3- (2-carboxyethyl) -2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl ] -imidazolidin- 2-one hydrochloride

Melting point: 293-299 ° C (decomp.)

Ber. : C 60.78 H 7.34 N 8.50 Cl 7.18

Found: C 60.62 7.41 8.30 7.35

(21) 1- [trans-4- (2-methoxycarbonyl) ethyl] cyclohexyl] -3- [3- (2-carboxyethyl) -2,3,4, 5-tetrahydro-IH-3-benzazepin-7-yl ] - imidazolidin-2-one hydrochloride

Starting material: compound of Example 5 (1) implementation with trifluoroacetic acid, isolation as hydrochloride

R _f value: 0.30 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) calc. : C 61.47 H 7.54 N 8.27 Cl 6.98 Found: C 61.41 7.63 8.24 6.82

(22) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- [3- (2,2, 2-tri-fluoroethyl) -2,3,4, 5-tetrahydro-IH-3-benzazepine -7-yl] imidazolino din-2-one hydrochloride

R _f value: 0.18 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4)

(23) 1- [1- (1-Phenyl-2-carboxyethyl) -4-piperidinyl] -3- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2 -on-dihydrochloride

(24) 1- [1- [1- (3-pyridyl) -2-carboxyethyl] -4-piperidinyl] -3- (2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) -imidazolidin-2-one trihydrochloride

R _f value: 0.55 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) Mass spectrum: (M + H) ⁺ = 464

(25) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- [3- (3-aminopropyl) -2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl ] -imidazolidine

2-one dihydrochloride

(26) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (9-fluoro-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2- on-hydrochloride R _f value: 0.44 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4)

(27) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (9-chloro-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidin-2- on hydrochloride

(28) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (8-fluoro-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2- on hydrochloride

(29) 1- [trans-4- [(α-carboxybenzyl) amino] cyclohexyl] -3- (2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidin-2-one - dihydrochloride

(30) 1- [trans-4- [(α-carboxybenzyl) amino] cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) -imidazolidin- 2-one-dihydrochloride

(31) 1- [trans-4- [[(3-pyridyl) carboxymethyl] amino] cyclohexyl] -3- (2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidine -2-one trihydrochloride

(32) 1- [trans-4- [[(3-pyridyl) carboxymethyl] amino] cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepine-7- yl) -imidazoli¬ din-2-one-trihydrochloride

(33) 1- [1- (1-Carboxy-2-propyl) -4-piperidinyl] -3- (2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidine -2-one-dihydrochloride Rf value: 0.65 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) (34) 1- [1- (2-Carboxy-1-propyl) -4-piperidinyl] -3- (2,3,4,5-tetra-hydro-lH-3-benzazepin-7-yl) imidazolidine -2-one dihydrochloride Rf value: 0.61 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4)

Mass spectrum: M ⁺ = 400

(35) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- [3- (3-pyridylmethyl) -2,3,4, 5-tetrahydro-IH-3-benzazepin-7-yl ] -imidazolidin- 2-one-dihydrochloride x 0.8 H2O

Rf value: 0.39 (reversed phase silica gel; methanol / 5% aqueous saline solution - 6: 4) calc. : C 59.63 H 7.08 N 9.93 Cl 12.57 Found: C 59.40 7.09 10.22 12.32

(36) 1- [trans-4- [(1-carboxyethyl) amino] cyclohexyl] -3- (3-methyl) -2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl ] -imidazolidin-2-one dihydrochloride

(37) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- [3- (2-methoxyethyl) -2,3,4, 5-tetrahydro-IH-3-benzazepin-7-yl ] -imidazolidin- 2-one hydrochloride x 0.5 H2O

Rf value: 0.33 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) calc. : C 61.40 H 8.04 N 8.59 Cl 7.25 Found: C 61.44 7.97 8.55 7.42

(38) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- [3- (3-hydroxypropyl) -2,3,4, 5-tetrahydro-IH-3-benzazepin-7-yl ] -imidazolidin-2-one hydrochloride x 0.3 H2O

Starting material: compound of Example 6 (7); Carrying out the ester cleavage with lithium hydroxide

Melting point: 212-215 ° C

Ber. : C 66.88 H 8.44 N 9.36

Found: C 66.92 8.47 9.47 (39) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- [3- (2-dimethylaminoethyl) -2,3,4, 5-tetrahydro-IH-3-benzazepin-7-yl ] -imidazolidin-2-one dihydrochloride

Melting point:> 250 ° C

Rf value: 0.39 (reversed phase silica gel; methanol / 5% aqueous saline solution = 6: 4)

(40) 1- [trans 4- (2-carboxyethyl) cyclohexyl] -3- (6-fluoro-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2-one -hydrochloride

Example 2

3- [trans-4- (2-methoxycarbonyl) ethyl] cyclohexyl] -1- (3-trifluoroacetyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) -5-methyl -hy- dantoin

To 5.0 g of N- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -N ¹ - [1- (methoxycarbonyl) ethyl] -N '- (3-trifluoroacetyl-2,3,, 5- Tetra-hydro-1H-3-benzazepin-7-yl) urea in boiling toluene is given 60 mg of potassium tert-butoxide and heated under reflux for 20 minutes. The reaction mixture is cooled, a little glacial acetic acid is added and the mixture is concentrated. The residue is taken up in ethyl acetate and washed twice with saturated sodium chloride solution. The organic phase is dried and concentrated.

Yield: 5.1 g (100% of theory) Rf value: 0.53 (silica gel; cyclohexane / ethyl acetate = 1: 1)

The following compound is obtained analogously to Example 2:

(1) 3- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -1- (3-tri-fluoroacetyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -5,5-di-methy1-hydantoin

Preparation by heating 7- [[2- (ethoxycarbonyl) -2-propyl] amino] -3-trifluoroacetyl-2,3,4,5-tetrahydro-1H-3-benzazepine and [trans-4- [ 2- (methoxycarbonyl) ethyl] cyclo¬ hexyl] isocyanate at 160-170 ° C. Melting point: 131-133 ° C Rf value: 0.61 (silica gel; cyclohexane / ethyl acetate = 1: 1)

Example 3

3- [trans-4- (2-Carboxyethyl) cyclohexyl] -1- (3-methyl-2, 3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -5-methyl-hydantoin-hydro - chloride x 0.65 NaCl

A mixture of 900 mg of 3- [trans-4- (2-carboxyethyl) cyclohexyl] -1- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -5-methyl- hydantoin hydrochloride, 336 mg sodium bicarbonate, 490 mg 37% formalin solution and 920 mg formic acid in 8 ml water are heated on the steam bath for 3 hours. The reaction mixture is concentrated, hydrochloric acid is added and the mixture is concentrated again. The residue is stirred with 2 ml of water and the supernatant is decanted from the residue. Toluene is added to the residue, the mixture is concentrated and the residue is stirred with acetone. The solid is filtered off, washed with acetone and dried.

Yield: 860 mg (86% of theory), Rf value: 0.11 (silica gel; methylene chloride / methanol / concentrated aqueous ammonia = 90: 10: 2) calc .: C 57.42 H 6.63 N 8 , 37 Cl 11.65 Found: 56.88 6.83 8.37 11.77

The following compounds are obtained analogously to Example 3:

(1) 3- [trans-4- (2-carboxyethyl) cyclohexyl] -1- (3-methyl-2, 3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -5, 5- dimethyl hydantoin x 1.5 HCl x 0.2 H ₂ 0

Rf value: 0.40 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) calc. : C 60.07 H 7.44 N 8.41 Cl 10.64 Found: 60.63 7.73 8.20 10.36

(2) 1- [1- (2-Carboxyethyl) -4-piperidinyl] -3- (3-methyl-2, 3, 4, 5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2 -on x 3.3 HCl x 1 NaCl x 3 H ₂ 0 Rf value: 0.73 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) calc. : C 41.72 H 6.57 N 8.85 Cl 24.07 Found: 40.90 6.21 8.58 24.08

(3) 2- [trans-4- (2-carboxyethyl) cyclohexyl] -4- (3-methyl-2, 3,4,5-tetrahydro-IH-3-benzazepin-7-yl) -5-methyl- 4H-1, 2,4-triazol-3-one hydrochloride

Rf value: 0.50 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4)

(4) 1- [trans-4- (N-benzyl-N-carboxymethylamino) cyclohexyl] -3- [3-methyl-2, 3,4,5-tetrahydro-lH-3-benzazepin-7-yl ) -imidazolidine-2-one x 2.5 HCl x 2.5 H2O

Starting material: compound of Example 8; subsequent ester cleavage by heating with 2N hydrochloric acid. Rf value: 0.56 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) calc. : C 55.57 H 7.32 N 8.93 Cl 14.14 Found: 55.73 7.15 8.73 13.71

(5) 1- [trans-4- (N-methyl-N-carboxymethylamino) cyclohexyl] -3- [3-methyl-2, 3, 4, 5-etrahydro-IH-3-benzazepin-7-yl ) -imidazolidine-2-one x 2.7 HCl x 4.1 H ₂ 0

Starting material: compound of Example 8 (1); subsequent ester cleavage by heating with 2N hydrochloric acid. Rf value: 0.67 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) calc. : C 47.07 H 7.71 N 9.55 Cl 16.31 Found: 47.02 7.81 9.53 16.28

(6) 1- [trans-4- (N-cyclopropyl-N-carboxymethylamino) cyclohexyl] -3- (3-methyl-2, 3,4,5-tetrahydro-IH-3-benzazepine-7 -yl) - imidazolidin-2-one dihydrochloride

Procedure analogous to example 3 (4)

(7) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (3-methyl-5- phenyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -5-methylimidazolidin-2-one hydrochloride

(8) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -5-methyl- imidazolidin-2-one hydrochloride

(9) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) -5,5- dimethyl-imidazolidin-2-one hydrochloride

(10) 1- [trans-4- (N-Butyl-N-carboxymethylamino) cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl ) -imidazoli¬ din-2-one dihydrochloride

Procedure analogous to example 3 (4)

(11) 1- [trans-4- (N-Cyclopentyl-N-carboxymethylamino) cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepine-7 -yl) - imidazolidin-2-one dihydrochloride

Procedure analogous to example 3 (4)

(12) 1- [4- (2-carboxyethyl) phenyl] -3- (3,4-dimethyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2- on hydrochloride

(13) 1- [1- (1-phenyl-2-carboxyethyl) -4-piperidinyl] -3- (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -imidazolidine

2-one dihydrochloride

(14) 1- [1- [1- (3-pyridyl) -2-carboxyethyl] -4-piperidinyl] -3- (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepine 7-yl) imidazolidin-2-one trihydrochloride

(15) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- [3- (3-dimethylaminopropyl) -2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl ] -imidazolidin-2-one dihydrochloride (16) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (9-fluoro-3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl ) imidazolidin-2-one hydrochloride

R _f value: 0.36 (reversed phase silica gel; methanol / 5% aqueous

Saline solution = 6: 4)

(17) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (9-chloro-3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl ) imidazolidin-2-one hydrochloride

(18) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (8-fluoro-3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl ) imidazolidin-2-one hydrochloride

(19) 1- [1- (1-Carboxy-2-propyl) -4-piperidinyl] -3- (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -imidazolidin-2-one dihydrochloride

R _f value: 0.40 (silica gel; methylene chloride / methanol / concentrated aqueous ammonia = 80: 20: 2)

(20) 1- [1- (2-Carboxy-1-propyl) - -piperidinyl] -3- (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) - imidazolidin-2-one dihydrochloride

R _f value: 0.47 (silica gel; methylene chloride / methanol / concentrated aqueous ammonia = 80: 20: 2)

(21) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (6-fluoro-3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl ] -imidazolidin- 2-one dihydrochloride

Example 4

1- [1- [2- (Methoxycarbonyl) ethyl] -4-piperidinyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidin-2 -on

To 750 mg of 1- [1- [2- (carboxyethyl) -4-piperidinyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidine 2-one x 3.3 HCl x 1 NaCl x 3 H ₂ 0 in 25 ml methanol, 720 mg thionyl chloride are added dropwise at -40 ° C. It is warmed to room temperature and stirred overnight. The reaction mixture is evaporated and the residue is mixed several times with toluene and methanol and evaporated. The residue is partitioned between methylene chloride and 2N potassium carbonate solution, the organic phase is separated off, dried and concentrated. Yield: 450 mg (90% of theory),

Rf value: 0.75 (silica gel; methylene chloride / methanol / concentrated aqueous ammonia = 80: 20: 2)

The following compounds are obtained analogously to Example 4:

(1) 1- [trans-4- (methoxycarbonylmethylamino) cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidin-2- on-dihydrochloride

Execution with thionyl chloride and hydrochloric acid gas Rf value: 0.64 (reversed phase silica gel; methanol / 5% aqueous saline solution = 6: 4)

(2) 1- [trans-4- (Ethoxycarbonylmethylamino) cyclohexyl] -3- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2-one dihydrochloride

Execution with hydrochloric acid gas

(3) 1- [trans-4- (ethoxycarbonylmethylamino) cyclohexyl] -3-

(3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) -imidazolidin-2-one-dihydrochloride Execution with hydrochloric acid gas

(4) 1- [trans-4- [2- (ethoxycarbonyl) ethyl] cyclohexyl] -3-

(2-ethoxycarbonyl-3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) -imidazolidin-2-one hydrochloride Execution with hydrochloric acid gas

(5) 1- [1- [2- (Ethoxycarbonyl) ethyl] 4-piperidinyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidine -2-on-di- hydrochloride

Carried out with hydrochloric acid gas and thionyl chloride Rf value: 0.80 (silica gel; methylene chloride / methanol / concentrated aqueous ammonia = 80: 20: 2)

(6) 1- [1- [2- (ethoxycarbonyl) ethyl] -4-piperidinyl] -3- (2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidin-2- on-dihydro¬ chloride

Carried out with hydrochloric acid gas and thionyl chloride Rf value: 0.53 (silica gel; methylene chloride / methanol / concentrated aqueous ammonia = 80: 20: 2)

(7) 1- [1- [2- (isobutyloxycarbonyl) ethyl] - piperidinyl] -3- (2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) imidazolidin-2-one - dihydrochloride

(8) 1- [1- [1- (3-pyridyl) -2- (ethoxycarbonyl) ethyl] -4-piperidinyl] -3- (2,3,4,5-tetrahydro-IH-3- benzazepin-7-yl) imidazolidein-2-one trihydrochloride

(9) 1- [1- [1- (3-pyridyl) -2- (ethoxycarbonyl) ethyl] -4-piperidinyl] -3- (3-methyl-2,3,4,5-tetrahydro- IH-3-benzazepin-7-yl) - imidazolidin-2-one trihydrochloride

(10) 1- [1- [1- (methoxycarbonyl) -2-propyl] -4-piperidinyl] -3- (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepine-7- yl) imidazolidin-2-one dihydrochloride

R _f value: 0.81 (silica gel; methylene chloride / methanol / concentrated aqueous ammonia = 8: 2: 0.2)

Example 5

1- [1- [2- (methoxycarbonyl) ethyl] -4-piperidinyl] -3 - (3-tert. Butyloxycarbonyl-2, 3, 4, 5 -tetrahydro-lH-3 -benzazepin-7-yl) -imida- zolidin-2 -one

2, 08 gl - (4 -piperidinyl) -3 - (3-tert. Butyl oxycarbonyl -2, 3, 4, 5-tetrahydro-lH-3 -benzazepin-7-yl) -imidazolidin-2 -one and 4, 3 g Methyl acrylate are refluxed in 10 ml of methanol for 3 hours. It is concentrated and the residue is purified by chromatography on a silica gel column with methylene chloride / methanol and then by crystallization from methanol. Yield: 1.8 g (72% of theory),

Melting point: 168-170 ° C

Rf value: 0.40 (silica gel; methylene chloride / methanol / concentrated aqueous ammonia = 95: 5: 2)

Analogously to example 5, the following compounds are contained:

(1) 1- [trans-4- (2-methoxycarbonyl) ethyl] cyclohexyl] -3- [3- [2- (tert. Butyloxycarbonyl) ethyl] -2,3,4,5-tetrahydro-IH-3- benz azepin-7-yl] imidazolidin-2-one

Carried out with tert-butyl acrylate

Rf value: 0.18 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) calc. : C 68.29 H 8.60 N 7.96 Found: 68.27 8.80 8.01

(2) 1- [trans-4- (2-methoxycarbonyl) ethyl] cyclohexyl] -3- [3- (2-cyanoethyl) -2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl ] -imida-zolidin-2-one

Execution with acrylonitrile

Rf value: 0.80 (silica gel; methylene chloride / methanol = 9: 1)

Ber. : C 68.99 H 8.02 N 12.38

Found: 69.00 8.12 12.32

(3) 1- [1- [1- (methoxycarbonyl) -2-propyl] -4-piperidinyl] -3-

(3-tert-butyloxycarbonyl-2,3,4,5-tetrahydro-IH-3-benzazepine

7-yl) imidazolidin-2-one

Execution with crotonic acid methyl ester

Melting point: 168-173 ° C

R _f value: 0.68 (silica gel; methylene chloride / methanol = 9: 1)

(4) 1- [1- [2- (methoxycarbonyl) -1-propyl] -4-piperidinyl] -3- (3-tert.butyloxycarbonyl-2,3,4,5-tetrahydro-IH-3-benzazepine

7-yl) imidazolidin-2-one

Carried out with methyl methacrylate

Melting point: 165-167.5 ° C

(5) 1- [1- [1- (3-pyridyl) -2- (ethoxycarbonyl) ethyl] -4-piperidinyl] -3- (3-tert-butyloxycarbonyl-2,3,4,5- tetrahydro-IH-3-benzazepin-7-yl) imidazolidin-2-one

Carried out with 3- (3-pyridyl) acrylic acid ethyl ester in ethanol at 100 ° C. in a pressure vessel

Rf value: 0.49 (silica gel: methylene chloride / methanol / concentrated aqueous ammonia = 95: 5: 0.2)

Example 6

1- [1- (Methoxycarbonylmethyl) -4-piperidinyl] -3- (3-tert.butyl¬ oxycarbonyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) -i idazolidine -2-one

2.08 g of 1- (4-piperidinyl) -3- (3-tert-butyloxycarbonyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -imidazolidin-2-one, 1, 26 g of methyl bromoacetate, 0.3 g of sodium iodide, 10 ml of acetonitrile and 1.05 g of N-ethyl-diisopropylamine are stirred at 60 ° C. for 6 hours. It is concentrated, the residue is partitioned between methylene chloride and water, the organic phase is separated off and dried. It is concentrated and the residue is purified by chromatography on a silica gel column with methylene chloride / methanol (95: 5). The product is stirred with 5 ml of methanol at 0 ° C., the solid is filtered off with suction, washed with a little cold methanol and then dried. Yield: 0.95 g (39% of theory),

Melting point: 173-178 ° C

Rf value: 0.39 (silica gel; methylene chloride / methanol = 95: 5)

The following compounds are obtained analogously to Example 6: (1) 1- [trans-4- (N-benzyl-N-tert-butyloxycarbonylmethylamino) cyclohexyl] -3- (3-trifluoroacetyl-2,3,4,5-tetrahydro-IH-3-benz- azepin-7-yl) imidazolidin-2-one

Melting point: 168-171 ° C

Rf value: 0.56 (silica gel; cyclohexane / ethyl acetate = 3: 2)

(2) 1- [trans-4- (N-methyl-N-tert-butyloxycarbonylmethylamino) cyclohexyl] -3- (3-trifluoroacetyl-2,3,4,5-tetrahydro-IH-3-benz- azepin-7-yl) imidazolidin-2-one

Melting point: 151-153 ° C

Rf value: 0.53 (aluminum oxide; cyclohexane / ethyl acetate = 1: 1)

(3) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (3-cinnamyl-2, 3,4, 5-tetrahydro-IH-3-benzazepin-7-yl) - imidazolidin- 2-one

Starting material: compound of Example XIV and cinnamyl chloride. Carried out at room temperature without the addition of sodium iodide.

Rf value: 0.34 (silica gel; methylene chloride / methanol / concentrated aqueous ammonia = 95: 5: 1)

(4) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (3-propargyl-2, 3,4,5-tetrahydro-lH-3-benzazepin-7-yl) - imidazoli¬ din-2-one

Melting point: 104-106 ° C

(5) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- [3- (3-pyridylmethyl) -2,3,4, 5-tetrahydro-IH-3-benzazepine-7 -yl) - imidazolidin-2-one

Melting point: 144-146 ° C

Rf value: 0.22 (aluminum oxide; methylene chloride / ethyl acetate = 8: 2)

(6) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- [3- (2-methoxyethyl) -2,3,4,5-tetrahydro-lH-3-benzazepine-7 -yl] - imidazolidin-2-one

Melting point: 110-112 ° C

Rf value: 0.42 (aluminum oxide; methylene chloride / ethyl acetate = 8: 2) (7) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- [3- (3-hydroxypropyl) -2,3,4,5-tetrahydro-lH-3-benzazepine-7 -yl] - imidazolidin-2-one

Melting point: 143-145 ° C

Rf value: 0.23 (aluminum oxide; methylene chloride / methanol = 100: 1)

(8) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- [3- [2- (dimethylamino) ethyl] -2,3,4,5-tetrahydro-lH-3- benzazepin-7-yl] imidazolidin-2-one

Melting point: sintering from 134 ° C

Rf value: 0.29 (aluminum oxide; methylene chloride / methanol =

100: 1.5)

Example 7

2- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -4- (3-tri-fluoroacetyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) -5- methyl-

4H-l, 2,4-triazol-3-one

4.9 g of l-acetyl-2- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -4- (3-trifluoroacetyl-2,3,4,5-tetrahydro-IH-3-benzazepine - 7-yl) -semicarbazide are heated to 165-175 ° C for 3 hours. After cooling, the residue is purified by chromatography on a silica gel column using cyclohexane / ethyl acetate (2: 3). Yield: 1.6 g (34% of theory), Rf value: 0.36 (silica gel; cyclohexane / ethyl acetate = 2: 3)

Example 8

1- [trans-4- (N-Benzyl-N-tert.butyloxycarbonylmethylamino) - cyclohexyl] -3- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -imi- dazolidin-2-one

To 1.9 g of 1- [trans-4- (N-benzyl-N-tert-butyloxycarbonylmethylamino) cyclohexyl] -3- (3-trifluoroacetyl-2,3,4,5-tetrahydro-IH-3-benzazepine -7-yl) -imidazolidin-2-one in a mixture of 20 ml of methanol and 20 ml of tetrahydrofuran are added 3 ml of 2N sodium hydroxide solution and stirred for 2 hours at room temperature. There will be 3 ml of 2N hydrochloric acid was added and then concentrated. The residue is mixed with water and sodium bicarbonate solution and extracted several times with ethyl acetate. The ethyl acetate phase is washed with water and saturated sodium chloride solution, dried and evaporated.

Yield: 1.6 g (100% of theory),

Rf value: 0.38 (reversed phase silica gel; methano / 5% aqueous sodium chloride solution = 6: 4)

The following compound is obtained analogously to Example 8:

(1) 1- [trans-4- (N-methyl-N-tert-butyloxycarbonylmethylamino) cyclohexyl] -3- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -imi- dazolidin-2-one

Rf value: 0.51 (reversed phase silica gel; methano / 5% aqueous saline solution = 6: 4)

Example 9

1- [trans-4- (carboxymethylamino) cyclohexyl] -3- (2,3,4,5-tetra-hydro-lH-3-benzazepin-7-yl) imidazolidin-2-one x 2 HCl x 2, 5 H ₂ 0

690 mg of 1- [trans-4- (N-benzyl-N-carboxymethylamino) cyclohexyl] -3- (2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidin-2 -on x 2.5 HCl x 3.5 H2O are hydrogenated in 40 ml of methanol for 4 hours at room temperature in the presence of 500 mg of palladium on carbon and a hydrogen pressure of 50 psi. The catalyst is filtered off and the filtrate is evaporated. The residue is stirred with acetone, the solid is filtered off with suction, washed with acetone and dried.

Yield: 410 mg (74% of theory),

Rf value: 0.76 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) calc .: C 50.00 H 7.39 N 11.10 Cl 14.10 found: 49, 58 7.44 10.90 14.18.

The following compound is obtained analogously to Example 9: (1) 1- [trans-4- (carboxymethylamino) cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidin-2-one X 2.5 HCl x 4 H ₂ 0

Rf value: 0.72 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) calc .: C 46.87 H 7.59 N 9.94 Cl 15.72 found: 46, 85 7.73 10.04 15.26

Example 10

1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (3-cyclopropyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidine 2- one

To 0.88 g of N- (2-hydroxyethyl) -N- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -N'- (3-cyclopropyl-2,3,4,5-tetrahydro- IH-3-benzazepin-7-yl) urea and 0.6 g of triphenylphosphine in 20 ml of acetonitrile are added dropwise with stirring at room temperature to 470 mg of diethyl azodicarboxylate in 5 ml of acetonitrile. After stirring overnight, the mixture is concentrated and the residue is purified by chromatography on a silica gel column using methylene chloride / methanol (99: 1 to 97: 3). The product is stirred with a little diethyl ether, suction filtered and dried. Yield: 0.3 g (23% of theory), melting point: 165-169 ° C. Rf value: 0.28 (silica gel; methylene chloride / methanol = 95: 5)

Example 11

1- [trans-4- (N-acetyl-N-carboxymethylamino) cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazoli - din-2-one

To 240 mg of 1- [trans-4- (N-acetyl-N-methoxycarbonylmethylamino) cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepine-7- yl) -imidazolidin-2-one in 5 ml of methanol, 0.2 ml of 8N NaOH are added and the mixture is stirred for 2 1/2 days at room temperature. It will 96/05194 PCIYEP95 / 03233

- 94 - mixed with 0.8 ml of 2N hydrochloric acid and evaporated. The residue is stirred with acetone, the solid is filtered off with suction, washed with acetone and dried. Yield: 290 mg (contains sodium chloride)

Rf value: 0.53 (reversed phase silica gel; methanol / 5% aqueous saline solution = 6: 4)

The following compounds are obtained analogously to Example 11:

(1) 1- [trans-4- (N-methanesulfonyl-N-carboxymethylamino) cyclohexyl] -3- (3-methyl-2, 3,4, 5-tetrahydro-IH-3-benzazepine-7 -yl) - imidazolidin-2-one

Rf value: 0.62 (silica gel; methanol / 5% aqueous sodium chloride solution

= 6: 4) Mass spectrum: (M + H) ⁺ = 479

(2) 1- [trans-4- (N-cyclopropylcarbonyl-N-carboxymethylamino) cyclohexyl] -3- (3-methyl-2, 3,4,5-tetrahydro-IH-3-benzazepine 7- yl) -imidazolidin-2-one

(3) 1- [trans-4- (N-cyclopentylcarbonyl-N-carboxymethylamino) cyclohexyl] -3- (3-methyl-2, 3,4,5-tetrahydro-IH-3-benzazepine 7- yl) -imidazolidin-2-one

(4) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (5-hydroxy-3-methyl-2, 3,4,5-tetrahydro-IH-3-benzazepin-7-yl ) -imidazolidin-2-one

(5) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (2-dimethylamino-carbonyl-3-methyl-2, 3,4,5-tetrahydro-IH-3-benzazepin-7-yl ) -imi¬ dazolidin-2-one

(6) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (5-cyano-3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) - imidazolidin-2-one

(7) 1- [trans-4r (N-butyryl-N-carboxymethylamino) cyclohexyl] - (3-methyl-2, 3,4, 5-tetrahydro-IH-3-benzazepin-7-yl) imidazoli - din-2 -on

(8) 1- [trans-4- (N-Butylsulfonyl-N-carboxymethylamino) cyclohexyl] - (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl ) -imi¬ dazolidin-2-one

(9) 1- [trans-4- (N-phenylsulfonyl-N-carboxymethylamino) cyclohexyl] - (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl ) -imi¬ dazolidin-2-one

(10) 1- [trans-4- (N-Benzoyl-N-carboxymethylamino) cyclohexyl] - (3-methyl-2, 3,4, 5-tetrahydro-IH-3-benzazepin-7-yl) - imidazolidine-2-one

(11) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- [3- (2-cyanoethyl) -2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl ] -imidazolidin- 2-one x H2O

Rf value: 0.52 (reversed phase silica gel; methanol / 5% strength aqueous saline solution = 6: 4) calc .: C 65.76 H 7.95 N 12.27 found: 65.60 8.09 12.09.

(12) 1- [2- [(2-carboxyethyl) aminocarbonyl] ethyl] -3- (3-tert-butyloxycarbonyl-2, 3,4,5-tetrahydro-IH-3-benzazepin-7-yl) -imi¬ dazolidin-2-one

Rf value: 0.26 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4)

(13) 1- [2- [(2-Carboxyethyl) aminocarbonyl] ethyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidin-2 -on x 2 H ₂ 0

Rf value: 0.69 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4) calc .: C 56.59 H 7.60 N 13.20 found: 56.91 7.20 13.18 (14) 1- [2- [(1-carboxy-2-propyl) aminocarbonyl] ethyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepine-7- yl) -imidazolidin-2-one Rf value: 0.70 (reversed phase silica gel; methanol / 5% aqueous saline solution = 6: 4)

Mass spectrum: M ⁺ = 402

(15) 1- [2- [(1-phenyl-2-carboxyethyl) aminocarbonyl] ethyl] - 3- (3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) -imidazolidin-2-one x 0.6 H2O

Melting point: 273-276 ° C

Ber. : C 65, 69 H 7, 04 N 11, 79

Gef. : 65, 91 6, 95 11, 73

(16) 1- [2- [[1- (3-pyridyl) 2-carboxyethyl] aminocarbonyl] ethyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepine-7 -yl) -imidazolidin-2-one

Rf value: 0.67 (reversed phase silica gel; methanol / 5% strength aqueous saline solution = 6: 4) mass spectrum: M ⁺ = 465

(17) 1- [2- [(l-Carboxy-2-propyl) aminocarbonyl] ethyl] -3- (3-tert-butyloxycarbonyl-2,3,4,5-tetrahydro-lH-3-benzazepine-7 -yl) -imi¬ dazolidin-2-one

Melting point: 123-125 ° C

Rf value: 0.23 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4)

(18) 1- [2- [[1-phenyl-2-carboxyethyl) aminocarbonyl] ethyl] -3- (3-tert-butyloxycarbonyl-2,3,4,5-tetrahydro-IH-3-benzazepine 7- yl) -imidazolidin-2-one

Melting point: 145-147 ° C

Rf value: 0.14 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4)

(19) 1- [2- [[1- (3-pyridyl) -2-carboxyethyl] aminocarbonyl] ethyl] -3- (3-tert-butyloxycarbonyl-2,3,4,5-tetrahydro-IH-3- benzazepin-7-yl) imidazolidin-2-one Rf value: 0.23 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4)

(20) 1- [[(2-Carboxyethyl) aminocarbonyl] methyl] -3- (3-tert-butyloxycarbonyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazo - lidin-2-one

Melting point: 155 ° C (dec.)

(21) 1- [[(1-phenyl-2-carboxyethyl) aminocarbonyl] methyl] -3- (3-tert-butyloxycarbonyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -imidazolidin-2-one

Melting point: 120-125 ° C

(22) 1- [[[1- (3-pyridyl) -2-carboxyethyl] aminocarbonyl] methyl] -3- (3-butyloxycarbonyl-2,3,4,5-tetrahydro-IH-3-benzazepine 7- yl) imidazolidin-2-one

Rf value: 0.15 (silica gel; methylene chloride / methanol 9: 1)

(23) 1- [[(2-Carboxyethyl) aminocarbonyl] methyl] -3- (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2-one Rf value: 0.63 (reversed phase silica gel; methanol / 5% aqueous

Saline = 6: 4) Mass spectrum: M ⁺ = 374

(24) 1- [[(1-Phenyl-2-carboxyethyl) aminocarbonyl] methyl] -3- (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazo - lidin-2-one

Rf value: 0.40 (reversed phase silica gel; methanol / 5% aqueous

Saline solution = 6: 4) Mass spectrum: M ⁺ = 450

(25) 1- [[[1- (3-pyridyl) -2-carboxyethyl] aminocarbonyl] ethyl] -3- (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepine-7- yl) -imidazolidin-2-one x 2 H2O

Melting point: 170-175 ° C Ber. : C 59, 12 H 6, 82 N 14, 14

Gef. : 59, 10 6, 65 14, 36

(26) 1- [2- [(Carboxymethyl) aminocarbonyl] ethyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidin-2-one

(27) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- [3- [3- (acetylamino) propyl] -2,3,4,5-tetrahydro-lH-3-benzazepine 7-yl] -imidazolidin-2-one

(28) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- [3- [3- (methanesulfonylamino) propyl] -2,3,4,5-tetrahydro-IH-3-benzazepine 7-yl] - imidazolidin-2-one

(29) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- [3- [2- (aminocarbonyl) ethyl] -2,3,4,5-tetrahydro-IH-3-benzazepine 7-yl] imidazolidin-2-one

(30) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- [3- [2- (dimethylaminocarbonyl) ethyl] -2,3,4,5-tetrahydro-IH-3-benzazepine 7-yl] - imidazolidin-2-one

(31) 1- [2- [N- (2-carboxyethyl) -N-methylaminocarbonyl] ethyl] -

3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl] imidazoline-2-one

(32) 1- [2- [N- (1-Carboxy-2-propyl) -N-methylaminocarbonyl] ethyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH- 3-benzazepin-7-yl] - imidazolidin-2-one

(33) 1- [2- [N- (1-Phenyl-2-carboxy-ethyl) -N-methylaminocarbonyl] ethyl] -3- (3-methyl-2,3,4,5-tetrahydro -IH-3-benzazepin-7-yl] - imidazolidin-2-one

(34) 1- [2- [N- [1- (3-pyridyl) -2-carboxyethyl] -N-methylaminocarbonyl] ethyl] -3- (3-methyl-2,3,4 , 5-tetrahydro-lH-3-benzazepin-7-yl] imidazolidin-2-one (35) 1- [2- [N- (Carboxymethyl) -N-methylaminocarbonyl] ethyl] -3- (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl ] -imidazolidine-2-one

(36) 1- [2- [(1-carboxyethyl) aminocarbonyl] ethyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl] imidazolidin-2 -on

(37) 1- [2- [(α-carboxybenzyl) aminocarbonyl] ethyl] -3- (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl] imidazolidin-2 -on

(38) 1- [2- [[{3-pyridyl) carboxymethyl] aminocarbonyl] ethyl] -

3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl] imidazoline-2-one

Example 12

1- [trans-4- (N-acetyl-N-methoxycarbonylmethylamino) cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) - imidazolidin-2-one

To 300 mg of 1- [trans-4- (methoxycarbonylmethylamino) cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazoidide- 2-one dihydrochloride in 3 ml methylene chloride, 0.07 ml acetic anhydride and 0.2 ml triethylamine are added and the mixture is stirred for 3 hours at room temperature. The reaction mixture is mixed with water and extracted three times with methylene chloride. The combined organic phases are washed with water, dried and evaporated. Yield: 270 mg (96% of theory)

Rf value: 0.45 (reversed phase silica gel; methanol / 5% aqueous saline solution = 6: 4) Example 13

1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (3,5-dimethyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) - imidazolidin-2-one hydrochloride

600 mg 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (3,5-dimethyl-2, 3,4,5-tetrahydro-lH-3-benzazepin-7-yl) - 3H-imidazol-2-one in 10 ml of methanol are hydrogenated for 5 hours at 50 ° C. and a hydrogen pressure of 50 psi in the presence of 200 mg palladium on activated carbon. The catalyst is filtered off and the filtrate is evaporated. The residue is purified by chromatography on an alumina column with methylene chloride / methanol (98: 2) and then converted into the hydrochloride using methanolic hydrochloric acid. Yield: 403 mg (61% of theory), melting point: 230-235 ° C (dec.)

The following compounds are obtained analogously to Example 13:

(1) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (1, 1, 3-trimethyl-2, 3,4, 5-tetrahydro-lH-3-benzazepine-7- yl) - imidazolidin-2-one hydrochloride

Melting point: 250 ° C (decomp.)

Calculated: C 65.32 H 8.43 N 8.79 Cl 7.42

Found: 65.00 8.56 8.63 7.46

(2) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- [3- (2,2,2-trifluoroethyl) -2, 3,4,5-tetrahydro-IH-3- benzazepin-7-yl] imidazolidin-2-one

Melting point: 167-170 ° C

Ber. : C 62.35 H 7.12 N 8.73

Found: 62.33 7.11 8.63

(3) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (9-fluoro-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -imidazolidin-2-one hydrochloride

Carried out in the presence of 1.2 equivalents IN hydrochloric acid R _f value: 0.18 (reversed phase silica gel; methanol / 5% aqueous

Saline solution = 6: 4)

(4) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (8-fluoro or 2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -imidazolidin-2-one hydrochloride

Example 14

1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (3,5-dimethyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) - 3H-imidazol-2-one

950 mg of N- (2,2-dirthethoxyethyl) -N- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -N ¹ - (3,5-dimethyl-2,3,4,5-tetrahydro -IH-3-benzazepin-7-yl) -urea with 10 ml of trifluoroacetic acid

Heated on the steam bath for 7 hours. The reaction mixture is concentrated, the residue is taken up in methylene chloride and a little methanol and shaken with dilute sodium hydroxide solution and then with water. The organic phase is separated off, dried and concentrated.

Yield: 630 mg (76% of theory),

R _f value: 0.17 (aluminum oxide; cyclohexane / ethyl acetate = 1: 1)

The following compounds are obtained analogously to Example 14:

(1) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (1,1,3-trimethyl-2,3,4,5-tetrahydro-lH-3-benzazepine-7- yl) -3H-imidazol-2-one

R _f value: 0.38 (aluminum oxide; cyclohexane / ethyl acetate = 1: 1)

(2) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- [3- (2,2,2-trifluoroethyl) -2,3,4,5-tetrahydro-IH-3- benzazepin-7-yl] - 3H-imidazol-2-one

Melting point: 132-135 ° C

(3) 1- [trans-4.- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (9-fluoro-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl ) -3H-imidazol-2-one starting material: compound of Example 1 (4) R _f value: 0.38 (aluminum oxide; cyclohexane / ethyl acetate = 100: 5)

(4) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (8-fluoro-2, 3,4,5-tetrahydro-IH-3-benzazepin-7-yl) -3H-imidazol-2-one

Example 15

1- [2- [(2-Carboxyethyl) aminocarbonyl] ethyl] -3- (2,3,4,5-tetra-hydro-lH-3-benzazepin-7-yl) imidazolidin-2-one x 3, 3 trifluoroacetic acid x H2O

To 310 mg of l- [2- [(2-carboxyethyl) aminocarbonyl] ethyl] -3- (3-tert.butyloxycarbonyl-2, 3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidine -2-one in 3 ml of methylene chloride, 3 ml of trifluoroacetic acid are added and the mixture is stirred at room temperature for 2.5 hours. It is concentrated, methylene chloride is added twice, and each is concentrated again and dried. Rf value: 0.73 (reversed phase silica gel; methanol / 5% aqueous

Saline = 6: 4) Calc .: C 40.00 H 4.10 N 7.29 Found: 39.95 4.13 7.29 Mass spectrum: M ⁺ = 374

The following compounds are obtained analogously to Example 15:

(1) 1- [2- [[2- (ethoxycarbonyl) ethyl] aminocarbonyl] ethyl] -3- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2- on, x 2.5 trifluoroacetic acid x H2O

R _f value: 0.56 (reversed phase silica gel; methanol / 5% aqueous

Saline = 6: 4) calc. : C 44.25 H 4.93 N 7.94 Found: 43.91 4.84 7.63

(2) 1- [2- [(1-carboxy-2-propyl) aminocarbonyl] ethyl] -3- (2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidin-2 -on-trifluoroacetate

Rf value: 0.68 (reversed phase silica gel; methanol / 5% aqueous

Saline solution = 6: 4) Mass spectrum: M ⁺ = 388

(3) 1- [2- [[1- (ethoxycarbonyl) -2-propyl] aminocarbonyl] ethyl] -3- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidine -2-one-trifluoroacetate

Rf value: 0.52 (reversed phase silica gel; methanol / 5% aqueous

Saline solution = 6: 4) Mass spectrum: M ⁺ = 416

(4) 1- [2- [(1-phenyl-2-carboxyethyl) aminocarbonyl] ethyl] -3- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2 -on- trifluoroacetate

Rf value: 0.58 (reversed phase silica gel; methanol / 5% aqueous

Saline solution = 6: 4) Mass spectrum: M ⁺ = 450

(5) 1- [2- [[l-phenyl-2- (ethoxycarbonyl) ethyl] aminocarbonyl] ethyl] -3- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl ) -imidazolidin-2-one x 3.5 trifluoroacetic acid x 1.5 H2O

Rf value: 0.41 (reversed phase silica gel; methanol / 5% aqueous

Saline = 6: 4) calc. : C 45.54 H 4.55 N 6.25 Found: 45.45 4.50 6.17

(6) 1- [2 - [[1- (3-pyridyl) -2-carboxyethyl] aminocarbonyl] ethyl] - 3- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) -imidazolidin-2-one trifluoroacetate

R _f value: 0.71 (reversed phase silica gel; methanol / 5% aqueous

Saline solution = 6: 4)

(7) 1- [2- [[1- (3-pyridyl) -2- (ethoxycarbonyl) ethyl] aminocarbonyl] ethyl] -3- (2,3,4,5-tetrahydro-1H-3- benzazepin-7-yl) -imi¬ dazolidin-2-one-trifluoroacetate

R _f value: 0.59 (reversed phase silica gel; methanol / 5% aqueous

Saline solution = 6: 4) Mass spectrum: M ⁺ = 479 (8) 1- [[(2-Carboxyethyl) aminocarbonyl] methyl] -3- (2, 3, 4, 5-te-trahydro-IH-3-benzazepin-7-yl) -imidazolidin-2-one-trifluoro - acetate

Rf value: 0.76 (reversed phase silica gel; methanol / 5% aqueous

Saline solution = 6: 4) Mass spectrum: M ⁺ = 360

(9) 1- [[(1-Phenyl-2-carboxyethyl) aminocarbonyl] methyl] -3- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2-one - trifluoroacetate

R _f value: 0.43 (reversed phase silica gel; methanol / 5% aqueous

Saline = 6: 4) Mass spectrum: M ⁺ = 436

(10) 1- [[[1-phenyl-2- (ethoxycarbonyl) ethyl] aminocarbonyl] methyl] -3- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) - imidazoli din-2-one x 2 trifluoroacetic acid x 0.5 H 0

Rf value: 0.25 (reversed phase silica gel; methanol / 5% aqueous

Saline = 6: 4) calc. : C 51.36 H 5.03 N 7.98 Found: 51.10 5.06 7.71

(11) 1- [[[1- (3-pyridyl) -2-carboxyethyl] aminocarbonyl] methyl] - 3- (2, 3, 4, 5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidine -2-one-trifluoroacetate

Rf value: 0.63 (reversed phase silica gel; methanol / 5% aqueous

Saline solution = 6: 4)

(12) 1- [[[1- (3-pyridyl) -2- (ethoxycarbonyl) ethyl] aminocarbonyl] methyl] -3- (2,3,4,5-tetrahydro-lH-3-benzazepine 7-yl) imidazolidin-2-one trifluoroacetate

Rf value: 0.65 (reversed phase silica gel; methanol / 5% aqueous

Saline = 6: 4) Mass spectrum: M ⁺ = 465 (13) 1- [2- [(Carboxymethyl) aminocarbonyl] ethyl] -3- (2, 3,4, 5-te-trahydro-IH-3-benzazepin-7-yl) -imidazolidin-2-one-trifluoro ¬ acetate

Example 16

1- [2- [[2- (Ethoxycarbonyl) ethyl] aminocarbonyl] ethyl] -3- (3- ^' tert.butyloxycarbonyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) - imidazolidin-2-one

To 1.0 g of 1- (2-carboxyethyl) -3- (3-tert-butyloxycarbonyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2-one, 410 mg of β-alanine ethyl ester hydrochloride and 860 mg of 2- (1H-benzotriazol-1-yl) -1,1,3,3-tetramethyluronium tetrafluoroborate in 25 ml of dimethylformamide are added to 2.1 ml of triethylamine and stirred for 18 hours at room temperature. The reaction mixture is mixed with 150 ml of water, the precipitate is filtered off, washed with water and dried at 60 ° C. Yield: 870 mg (70% of theory), melting point: 86-89 ° C. Rf value: 0.73 (silica gel; methylene chloride / methanol = 9: 1)

The following compounds are obtained analogously to Example 16:

(1) 1- [2- [[2- (ethoxycarbonyl) ethyl] aminocarbonyl] ethyl] -3- (3-methyl-2, 3,4, 5-tetrahydro-IH-3-benzazepin-7-yl) - imidazolidin- 2-one

R _f value: 0.57 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4)

(2) 1- [2- [[1- (ethoxycarbonyl) -2-propyϊ] aminocarbonyl] ethyl] -3- (3-methyl-2, 3,4, 5-tetrahydro-IH-3-benzazepine-7- yl) -imidazolidine-2-one x 0.5 H2O

Melting point: 87-90 ° C

Ber. : C 62, 85 H 8, 03 N 12, 75

Gef. : 62, 93 8, 10 12, 54 (3) 1- [2- [[1-phenyl-2- (ethoxycarbonyl) ethyl] aminocarbonyl] ethyl] -3- (3-methyl-2,3,4,5-tetrahydro-lH-3-benzazepine -7-yl) - imidazolidin-2-one

R _f value: 0.40 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4)

(4) 1- [2- [[1- (3-pyridyl) -2- (ethoxycarbonyl) ethyl] aminocarbonyl] ethyl] -3- (3-methyl-2, 3,4, 5-tetrahydro- IH-3-benzazepin-7-yl) imidazolidin-2-one

R _f value: 0.57 (reversed phase silica gel; methanol / 5% strength aqueous saline solution = 6: 4) mass spectrum: M ⁺ = 493

(5) 1- [2- [[1- (ethoxycarbonyl) -2-propyl] aminocarbonyl] ethyl] -3- (3-tert-butyloxycarbonyl-2, 3,4,5-tetrahydro-IH-3-benzazepine 7-yl) imidazolidin-2-one

Melting point: 93-96 ° C

R _f value: 0.73 (silica gel; methylene chloride / methanol = 9: 1)

(6) 1- [2- [[l-phenyl-2- (ethoxycarbonyl) ethyl] aminocarbonyl] ethyl] -3- (3-tert-butyloxycarbonyl-2, 3,4,5-tetrahydro-IH-3 - benzazepin-7-yl) -imidazolidin-2-one

Rf value: 0.81 (silica gel; methylene chloride / methanol = 3: 1)

(7) 1- [2- [[1- (3-pyridyl) -2- (ethoxycarbonyl) ethyl] aminocarbonyl] ethyl] -3- (3-tert-butyloxycarbonyl-2, 3,4, 5- tetrahydro-1H-3-benzazepin-7-yl) imidazolidin-2-one

R _f value: 0.10 (reversed phase silica gel; methanol / 5% aqueous sodium chloride solution = 6: 4)

(8) 1- [[[2- (ethoxycarbonyl) ethyl] aminocarbonyl] methyl] -3- (3-tert-butyloxycarbonyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) - imidazolidin-2-one

Melting point: 135-137 ° C

(9) 1- [[[1-phenyl-2- (ethoxycarbonyl) ethyl] aminocarbonyl] methyl] -3- (3-tert-butyloxycarbonyl-2, 3,4,5-tetrahydro-IH- 3-benzazepin-7-yl) -imidazolidin-2-one Melting point: 122-124 ° C

(10) 1- [[[1- (3-pyridyl) -2- (ethoxycarbonyl) ethyl] aminocarbonyl] methyl] -3- (3- ert. Utyloxycarbonyl-2,3,4,5-tetrahydro- 1H-3-benzazepin-7-yl) imidazolidin-2-one

Melting point: 138-141 ° C

(11) 1- [[[2- (ethoxycarbonyl) ethyl] aminocarbonyl] methyl] -3- (3-methyl-2, 3,4, 5-tetrahydro-lH-3-benzazepin-7-yl) imidazo lidin-2-one

Melting point: 116-118 ° C Mass spectrum: M ⁺ = 402

(12) 1- [[[1-phenyl-2- (ethoxycarbonyl) ethyl] aminocarbonyl] methyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepine-7 -yl) - imidazolidin-2-one

Rf value: 0.57 (silica gel; methylene chloride / methanol / conc. Aqueous ammonia = 4: 1: 0.1) mass spectrum: M ⁺ = 478

(13) 1- [[[1- (3-pyridyl) -2- (ethoxycarbonyl) ethyl] aminocarbonyl] methyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH- 3-benzazepin-7-yl) imidazolidin-2-one x 0.5 H2O

R _f value: 0.62 (silica gel; methylene chloride / methanol / concentrated aqueous ammonia = 4: 1: 0.1) calc. : C 63.91 H 7.01 N 14.33 Found: 63.88 7.05 13.97

Example 17

Dry ampoule with 2.5 mg active ingredient per l ml

Composition:

Active ingredient 2.5 mg

Mannitol 50.0 mg Water for injections ad 1.0 ml

Manufacturing:

Active ingredient and mannitol are dissolved in water. After filling, freeze-drying is carried out. The dissolution to the ready-to-use solution takes place with water for injection purposes.

Example 18

Dry ampoule with 35 mg of active ingredient per 2 ml

Composition:

Active ingredient 35.0 mg

Mannitol 100.0 mg

Water for injections ad 2.0 ml

Manufacturing:

Active ingredient and mannitol are dissolved in water. After filling, freeze-drying is carried out.

The ready-to-use solution is dissolved with water for injection purposes.

Example 19

Tablet with 50 mg of active ingredient

Composition:

(1) Active ingredient 50.0 mg

(2) milk sugar 98.0 mg

(3) corn starch 50.0 mg

(4) Polyvinylpyrrolidone 15.0 mg

(5) Magnesium stearate 2.0 mσ

215.0 mg Manufacturing:

(1), (2) and (3) are mixed and granulated with an aqueous solution of (4). (5) is added to the dried granulate. Tablets are pressed from this mixture, biplan with facets on both sides and partial notch on one side. Tablet diameter: 9 mm.

Example 20

Tablet with 350 mg of active ingredient

Composition:

(1) Active ingredient 350.0 mg

(2) milk sugar 136.0 mg

(3) corn starch 80.0 mg

(4) polyvinyl pyrrolidone 30.0 mg

(5) Magnesium stearate 4.0 mg

600.0 mg

Manufacturing:

(1), (2) and (3) are mixed and granulated with an aqueous solution of (4). (5) is added to the dried granulate. Tablets are pressed from this mixture, biplan with facets on both sides and partial notch on one side. Tablet diameter: 12 mm.

Example 21

Capsules with 50 mg of active ingredient

Composition:

(1) Active ingredient 50.0 mg

(2) Corn starch dried 58.0 mg

(3) Milk sugar powdered 50.0 mg (4) Magnesium stearate 2.0 mg

160.0 mg

Manufacturing:

(1) is triturated with (3). This trituration is added to the mixture of (2) and (4) with intensive mixing.

This powder mixture is filled into size 3 hard gelatin capsules on a capsule filling machine.

Example 22

Capsules with 350 mg of active ingredient

Composition:

(1) Active ingredient 350.0 mg

(2) Corn starch dried 46.0 mg

(3) Milk sugar powdered 30.0 mg

(4) Magnesium stearate 4-0

430.0 mg

Manufacturing:

This powder mixture is filled in a size 0 hard gelatin capsule on a capsule filling machine.

Claims

claims

1. Cyclic urea derivatives of the general formula

with the provisos that

(ii) at least one of the radicals R 1 to R _{β has} no hydrogen atom,

(iii) Rg is a cyclopropyl group, an alkenyl group with 3 to 6 carbon atoms substituted by an aryl group or an alkynyl group with 3 to 6 carbon atoms optionally substituted by an aryl group, a heteroarylalkyl group with 1 to 3 carbon atoms in the alkyl part, a 2.2 , 2-trifluoroethyl group, an alkyl group through an alkoxy, cyano, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, amino, alkylamino, dialkylamino, alkylcarbonylamino, N-alkylalkylcarbonylamino, alkylsulfonylamino - or N-alkyl-alkylsulfonylamino group is substituted, an alkyl group having 2 to 4 carbon atoms which is substituted by a carboxy or alkoxycarbonyl group ', or an alkyl group having 3 or 4 carbon atoms which is substituted by a hydroxy group , (iv) D is a cycloalkylene group with 5 to 7 carbon atoms, optionally substituted by one or two alkyl groups, in which a> CH unit is replaced by a nitrogen atom and, moreover, one each in the 5- to 7-membered rings mentioned above a methylene group adjacent to a nitrogen atom can be replaced by a carbonyl group,

(v) E is a -CONH-alkylene, -CON (alkyl) -alkylene, -NHCO-alkylene or -N (alkyl) CO-alkylene group, the alkylene part of the above-mentioned groups each having one or two alkyl groups ¬ groups or can be substituted by an aryl or heteroaryl group, or an -N (Ri ₄ ) alkylene group, the alkyl part additionally having one or two alkyl groups each having 1 to 6 carbon atoms, one Alkenyl or alkynyl group each having 2 to 4 carbon atoms, by a hydroxy, amino, aryl or heteroaryl group, by an alkoxy or alkylamino group each having 1 to 6 carbon atoms, by a dialkylamino group having a total of 2 to 8 carbon atoms , can be substituted by an HN ₁₃ - or N-alkyl-NRi ₃ group,

(vi) R _{a is} not a hydrogen atom

A is a straight-chain alkylene or alkenylene group each having 2 to 3 carbon atoms, which can additionally be substituted by one or two alkyl groups, by a trifluoromethyl, aryl or arylalkyl group and in which a methylene group can also be replaced by a carbonyl group ,

a 1,2-cycloalkylene or 1,2-cycloalkenylene group each having 5 to 7 carbon atoms, each of which can be substituted by one or two alkyl groups, a 1,2-arylene group,

a -CO-NH or -NH-CO group, in which the hydrogen atom can in each case be replaced by an alkyl, aryl or arylalkyl group, or a -CH = N or -N-CH group, in which the hydrogen atom can in each case be replaced by an alkyl, trifluoromethyl, aryl or arylalkyl group,

R _a and R] -), which may be the same or different, a hydrogen, fluorine, chlorine, bromine or iodine atom, an alkyl, trifluoromethyl, alkoxy or cyano group,

R ₁ and R ₃ independently of one another each represent a hydrogen atom, an alkyl, aryl, hydroxy, alkoxy, cyano, carboxy, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl or dialkylaminocarbonyl group,

R together with R2 or R ₃ together with R _{4 also} each have an oxygen atom,

Rg is a hydrogen atom, an alkyl group with 1 to 8 carbon atoms, a cycloalkyl group with 3 to 7 carbon atoms, a cycloalkylalkyl group with 3 to 7 carbon atoms in the cycloalkyl part and 1 to 3 carbon atoms in the alkyl part, an alkenyl group optionally substituted by an aryl group with 3 to 6 carbon atoms, where the alkenyl group cannot be connected to the nitrogen atom via the vinyl part, an alkynyl group with 3 to 6 carbon atoms optionally substituted by an aryl group, the alkynyl group not having the nitrogen via the ethynyl part Substance atom can be connected, an arylalkyl or heteroaryl alkyl group each having 1 to 3 carbon atoms in the alkyl part, a hydroxyalkyl, alkoxyalkyl, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, alkylcarbonylaminoalkyl, N-alkylalkylcarbonylaminoalkyl, alkylsulfonylaminoalkyl , N-alkyl-alkylsulfonylaminoalkyl-, cyanoalkyl-, carboxyalkyl-, alkoxy- carbonylalkyl-, aminocarbonylalkyl-, N-alkylaminocarbonylalkyl-, N, N-dialkylaminocarbonylalkyl-, alkoxycarbonyl-, aryl- methyloxycarbonyl-, for yl-, acetyl- , Trifluoroacetyl, 2,2,2-trifluoroethyl, amidino or Rι ₀ CO-O- (11CR12) -0-CO- group, in the

R 2 _l is a hydrogen atom or an alkyl group,

D is an alkylene group,

an arylene group,

a cycloalkylene group with 5 to 7 carbon atoms optionally substituted by one or two alkyl groups, in which a> CH unit is replaced by a nitrogen atom, the ring nitrogen atom being linked to a carbon atom of group E, and also in the abovementioned 5- up to 7-membered rings each have a nitrogen atom neighboring methylene group can be replaced by a carbonyl group,

E is an alkylene group with 1 to 6 carbon atoms, through one or two alkyl groups, each with 1 to 6 carbon atoms, with an alkenyl or alkynyl group, each with 2 to 4 carbon atoms, with a hydroxy, amino, aryl or He¬ teroaryl group, by an alkoxy or alkylamino group each having 1 to 6 carbon atoms, by a dialkylamino group having a total of 2 to 8 carbon atoms, by an HNR ₁₃ - or N-alkyl-NRi ₃ group, where

or an alkylene group linked via the radical W to the radical D, in which W represents an oxygen or sulfur atom, a sulfonyl, sulfonyl or -NR ^ group, where

R ₁ 4 is a hydrogen atom, an alkyl group, a cycloalkyl, cycloalkylalkyl, cycloalkylcarbonyl or cycloalkylsulfonyl group each having 3 to 7 carbon atoms in the cycloalkyl part, an aryl, heteroaryl, arylalkyl, heteroarylalkyl, alkylcarbonyl Represents alkylsulfonyl, arylcarbonyl, heteroarylcarbonyl, arylsulfonyl or heteroarylsulfonyl group,

and the alkylene group additionally by one or two alkyl groups each having 1 to 6 carbon atoms, by an alkenyl or alkynyl group each having 2 to 4 carbon atoms, by a hydroxyl, amino, aryl or heteroaryl group, by one Alkoxy or alkylamino groups each having 1 to 6 Carbon atoms, can be substituted by a dialkylamino group with a total of 2 to 8 carbon atoms, by an -HNR ₁₃ - or N-alkyl-NR ₁₃ group, the hetero atom of the additional substituent being substituted by at least 2 carbon atoms from a hetero atom of the rest W is separated and ^R ₁₃ ^w: "- ^{e is} defined above,

or represent a RιgC0-0-CHRi7-0-C0 group., wherein

Rig an alkyl or alkoxy group each having 1 to 6 carbon atoms, a cycloalkyl or cycloalkoxy group each having 5 to 7 carbon atoms in the cycloalkyl part, an aryl, aryloxy, arylalkyl or arylalkoxy group and

R _l 7 represent a hydrogen atom or an alkyl group,

unless otherwise mentioned, among the aryl parts mentioned in the definition of the above radicals, a phenyl group which is monosubstituted by rig, mono-, di- or trisubstituted by R _i g or monosubstituted by R _i and additionally mon or disubstituted by R _i , where the substituents can be the same or different and

Rig a cyano, carboxy, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxycarbonyl, alkylcarbonyl, alkylsulfonyl, alkylsulfinyl, alkylsulfonyl, alkylsulfonyloxy, perfluoroalkyl, perfluoroalkoxy, nitro, Amino, alkylamino, dialkylamino, alkylcarbonylamino, phenylalkylcarbonylamino, phenylcarbonylamino, alkylsulfonylamino, phenylalkylsulfonylamino, phenylsulfonylamino, N, alkylalkylcarbonylamino, N-alkylphenylalkylcarbonylamino phenylcarbonylamino, N-alkyl-alkyl sulfonylamino, N-alkyl-phenylalkylsulfonylamino, N-alkylphenylsulfonylamino, aminosulfonyl, alkylaminosulfonyl or dialkylaminosulfonyl group and

among the arylene parts mentioned in the definition of the above radicals, a phenylene group which can be mono-substituted by Rig, mono- or disubstituted by Ri or monosubstituted by Rig and additionally monosubstituted by Rig, where the substituents can be the same or different and as above mentioned are defined

among the heteroaryl parts mentioned in the definition of the above radicals, a 5-membered heteroaromatic ring which contains an oxygen, sulfur or nitrogen atom, a nitrogen contains atom and one oxygen, sulfur or nitrogen atom or two nitrogen atoms and one oxygen, sulfur or nitrogen atom, or a 6-membered heteroaromatic ring which contains 1, 2 or 3 nitrogen atoms and in which additionally one or two - CH-N groups can each be replaced by a -CO-NH group, where

their tautomers, their stereoisomers and salts.

2. Cyclic urea derivatives of the general formula I according to claim 1, in which, with the exception of

1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (3-cyclopropyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidin-2-one,

1- [1- (2-Carboxyethyl) -4-piperidinyl] -3- (2,3,, 5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidin-2-one,

1- [1- (2-Carboxyethyl) -4-piperidinyl] -3- (3-methyl-2,3,4,5-tetra-hydro-lH-3-benzazepin-7-yl) imidazolidin-2- on and 1- [2- [(2-Carboxyethyl) aminocarbonyl] ethyl] -3- (2,3,4, 5-tetrahydro-IH-3-benzazepin-7-yl) -imidazolidin-2-one

and with the provisos that

(ii) at least one of the radicals Ri to Rg has no hydrogen atom,

(iii) Rg is a cyclopropyl group, an alkenyl radical having 3 to 6 carbon atoms substituted by an aryl group or an alkynyl radical having 3 to 6 carbon atoms optionally substituted by an aryl group, a heteroarylalkyl group having 1 to 3 carbon atoms in the alkyl part, a 2.2 , 2-trifluoroethyl group, an alkyl group through an alkoxy, cyano, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, amino, alkylamino, dialkylamino, alkylcarbonylamino, N-alkylalkylcarbonylamino, alkylsulfonylamino - or N-alkyl-alkylsulfonylamino group is substituted, an alkyl group with 2 to 4 carbon atoms which is substituted by a carboxy or alkoxycarbonyl group, or an alkyl group with 3 or 4 carbon atoms which is substituted by a hydroxy group,

(iv) D is a cycloalkylene group with 5 to 7 carbon atoms, optionally substituted by one or two alkyl groups, in which a> CH unit is replaced by a nitrogen atom and, moreover, one each in the 5- to 7-membered rings mentioned above a methylene group adjacent to a nitrogen atom can be replaced by a carbonyl group, (v) E is a -CONH-alkylene, -CON (alkyl) alkylene, - HCO-alkylene or -N (alkyl) CO-alkylene group, the alkylene part of the above-mentioned groups in each case having one or two alkyl groups ¬ groups or can be substituted by an aryl or heteroaryl group, or an -N (Rι ₄ ) alkylene group, the alkyl part additionally by one or two alkyl groups each having 1 to 6 carbon atoms, by one Alkenyl or alkynyl group each having 2 to 4 carbon atoms, by a hydroxy, amino, aryl or heteroaryl group, by an alkoxy or alkylamino group each having 1 to 6 carbon atoms, by a dialkylamino group having a total of 2 to 8 carbon atoms , can be substituted by an HNR ₃ - or N-alkyl-NR ₁₃ group, and

(vi) R _{a is} not a hydrogen atom

a 1,2-arylene group,

a -CO-NH or -NH-CO group, in which the hydrogen atom can in each case be replaced by an alkyl, aryl or arylalkyl group, or a -CH-N or -N-CH group, in which the hydrogen atom can in each case be replaced by an alkyl, trifluoromethyl, aryl or arylalkyl group, R _a and R ^, which may be the same or different, a hydrogen, fluorine, chlorine, bromine or iodine atom, an alkyl, trifluoromethyl, alkoxy or cyano group,

R2, R ₄ R _ß and Rg each independently represent a hydrogen atom or an alkyl group or

R ₁ together with R ₂ or R3 together with R ₄ each also have an oxygen atom,

Rg is a hydrogen atom, an alkyl group with 1 to 8 carbon atoms, a cycloalkyl group with 3 to 7 carbon atoms, a cycloalkylalkyl group with 3 to 7 carbon atoms in the cycloalkyl part and 1 to 3 carbon atoms in the alkyl part, an alkenyl group optionally substituted by an aryl group with 3 to 6 carbon atoms, whereby the alkenyl group cannot be connected to the nitrogen atom via the vinyl part, an alkynyl group with 3 to 6 carbon atoms optionally substituted by an aryl group, the alkynyl group not with the stick part via the ethynyl part Substance atom can be connected, an arylalkyl or heteroaryl alkyl group each having 1 to 3 carbon atoms in the alkyl part, a hydroxyalkyl, alkoxyalkyl, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, alkylcarbonylaminoalkyl, N-alkylalkylcarbonylaminoalkyl, alkylsulfonylaminoalkyl -, N-Alkyl- alkylsulfonylaminoalkyl-, cyanoalkyl-, carboxyalkyl-, alkoxy- c arbonylalkyl, aminocarbonylalkyl, N-alkylaminocarbonylalkyl, N, N-dialkylaminocarbonylalkyl, alkoxycarbonyl, aryl methyloxycarbonyl, formyl, acetyl, trifluoroacetyl,

2,2,2-trifluoroethyl, amidino or RI _Q CO-O- (R ₁₁ CR ₁₂ ) -O-CO-

Group in which

R 2 _l is a hydrogen atom or an alkyl group,

D is an alkylene group,

an arylene group,

E is an alkylene group with 1 to 6 carbon atoms, through one or two alkyl groups, each with 1 to 6 carbon atoms, with an alkenyl or alkynyl group, each with 2 to 4 carbon atoms, with a hydroxy, amino, aryl or He¬ teroaryl group ', by an alkoxy or alkylamino group each having 1 to 6 carbon atoms, by a dialkylamino group pe with a total of 2 to 8 carbon atoms, can be substituted by an HNR ₁₃ - or N-alkyl-NR ₃ group, where

R ₁ 3 is an alkylcarbonyl or alkylsulfonyl group each having 1 to 6 carbon atoms in the alkyl part, an alkyloxycarbonyl group having a total of 2 to 5 carbon atoms, a cycloalkylcarbonyl or cycloalkylsulfonyl group each having 5 to 7 carbon atoms in the cycloalkyl part, an arylalkylcarbonyl, arylalkylsulfonyl group Represents arylalkoxycarbonyl, arylcarbonyl or arylsulfonyl group,

or an alkylene group linked via the radical W to the radical D, in which W represents an oxygen or sulfur atom, a sulfonyl, sulfonyl or -NR1 ₄ group, where

and the alkylene group additionally by one or two alkyl groups each having 1 to 6 carbon atoms, by an alkenyl or alkynyl group each having 2 to 4 carbon atoms, by a hydroxyl, amino, aryl or heteroaryl group, by one Alkoxy or alkylamino groups each having 1 to 6 carbon atoms, by a dialkylamino group having a total of 2 to 8 carbon atoms, can be substituted by a.-HNRi ₃ - or N-alkyl-N 13 group, the hetero atom of the additional substituent being substituted at least 2 carbon atoms are separated from a heteroatom of the radical W and R _{13 is} as defined above,

a -CONH-alkylene, -CON (alkyl) alkylene, -NHCO-alkylene or -N (alkyl) CO-alkylene group, the alkylene part of the above groups mentioned may in each case be substituted by one or two alkyl groups or by an aryl or heteroaryl group, and

or represent a RigCO-O-CHR ^ -O-CO group, where

R _{17 represents} a hydrogen atom or an alkyl group,

unless otherwise mentioned,

Among the aryl parts mentioned in the definition of the above radicals, a phenyl group which is monosubstituted by rig, mono-, di- or tri-substituted by rig or monosubstituted by rig and additionally mono- or disubstituted by rig, where the substituents can be the same or different and

Rig a cyano, carboxy, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxycarbonyl, alkylcarbonyl, alkylsulfenyl, alkylsulfinyl, alkylsulfonyl, AI kylsulfonyloxy, perfluoroalkyl, perfluoroalkoxy, nitro, amino, alkylamino, dialkylamino, alkylcarbonylamino, phenylalkylcarbonylamino, phenylcarbonylamino, alkylsulfonylamino, phenylalkylsulfonylamino, phenylsulfonylamino, noyl N-alkyl-phenylalkyl-carbonylamino, N-alkyl-phenylcarbonylamino, N-alkyl-alkyl-sulfonylamino, N-alkyl-phenylalkylsulfonylamino, N-alkyl-phenylsulfonyl-amino, aminosulfonyl, alkylaminosulfonyl or dialkylaminosulfonyl group and

Ri represents an alkyl, hydroxyl or alkoxy group, a fluorine, chlorine, bromine or iodine atom, with two radicals Rig, if these are bonded to adjacent carbon atoms, also an alkylene group with 3 to 5 carbon atoms, a 1,3- Can represent butadiene-1,4-diylene group or a methylenedioxy group,

among the arylene parts mentioned in the definition of the above radicals, a phenylene group which can be monosubstituted by Rig, mono- or disubstituted by Ri or monosubstituted by Rig and additionally monosubstituted by Ri, where the substituents can be the same or different and as above mentioned are defined

the heteroaromatic rings mentioned above by one or two alkyl groups or on the carbon skeleton also by one Fluorine, chlorine, bromine or iodine atom, which may be substituted by a hydroxyl or alkoxy group,

is to be understood, and, unless stated otherwise, the alkyl, alkylene or alkoxy parts mentioned above may each contain 1 to 4 carbon atoms, and each carbon atom in the above-mentioned alkylene and cycloalkylene parts with at most one heteroatom is linked

their tautomers, their stereoisomers and salts.

3. Cyclic urea derivatives of the general formula I according to claim 1, in which, with the exception of

1- [1- (2-carboxyethyl) -4-piperidinyl] -3- (2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) imidazolidin-2-one,

1- [1- (2-Carboxyethyl) -4-piperidinyl] -3- (3-methyl-2,3,4,5-tetra hydro-lH-3-benzazepin-7-yl) imidazolidin-2-one and

and with the provisos that

(i) A is a -CH2CH2, -CH2CH2CH2, -CH2CO or -COCH2 group, each of which is substituted by one or two methyl groups, or a -C (CH3) = N group, (ii) at least one of the radicals R to Rg has no hydrogen atom,

(iii) Rg is a cyclopropyl, cinnamyl or 2,2,2-trifluoroethyl group, an alkynyl group with 3 or 4 carbon atoms, a pyridylalkyl group with 1 to 3 carbon atoms in the alkyl part or an alkyl group which is substituted by an alkoxy, cyano , Amino¬ carbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, amino, alkylamino, dialkylamino, alkylcarbonylamino, N-alkyl-alkylcarbonylamino, alkylsulfonylamino or N-alkyl-alkylsulfonylamino group is substituted, an alkyl group having 2 to 4 Carbon atoms which are substituted by a carboxy or alkoxycarbonyl group or an alkyl group having 3 or 4 carbon atoms which is substituted by a hydroxyl group,

(v) E is an -N (Rι ₄ ) alkylene, -CONH-alkylene or -CON (alkyl) alkylene group group, in each of which the alkylene part is straight-chain and in each case by an alkyl, pyridyl, Pyridazinyl, pyrimidinyl or pyrazinyl group or can be substituted by an optionally substituted phenyl group,

(vi) Ra no hydrogen atom

A a -CH ₂ CH ₂ -, -CH ₂ CH ₂ CH2-, -CH = CH-, -CH ₂ C0- or

-COCH2 group, which can each be substituted by one or two methyl groups,

a -CH = N- or -N-CH group, in each of which the hydrogen atom can be replaced by a methyl group, R _{a is} a hydrogen, fluorine, chlorine, bromine or iodine atom, a methyl, trifluoromethyl, methoxy or cyano group,

R_, a hydrogen atom,

R together with R ₂ or R ₃ together with R _{4 also} each have an oxygen atom,

R 5 and R ₇ each independently represent a hydrogen atom, an alkyl, phenyl, carboxy, alkoxycarbonyl, Aminocarbon¬ yl, alkylaminocarbonyl or dialkylaminocarbonyl group,

Rg is a hydrogen atom, an alkyl group with 1 to 6 carbon atoms, a cycloalkyl group with 3 to 7 carbon atoms, a cycloalkylalkyl group with 3 to 7 carbon atoms in the cycloalkyl part and 1 to 3 carbon atoms in the alkyl part, an alkenyl group optionally substituted by a phenyl group with 3 to 6 carbon atoms, where the alkenyl group cannot be connected to the nitrogen atom via the vinyl part, an alkynyl group with 3 or 4 carbon atoms, where the alkynyl group cannot be connected to the nitrogen atom via the ethynyl part, or a phenylalkyl or pyridylalkyl group in each case 1 to 3 carbon atoms in the alkyl part, one hydroxyalkyl, alkoxyalkyl, carboxyalkyl, alkoxycarbonylalkyl, aminocarbonylalkyl, alkylaminocarbonylalkyl, dialkylaminocarbonylalkyl, 2,2,2-trifluoroethyl, alkoxycarbonyl, phenylmethyloxycarbonyl, formyl, Acetyl or trifluoroacetyl group or an alkyl group through a Amino, alkylamino, dialkylamino, cyano, alkylcarbonylamino, N-alkylalkylcarbonylamino, alkylsulfonylamino or N-alkylalkylsulfonylamino group,

D is an alkylene group,

a 1,4-phenylene group,

a 1,4-cyclohexylene group optionally substituted by one or two methyl groups,

a straight-chain alkylene group linked via the radical W to the radical D, in which W represents an oxygen or sulfur atom, a sulfinyl, sulfonyl or -NR1 ₄ group, the alkylene part being substituted by an alkyl, phenyl or pyridyl group -, Pyridazinyl-, Pyrimidinyl- or Pyrazinylgruppe can be substituted and

R _{14 is} a hydrogen atom, an alkyl group, a cycloalkyl, cycloalkylalkyl, cycloalkylcarbonyl or cycloalkylsulfonyl group each having 3 to 7 carbon atoms in the cycloalkyl part, a phenylalkyl, pyridylalkyl, alkylcarbonyl, alkylsulfonyl, phenylcarbonyl or phenylsulfonyl group each represents 1 to 3 carbon atoms in the alkyl parts of the cycloalkylalkyl, phenylalkyl and pyridylalkyl group,

a -CONH-alkylene or -C0N (alkyl) alkylene group group, in each of which the alkylene part is straight-chain and can in each case be substituted by an alkyl, phenyl, pyridyl, pyridazinyl, pyrimidinyl or pyrazinyl group, F is a carbonyl group which is substituted by a hydroxyl group or by an alkoxy group having 1 to 6 carbon atoms or by a cycloalkoxy group having 5 to 7 carbon atoms,

the phenyl parts of the groups mentioned above can each be substituted by a fluorine, chlorine or bromine atom, by a methyl, trifluoromethyl, hydroxyl or methoxy group,

their tautomers, their stereoisomers and salts.

4. Cyclic urea derivatives of the general formula I according to claim 1, in which, with the exception of

2- [trans-4- (2-carboxyethyl) cyclohexyl] -4- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) -5-methyl-4H -1,2,4-triazol-3-one,

1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (3-cyclopropyl-2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2-one, 1- [1- (2-carboxyethyl) - -piperidinyl] -3- (2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) -imidazolidin-2-one,

1- [2- [(2-Carboxyethyl) aminocarbonyl] ethyl] -3- (2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) -imidazolidin-2-one

and with the provisos that

(i) A is a -CH2CH ₂ -, -CH CO- or -COCH group, each of which is substituted by one or two methyl groups, or a -C (CH3) = N group,

(ii) at least one of the radicals Ri to Rg has no hydrogen atom,

(iii) Rg is cyclopropyl, propargyl, cinnamyl, pyridylmethyl, 2-carboxyethyl, 2- (Ci.4-alkoxycarbonyl) ethyl,

2- (aminocarbonyl) ethyl, 2- (methylaminocarbonyl) ethyl, 2- (dimethylaminocarbonyl) ethyl, 2-cyanoethyl, 2-methoxyethyl,

2-aminoethyl, 2- (methylamino) ethyl, 2- (dirnethylamino) ethyl.

3-hydroxypropyl, 3-aminopropyl, 3- (methylamino) propyl,

(iv) D is a 1,4-piperidinylene group,

(v) E is a -N (Ri ₄ ) -CH ₂ group, in which the -CH ₂ ~ group can be substituted by a methyl, phenyl or pyridyl group, or

a -CONHCH ₂ -, -CON (CH ₃ ) CH ₂ -, -CONHCH ₂ CH ₂ - or

-CON (CH3) CH2CH ₂ group, in which the alkylene part can in each case be substituted by a methyl, phenyl or pyridyl group, (vi) R _{a is} a fluorine or chlorine atom

A is a -CH ₂ CH2, -CH2CO or -COCH2 group which can in each case be substituted by one or two methyl groups,

R _{a is} a hydrogen, fluorine or chlorine atom,

R_, a hydrogen atom,

R ₁ and R ₃ independently of one another each represent a hydrogen atom, a methyl, phenyl, hydroxy, methoxy, cyano, carboxy, methoxycarbonyl, ethoxycarbonyl, aminocarbonyl, methylamino carbonyl or dimethylaminocarbonyl group,

2 » ^R ₄ ^R ₆ ^{and R} ₈ each independently of one another are a hydrogen atom or a methyl group or

R _l together with R2 or R3 together with R ₄ each also have an oxygen atom,

R5 and R7 independently of one another each represent a hydrogen atom, a methyl, phenyl, carboxy, methoxycarbonyl, ethoxycarbonyl, aminocarbonyl, methylaminocarbonyl or dimethylaminocarbonyl group,

Rg is a hydrogen atom, an alkyl group with 1 to 4 carbon atoms, a cycloalkyl group with 3 to 6 carbon atoms, an allyl group optionally substituted in the 3-position by a phenyl group or one or two methyl groups, a propargyl, 2-carboxyethyl, 2- (Ci. ₄ -alkoxycarbonyl) ethyl, 2- (aminocarbonyl) ethyl, 2- (methylaminocarbonyl) ethyl, 2- (dimethylaminocarbonyl) ethyl, 2-cyanoethyl, 2-methoxyethyl, 2-aminoethyl, 2- (methylamino) ethyl, 2- (dimethylamino) ethyl. 3-hydroxypropyl-, 3-aminopropyl-, 3- (methyl¬ amino) propyl-, 3- (dimethylamino) propyl-, 3- (acetylamino) propyl-, 3- (methanesulfonylamino) propyl-, 2,2,2 Trifluoroethyl or pyridylmethyl group,

D is a methylene, ethylene or 1,4-phenylene group,

a 1,4-cyclohexylene group or

a methylene group linked via the radical W to the radical D, in which W represents an oxygen atom or an -NR1 ₄ group, where the methylene group can be substituted by a methyl, phenyl or pyridyl group, and

R _{14 is} a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, a cycloalkyl, cycloalkylcarbonyl or cycloalkylsulfonyl group each having 3 to 6 carbon atoms in the cycloalkyl part, a benzyl, alkylcarbonyl or alkylsulfonyl group each having 1 to 4 carbon atoms in the alkyl part represents a phenylcarbonyl or phenylsulfonyl group,

a -CONHCH ₂ -, -CON (CH ₃ ) CH ₂ -, -C0NHCH ₂ CH ₂ - or -C0N (CH ₃ ) CH2CH2 group, where the alkylene part of the above-mentioned groups each by a methyl, phenyl or pyridyl group can be substituted, and F represents a carbonyl group which is substituted by a hydroxyl group or by an alkoxy group having 1 to 4 carbon atoms,

their tautomers, their stereoisomers and salts,

5. Cyclic urea derivatives of the general formula I according to claim 1, in which, with the exception of

and with the provisos that

(i) A is a -CH ₂ CO group substituted by one or two methyl groups or a -C (CH ₃ ) = N group, (ii) Rg is a cyclopropyl, cinnamyl, propargyl, 2,2,2-trifluoroethyl, 2-carboxyethyl, 2- (tert-butyloxycarbonyl) ethyl or 2-cyanoethyl group,

(iii) D is a 1,4-piperidinylene group,

(iv) E is a -N (Ri4) -CH2 group or a -CONHCH2CH2 group, in which the ethylene part can be substituted by a methyl, phenyl or pyridyl group,

(v) Ri or R2 or Ri and R2 is a methyl group,

(vi) R _{a is} a fluorine atom

A is a -CH2-CH2 group, a -C ^ CO group substituted by one or two methyl groups or a -C (CH3) = N group,

R _{a is} a hydrogen or fluorine atom,

R_, a hydrogen atom,

_R1 and R2, which may be the same or different, each represent a hydrogen atom or a methyl group,

R3 to Rg each represent a hydrogen atom,

D is a -CH ₂ - -CH ₂ CH2, 1,4-cyclohexylene group or

a 1,4-piperidinylene group, the ring nitrogen atom being linked to a carbon atom of group E, E is a -CH2 ~ group, a -CH2CH2 group optionally substituted by a methyl group or a -CONHCH2CH2 group, in which the ethylene part can be substituted by a methyl, phenyl or pyridyl group,

a -NR1 ₄ -CH2- group linked via the nitrogen atom to the 1,4-cyclohexylene group of the radical D, where

the shortest distance between the radical F and the nitrogen atom substituted by R is at least 11 bonds,

their tautomers, their stereoisomers and salts.

6. The following cyclic urea derivatives of the general formula I according to claim 1:

(1) 1- [trans-4- (carboxymethylamino) cyclohexyl] -3- (2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl) -imidazolidin-2-one,

(2) 1- [trans-4- (N-methyl-N-carboxymethylamino) cyclohexyl] -

3- (2,3,4, 5-tetrahydro-IH-3-benzazepin-7-yl) imidazolidin-2-one,

(3) 1- [trans-4- (N-benzyl-N-carboxymethylamino) cyclohexyl] -

3- (2,3,4,5-tetrahydro-lH-3-benzazepin-7-yl) imidazolidin-2-one,

(4) 1- [trans-4- (N-methyl-N-carboxymethylamino) cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-IH-3-benzazepin-7-yl ) -imidazoli- din-2-one, (5) 1- [trans-4- (N-benzyl-N-carboxymethylamino) cyclohexyl] -3- (3-methyl-2, 3,4, 5-tetrahydro-lH-3-benzazepin-7-yl ) -imidazoli- din-2-one,

(7) 1- [trans-4- (N-acetyl-N-carboxymethylamino) cyclohexyl] -3- (3-methyl-2, 3,4, 5-tetrahydro-IH-3-benzazepin-7-yl ) -imidazoli- din-2-one,

their tautomers, their stereoisomers and salts.

7. Physiologically compatible salts of the compounds according to at least one of claims 1 to 6 with inorganic or organic acids or bases.

8. Medicament containing a compound according to at least one of claims 1 to 6 or a physiologically tolerable salt according to claim 7 in addition to optionally one or more inert carriers and / or diluents.

9. Use of a compound according to at least one of claims 1 to 7 for the manufacture of a medicament which is suitable for combating or preventing diseases in which smaller or larger cell aggregates occur or cell matrix interactions play a role .

10. A process for the preparation of a medicament according to claim 8, characterized in that a compound according to at least one of claims 1 to 7 is incorporated into one or more inert carriers and / or diluents by a non-chemical route.

11. A process for the preparation of the compounds of general formula I according to claims 1 to 7, characterized in that a) for the preparation of compounds of general formula I, in which Rg is as defined in claims 1 to 6 and F represents a carboxyl group or F is defined in claims 1 to 6 and Rg represents a hydrogen atom, a compound of general formula

in the

A, D, E, Ri to Rg, R _a and R_, with the proviso as defined in claims 1 to 6 that F ^{1 has} the meanings mentioned for F in claims 1 to 6 and Rg one by means of hydrolysis , Treatment with an acid or base, thermolysis or hydrogenolysis cleavable protective residue for an imino group or

Rg 'has the meanings mentioned for Rg in Claims 1 to 6 and F' denotes a group which can be converted into a carboxyl group by means of hydrolysis, treatment with an acid or base, thermolysis or hydrogenolysis,

into a compound of the general formula I in which Rg is as defined in claims 1 to 6 and F represents a carboxyl group or F as defined in claims 1 to 6 and Rg represents a hydrogen atom, by hydrolysis, treatment with a Acid or base, thermolysis or hydrogeolysis is converted into a corresponding compound of the general formula I or

b) for the preparation of compounds of the general formula I in which A is a straight-chain alkylene group having 2 to 3 carbon atoms Substance atoms which can additionally be substituted by one or two alkyl groups, by a trifluoromethyl, aryl or arylalkyl group and in which a terminal methylene group is additionally replaced by a carbonyl group, a compound of the general formation which may be formed in the reaction mixture my formula

in the

R ₁ to Rg, R _a , R] - ,, D, E and F are as defined in claims 1 to 6, one of the radicals Ui or U2 is a hydrogen atom and the other of the radicals Ui or U is optionally one or two Alkyl groups, substituted by a trifluoromethyl, aryl or arylalkyl group, straight-chain alkylene group having 2 to 3 carbon atoms, in which a terminal methylene group is replaced by a Zi-CO group, Zi being a nucleophilic leaving group, is cyclized or

c) For the preparation of compounds of the general formula I in which Rg is one of the optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl radicals mentioned in the definition of the radical Rg in claims 1 to 6, Represents arylalkyl or heteroarylalkyl radicals, a compound of the general formula

in the

Rl to Rg, R _a , R_ ,, A, D, E and F as defined in claims 1 to 6, with a compound of the general formula

Z ₂ - R20, (V)

in the

R20 is an alkyl group with 1 to 8 carbon atoms, a cycloalkyl group with 3 to 7 carbon atoms, a cycloalkylalkyl group with 3 to 7 carbon atoms in the cycloalkyl part and up to 3 carbon atoms in the alkyl part, an alkenyl group with 3 to 6 carbon atoms which is optionally substituted by an aryl group , where the alkenyl group cannot be connected to the nitrogen atom via the vinyl part, an alkynyl group having 3 to 6 carbon atoms optionally substituted by an aryl group, where the alkynyl group cannot be connected to the nitrogen atom via the ethynyl part, an arylalkyl or heteroarylalkyl group each having 1 up to 3 carbon atoms in the alkyl part, a hydroxyalkyl, alkoxyalkyl, 2,2,2-trifluoroethyl, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, alkylcarbonylaminoalkyl, N-alkylalkylcarbonylaminoalkyl, alkylsulfonylaminoalkyl, N-alkyl-alkylsulfonylaminoalkyl, cyanoalkyl, carboxyalkyl, alkoxycarbonyl alkyl, aminocarbonylalkyl, N-alkylaminocarbonylalkyl or N, N-dialkylaminocarbonylalkyl group in which the aryl part and the alkyl parts are as defined at the beginning, and Z2 is a nucleophilic leaving group or

Z2 together with an adjacent hydrogen atom of the radical R20 represent an oxygen atom, is reacted or d) for the preparation of compounds of the general formula I in which F represents a carbonyl group which is substituted by an alkoxy group having 1 to 8 carbon atoms, by an arylalkoxy group or by an R ^ O group, a carboxylic acid of the general formula

in the

Rl to Rg, R _a , Rfc, A, D, and E as defined in claims 1 to 6, or their reactive derivatives optionally prepared in the reaction mixture with an alcohol of the general formula

HO - R _2i , (VII)

in the

R21 is an alkyl group of 1 to 8 carbon atoms, one

Arylalkyl group or an R15 group, wherein

Rl5 represents a cycloalkyl group with 4 to 7 carbon atoms or a cycloalkylalkyl group with 3 to 7 carbon atoms in the cycloalkyl part, a benzocycloalkyl group with 9 to 12 carbon atoms or an aryl group,

mean, is implemented or

e) for the preparation of compounds of general formula I, in which F represents a RI _Q CO-O- (11CR12) -O-CO group, a carboxylic acid of the general formula

in the

R ₁ to Rg, R _a , Rb, A, D, and E as defined in claims 1 to 6, with a compound of the general formula

Z ₃ - R ₂ 2, (VIII)

in the

R22 is a RIQCO-O- (R1 ₁ CR12) group, Rio to R12 as in de

Claims 1 to 6 are defined mentioned, and

Z3 represents a nucleophilic leaving group, is implemented or

f) for the preparation of compounds of general formula I, in which Rg represents an alkyl group having 2 carbon atoms, in the 2-position by a cyano, carboxy, alkoxycarbonyl, aminocarbonyl, N-alkylaminocarbonyl or N, N-dialkylaminocar - Bonyl group is substituted, a compound of the general formula

in the

R _l to Rg, R _a , RJ- _J , A, D, E and F are as defined in claims 1 to 6,

is reacted with an ethylene which is substituted by a cyano, carboxy, alkoxycarbonyl, aminocarbonyl, N-alkylaminocarbonyl or N, N-dialkylaminocarbonyl group or

g) for the preparation of compounds of the general formula I in which A represents a —CH = N or —N-CH group which is optionally substituted by an alkyl, trifluoromethyl, aryl or arylalkyl group, an optionally formed in the reaction mixture Compound of the general formula

in the

R ₁ to Rg, R _a , R_ ,, D, E and F are as defined in claims 1 to 6, one of the radicals U3 or U _{4 is} a hydrogen atom and the other of the radicals U3 or U4 is an R2 ₃ -CO-NH Group mean, where R2 _{3 is} a hydrogen atom, an alkyl, trifluoromethyl,

Aryl or aralkyl group, is cyclized or

h) for the preparation of compounds of the general formula I in which A represents a straight-chain alkylene group having 2 or 3 carbon atoms, which can additionally be substituted by one or two alkyl groups, by a trifluoromethyl, aryl or arylalkyl group , a compound of the general formula optionally formed in the reaction mixture

in the

R ₁ to Rg, R _a , R] -, D, E and F are as defined in claims 1 to 6, mine of the radicals U5 or Ug is a hydrogen atom and the other of the radicals U5 or Ug is optionally by one or two

Alkyl groups, straight-chain alkylene group with 2 or 3 substituted by a trifluoromethyl, aryl or aralkyl group

Carbon atoms mean, which is additionally substituted at the end by a nucleophilic leaving group, is cyclized or

i) for the preparation of compounds of the general formula I in which D represents a cycloalkylene group with 5 to 7 carbon atoms optionally substituted by one or two alkyl groups, in which a> CH unit is replaced by a nitrogen atom and also in those mentioned above 5- to 7- membered rings each a methylene group adjacent to a nitrogen atom can be replaced by a carbonyl group, a compound of the general formula

in the R _l to Rg, R _a , Rb and A are as defined in claims 1 to 6 and

D 'represents a cycloalkylene group with 5 to 7 carbon atoms, optionally substituted by one or two alkyl groups, in which a> CH unit is replaced by a nitrogen atom, the ring nitrogen atom being linked to a hydrogen atom and also in the above 5- to 7- membered rings each a methylene group adjacent to a nitrogen atom can be replaced by a carbonyl group, with a compound of the general formula

Z ₅ -E'-F, (XII)

or with a compound of the general formula

CH ₂ = CH-F, (XIII)

in which

F is as defined in claims 1 to 6, E 'is an alkylene group having 1 to 6 carbon atoms, which is separated by one or two alkyl groups each having 1 to 6 carbon atoms, by an alkenyl or alkynyl group each having 2 to 4 carbon atoms a hydroxyl, amino, aryl or heteroaryl group, by an alkoxy or alkylamino group each having 1 to 6 carbon atoms, by a dialkylamino group having a total of 2 to 8 carbon atoms, by an HNR13 or N-alkyl NRi ₃ -Group can be substituted, wherein R1 _{3 is} as defined in claims 1 to 6, Z5 is a nucleophilic leaving group and additionally the vinyl group in a compound of general formula XIII by one or two alkyl groups each having 1 to 6 carbon atoms, by an alkenyl - or alkynyl group each having 2 to 4 carbon atoms, which may be substituted by an aryl or heteroaryl group, is reacted or

j) for the preparation of compounds of the general formula I in which A is one of the straight represents chain alkenylene groups with 2 or 3 carbon atoms, which can additionally be substituted by one or two alkyl groups, by a trifluoromethyl, aryl or arylalkyl group, a compound of the general formula which may be formed in the reaction mixture

in the

R ₁ to Rg, * -a 'Rb-D, E and F are defined as in claims 1 to 6, one of the radicals U ₇ or Ug represents a hydrogen atom and the other of the radicals U ₇ or Ug one in the alkylidene part ¬ denoted by one or two alkyl groups, substituted by a trifluoromethyl, aryl or aralkyl group - (CH2) _m HC ⁽ OR2 ₄ ) 2- ^Gru PP ^e , where

m is the number 1 or 2 and

R2 _{4 represents} an alkyl group with 1 to 4 carbon atoms,

we cyclize or

k) for the preparation of compounds of general formula I in which E is a -CONH-alkylene, -CON (alkyl) alkylene, -NHCO-alkylene or -N (alkyl) CO-alkylene group which is optionally substituted in the alkylene part represents a compound of the general formula

with an amine of the general formula

HNR25 ~ ^E "(XVI)

or an amine of the general formula

with a carboxylic acid of the general formula

HOOC - E "- F (XVIII)

in which

R ₁ to Rg, R _a , Rb, A, D and F are as defined in claims 1 to 6,

E "an optionally substituted alkylene group as mentioned in claims 1 to 6,

R ₂ 5 and R2 ₆ 'di may be the same or different, each represent a hydrogen atom or an alkyl group, or is reacted with their reactive derivatives and if desired, a compound of the general formula I thus obtained, in which R1 _{4 represents} a hydrogen atom, is converted by acylation or sulfonation into a corresponding compound of the general formula I in which R1 _{4 is} an alkylcarbonyl, alkylsulfonyl, cycloalkylcarbonyl, cycloalkylsulfonyl Represents arylcarbonyl, heteroarylsulfonyl or heteroarylcarbonyl group, and / or

if necessary, a protective residue used in the implementations described above is split off again and / or

if desired, a compound of the general formula I thus obtained is separated into its stereoisomers and / or

a compound of the general formula I thus obtained is converted into its salts, in particular for its pharmaceutical use into its physiologically tolerable salts.